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ABSTRACT 
 
Paediatric HIV remains one of the most significant challenges to face children, their 
families and their health care providers in South Africa. The prevalence rate of paediatric 
HIV infection in South Africa is set to remain high until such time as universal access to 
antiretrovirals for prevention of mother to child transmission is achieved, and the mother 
to child transmission rates of HIV start to come down. 
 
HIV is neurotrophic and is known to invade the developing central nervous system and 
cause widespread damage. The result of this is a well described encephalopathy which 
has the potential to affect all facets of development. 
 
Children in South Africa who are infected with HIV are vulnerable to a number of factors 
which may cause developmental delay. Poverty and malnutrition are likely to exacerbate 
the developmental delay caused by HIV encephalopathy. Physiotherapists in South 
Africa have not become involved in the long term management of children infected with 
HIV and paediatric HIV clinics do not routinely offer any rehabilitation services. 
 
The prevalence and extent of developmental delay in HIV infected children in South 
Africa has not been established. Despite the fact that a number of studies have 
highlighted the prevalence of developmental delay in Western countries, no intervention 
studies addressing this problem could be found. 
 
Caregivers of HIV infected children face numerous stressors. Poverty, stigma and their 
own health care needs make parenting an HIV positive child even more challenging. 
The needs of caregivers of HIV infected children have not been well researched in the 
context of developing countries. 
 
The aim of this study was therefore to establish whether a basic home stimulation 
programme would have any impact on the neurodevelopmental status of young children 
infected with HIV, and on the parenting stress levels of their caregivers. Further 
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objectives of the study were to establish the prevalence and progression of 
developmental delay in HIV infected children; to monitor the effect of antiretrovirals on 
neurodevelopment; to determine who the caregivers of HIV infected children were and 
to determine what factors were predictive of neurodevelopmental status and parenting 
stress levels. 
 
In order to meet these objectives a longitudinal randomized controlled trial was 
conducted. One hundred and twenty two HIV positive children, under two and a half 
years of age, were recruited for this study at Harriet Shezi Children’s Clinic at Chris Hani 
Baragwanath Hospital in Soweto.  
 
Children were randomly assigned to a control or an experimental group. The 
developmental status of all children was monitored over a year using the Bayley Scales 
of Infant Development II. Parenting stress was monitored with the Parenting Stress 
Index/Short Form. Children in the experimental group received a basic home stimulation 
programme, which was updated every three months when they came to visit the clinic, 
as well as all the usual clinic services. Children in the control group received all the 
usual services at the clinic but no stimulation programme. 
 
Most of the children in the sample were cared for by their biological mothers. They came 
from poor homes with limited access to common household amenities. Most of the 
caregivers had not completed 12 years of schooling. 
 
The children in the control and experimental groups were well matched for all their 
baseline measurements and demographic characteristics. At baseline the children were 
wasted and stunted and had very low CD4 counts. Only 16% of the children were on 
antiretrovirals at baseline assessment. The children were severely delayed with respect 
to both motor and cognitive development. The parenting stress levels of the caregivers 
were very high at baseline. 
 
Over the period of one year the children in the experimental group showed a 
significantly greater improvement in cognitive (p=0.01) and motor (p=0.02) development 
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when compared to children in the control group. Although the children improved, they 
still had a degree of developmental delay at the end of the study period. 
 
The parenting stress levels decreased significantly for caregivers in both the control and 
the experimental groups (p<0,001), but there was no significant difference between the 
two groups (p=0.057). 
 
The groups were well matched at all time points for anthropometric measures and CD4 
counts with no significant differences being found. There was also no difference in the 
number of children on antiretroviral therapy between the groups at any time. 
 
Children who were antiretroviral naïve at the start of the study and then started highly 
active antiretroviral therapy showed a significant improvement in motor development 
(p<0.001), but no improvement in cognitive development (p=0.77). 
 
A combination of a number of factors was predictive of developmental status. This 
included growth parameters, CD4 counts and the age of the child. Being in the 
experimental group and being older at baseline assessment were important predictors of 
improvement in MDI and PDI over time. Parenting stress was predicted by a number of 
factors, including educational level of the caregiver, type of housing and the number of 
children in the household. A decrease in parenting stress was most likely in caregivers 
who were better educated and who lived in households with fewer adults. 
 
These results signify that a basic home programme can significantly improve both the 
cognitive and motor development of young children infected with HIV. This programme 
was simple and easily implemented and should become standard practice at paediatric 
HIV clinics in South Africa. The current protocol for administering antiretrovirals in South 
Africa allowed for motor, but not cognitive improvement in young children commencing 
treatment. Parenting stress was not affected by the addition of a basic home stimulation 
programme. 
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The psychosocial and developmental needs of South African children infected with HIV 
are complex and multifaceted. Further research is needed to establish the best possible 
interventions for these children and their families. 
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Chapter 1 
INTRODUCTION 
 
1.1 Paediatric HIV in South Africa 
More than twenty years after it was first diagnosed, HIV remains a major global health 
problem. Sub-Saharan Africa is the region that has been most severely affected by HIV 
and continues to have the highest prevalence of HIV in the world (Lau and Muula, 
2004). At present there are approximately one million children in Sub-Saharan Africa 
infected with HIV, this accounts for over 90% of the HIV infected children in the world 
(UNAIDS report, 2005). In Southern Africa HIV related illness has become the leading 
cause of death in children less than five years of age (Brown et al, 2000). 
 
Despite being one of the better resourced countries in the region with a relatively well 
developed health care system, South Africa has not managed to escape the impact of 
HIV. The epidemic in South Africa shows no sign of relenting (UNAIDS, 2005). In South 
Africa young women between the ages of 25 and 35 years have the highest prevalence 
rates of HIV infection (UNAIDS, 2005). As more young women of child bearing age 
become infected with HIV, so the number of infants born with vertically transmitted HIV 
will continue to rise. The health care costs for these children are largely borne by the 
state as the majority are unable to afford private health care. At present the mother-to-
child transmission of HIV in South Africa remains high, at approximately 30% (Meyers et 
al, 2000). Even though this figure is expected to come down as more women get access 
to antiretroviral therapy perinatally, there are still many thousands of HIV infected infants 
in our health care system.  
 
Access to antiretroviral therapy in Sub-Saharan Africa remains an issue of grave 
concern. According to UNAIDS (2005), by mid 2005 only one in ten African people who 
need antiretrovirals were actually receiving them. Achieving universal access forms part 
of the long-term challenge of bringing HIV under control in Africa. 
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Until April 2004 most paediatric HIV clinics in South Africa only saw children over two 
years of age as these children had a better prognosis for long term survival. In April 
2004 when antiretroviral treatment became available in the public sector, paediatric HIV 
services were extended to include infants. However there is still a general lack of 
experience among health care workers in managing young children infected with HIV 
and a need for treatment guidelines and protocols exists. 
 
Neurological complications have been identified in children with HIV infection since the 
disease was first described in children in the early 1980s (Belman et al 1985; Epstein et 
al 1985). Several key international studies have identified the prevalence of neurological 
complication in HIV infected children to be 30-40% (Belman et al, 1996; Msellati et al, 
1993; European Collaborative Study, 1990). Little research has been done in South 
Africa to describe the magnitude of the problem. One study done on infants under one 
year of age found that 40% of HIV infected infants in this age group presented with 
developmental delay (Potterton and Eales, 2001). As yet there have been no 
longitudinal studies done in South Africa to monitor the progression of developmental 
problems in HIV infected children. 
 
Although numerous studies from developed countries have identified 
neurodevelopmental problems in HIV infected children, most of these studies have been 
prevalence studies and have not followed the children’s progress over a period of time. 
A limited number of longitudinal studies have been done to monitor children’s 
developmental progress, but these studies have all been done in developed countries 
where children have access to antiretroviral therapy (Llorente et al, 2003; Belman et al, 
1996; Nozyce et al, 1994). No longitudinal studies done in South Africa could be found. 
The impact of antiretroviral therapy on childhood development has only been studied in 
well resourced countries and is still a contentious issue. There is therefore little 
information available on the natural progression of developmental problems in children 
infected with HIV. This makes it difficult to plan management programmes for these 
children and to monitor the effectiveness of programmes implemented. 
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South African physiotherapists have had little input into the long term management of 
children infected with HIV. Present staffing levels at provincial hospitals make it difficult 
to offer regular physiotherapy services to all HIV infected children in South Africa. To 
date no physiotherapy intervention studies have been done in the field of paediatric 
developmental delay due to HIV. There are no existing guidelines as to whether 
physiotherapy intervention would be of any benefit to these children in the South African 
setting. A study by Spiegel and Mayers (1991) found that a regular home-based 
physiotherapy programme provided a sense of purpose and competence for caregivers 
of HIV infected children. The study does not describe the physiotherapy programme, nor 
discuss its possible impact on the child. A few studies have been done on the role of 
physiotherapy in the management of patients infected with HIV, however all of them 
focus on the treatment of adults and do not mention the treatment of children (McLure, 
1993). There is therefore very little information available to guide physiotherapists in 
determining whether or not to treat children infected with HIV, and what treatment would 
be most appropriate. As more children gain access to antiretrovirals and survive for 
longer so their rehabilitation needs are likely to increase (Nixon and Cott, 2000). 
 
Recent research in paediatric physiotherapy has highlighted the need for a family-
centered approach to the management of children with disabilities (O’Neil et al 2001, 
King et al 1999, Viscardis 1998). This approach requires that the needs of the disabled 
child must be met within the context of their individual family and that any rehabilitation 
programme given to the child must be designed specifically for the individual with input 
from the family. Goal setting must be done with the family. This therefore means that no 
two children will have exactly the same programme although similar principles of 
management will exist for children with similar conditions.  
 
Paediatric HIV is a multigenerational disorder. The diagnosis of a child as HIV positive 
has far reaching social and financial implications for the family, over and above the 
immediate health concerns. Although the impact of chronic childhood illness and 
disability on family functioning and parenting stress has been previously studied (O’Neil 
et al, 2001; Button et al, 2001; Dyson, 1991), the situation of families in South Africa 
caring for children infected with HIV is a unique one which has not been studied in 
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depth. A number of studies conducted in the USA have highlighted high levels of 
parenting stress in caregivers of HIV infected and affected children (Goldstein et al, 
2005;Linsk et al, 2004; Silver et al, 2003; Weiner et al, 2001). 
 
1.2 Problem Statement 
In their review article, Lwin and Melvin (2001) highlight the fact that very little research in 
the field of paediatric HIV has adopted a longitudinal, family focused approach. No 
studies have investigated the parenting stress in relation to the HIV infected child’s 
developmental status.  In developing countries such as South Africa, the emphasis is on 
providing basic health and social care to families affected by HIV and studies of 
psychosocial aspects, such as parenting stress, which affect quality of life have not been 
seen as a priority. Very little information is available on the developmental status of HIV 
positive children in South Africa. There is therefore a great need for studies that take 
both clinical and psychosocial markers into account. 
 
1.3 Research Question 
Does a basic home management programme impact on the neurodevelopmental status 
of HIV infected children and decrease the parenting stress of caregivers of HIV infected 
children who attend a busy paediatric outpatient clinic? 
 
1.4 Aim 
The aim of this study was to determine whether a basic home management programme 
had a positive impact on the parenting stress of caregivers of HIV infected children and 
the neurodevelopmental status of the children attending a busy paediatric outpatient 
clinic. 
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1.5 Objectives 
The objectives of this study were as follows: 
• to describe the extent and progression of neurodevelopmental delay in a 
population of HIV infected children 
• to monitor the impact of a basic home management programme on the 
neurodevelopmental status of the child  
• to determine what factors were predictive of neurodevelopmental status and 
parenting stress 
• to determine whether a basic home management programme decreased the 
parenting stress experienced by the child’s caregiver 
• to monitor the neurodevelopmental progress of children who received 
antiretroviral therapy  
• to determine what other factors impacted on the stress levels of caregivers of HIV 
infected children      
• to determine who the main caregivers of HIV infected children attending HIV 
clinics were. 
 
 
1.6 Significance of the Study 
HIV continues to have adverse effects on the health and well being of children in South 
Africa. At present these children are not being offered any rehabilitation services at 
paediatric HIV clinics in South Africa, despite the fact that neurodevelopmental delay is 
a common complication of paediatric HIV. The results of this study will establish whether 
a home management programme, delivered in the context of a busy outpatient 
paediatric HIV clinic, can have a positive influence on the neurodevelopmental status of 
HIV positive children and reduce the parenting stress experienced by their caregivers. 
This knowledge can guide future practice and help to ensure that the needs of HIV 
positive children are met in a more holistic manner. 
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Chapter 2 
LITERATURE REVIEW 
 
2.1 Introduction 
In this chapter the epidemiology of HIV in Sub-Saharan Africa will be discussed with 
particular reference to paediatric HIV. An overview of paediatric HIV will be given with a 
more detailed discussion on the neurological complications of this disease. The impact 
of paediatric  HIV on the family will be discussed and various intervention strategies will 
be presented. The context in which South African children infected with HIV find 
themselves will be summarised. Literature relating to school going children and 
institutionalised children is not discussed in detail in this review. 
  
Articles were sourced for this review using Pubmed, CINAHL, PSYCHInfo, Pedro and 
Cochrane Collaboration searches. A hand search was also conducted in the Health 
Sciences Library of the University of the Witwatersrand. Key words used in searches 
included; HIV, children, encephalopathy, developmental delay, neurodevelopment, 
parenting stress, psychosocial.  
 
2.2 Epidemiology 
Sub-Saharan Africa is home to only 10% of the world’s population and yet 60% of all 
HIV positive people live in this region. An estimated 2.4 million adults and children died 
of AIDS in Sub-Saharan Africa in 2005 (UNAIDS, 2005). Although prevalence rates are 
coming down slowly in three African countries, Kenya, Uganda and Zimbabwe, HIV 
prevalence rates remain extremely high in other African countries and might not have 
reached their peaks in some countries (UNAIDS, 2005).  Economic and social diversity 
between countries and even within countries mean that there is no one “African AIDS 
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epidemic”. As prevalence rates vary enormously from country to country and even from 
one area to another within countries, generalisations must be made with caution. 
 
South Africa has one of the fastest growing HIV epidemics in the world. Data collected 
over the last few years show that the epidemic has started to level off but this is 
probably due to natural saturation of the epidemic rather than the result of any particular 
intervention. The prevalence varies by age, gender and geographical area (Gouws and 
Karim, 2005). Recent data from the South African Department of Health, collected in 
ante-natal clinics, show that the prevalence in pregnant women has reached its highest 
yet at 29.5% (UNAIDS, 2005). Prevalence was highest in women between 25-34 years 
of age with more than one in three women in this age group being HIV positive. The 
prevalence was almost as high in women between 20-25 years of age. In KwaZulu-
Natal, the province worst hit by HIV in South Africa, the prevalence reached 40% 
(UNAIDS, 2005) 
 
Data on the prevalence of HIV in children is not easy to find, and is often extrapolated 
from antenatal studies. Mother-to-child transmission of HIV remains high in South Africa 
especially in areas where antiretrovirals are not available. According to Coovadia and 
Meyers (2001) mother to child transmission of HIV in South Africa is approximately 30%. 
In  an extensive study commissioned by the Nelson Mandela Foundation and conducted 
in the Free State 47% of children with an HIV positive mother were infected as well 
(Shisana et al, 2005). In 2001 10% of all HIV infected individuals in South Africa were 
children under 14 years of age (Lau and Muula, 2004), and this translated to a quarter of 
a million children in 2003 (Saloojee and Pettifor, 2005).  In the first nationwide study of 
HIV prevalence in children conducted in 2004, Brookes et al found that 5.4% of South 
African children were HIV positive. When they looked at younger children between two 
and nine years of age the prevalence was 6.2%.The authors of this report do caution 
that further studies should be done to confirm these prevalence rates which were higher 
than expected.  As long as the prevalence rate of HIV in young women of child bearing 
age remains so high it can be anticipated that the number of paediatric infections will 
continue to increase, especially as universal access to HAART remains out of reach in 
most African countries.  
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The underlying reasons for Sub-Sahara’s vulnerability to HIV are multifactorial and 
complex. Some of the reasons put forward as playing contributory roles include the 
following: 
• Africa was exposed to HIV very early in the course of the disease’s history, the 
epidemic has therefore had more time to affect African communities. 
• HIV has spread very rapidly in Sub-Saharan Africa due to high rates of other 
sexually transmitted diseases and inadequate management to prevent 
transmission. 
• Multiple sexual partners are common in Sub-Saharan Africa which facilitates the 
spread of HIV. 
• Women hold a subordinate role in most African cultures and have little or no 
control over their sex lives, this places them at great risk of being infected. HIV is 
a taboo topic in many cultures which hinders discussion on the topic and makes 
prevention, diagnosis and treatment more complex. 
• Poor nutritional status and poverty increases vulnerability to HIV and hunger may 
lead people to expose themselves to the risk of HIV through transactional sex. 
Chronic poverty means that large sectors of the country have reduced access to 
medical care. 
• Political instability and violence inevitably leads to a decline in social services 
which makes initiation and maintenance of public health measures difficult. 
• International funding agencies are reluctant to invest in programmes that may not 
be sustainable. 
• Rape is common in conflict zones and basic health care and hygiene cease to be 
priorities, people are also less likely to change their behaviour when their futures 
are bleak. 
• Urbanisation and migration of people in search for work or as refugees fuels the 
spread of HIV as people may have multiple sexual partners in different 
geographical areas. Urbanisation and the constant movement of people has also 
lead to the breakdown of traditional family structures and moral norms. 
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• Antiretroviral therapy is not universally accessible in Sub-Saharan Africa with 
rural communities being less likely to have access. Untreated individuals with 
high viral loads are more likely to spread HIV. 
• Low levels of literacy and lack of understanding of a biomedical model have 
meant that the many education programmes started in Sub-Saharan Africa have 
had little impact. 
• Leaders in Sub-Saharan Africa have been reluctant to recognise the potential 
impact of HIV and public health policies to address the issues have been slow to 
materialise (Lau and Muula, 2004). 
 
This list is by no means exhaustive and may reflect certain biases on the part of the 
authors, the relative impact of each of these factors therefore warrants further 
investigation. 
 
Thus far only three countries in Sub-Saharan Africa, Uganda, Kenya and Zimbabwe 
have been able to show a decrease in the spread of HIV. It would appear that 
prevention programmes initiated over the past decade are finally having an effect in 
these countries and more people are presenting themselves for testing and counselling 
as antiretrovirals become available (UNAIDS, 2005). In South Africa a multisectoral, 
sustained and coordinated effort is required to control the epidemic. 
 
2.3 Paediatric HIV 
2.3.1 Mother to child transmission of HIV. 
Most HIV infection in infants is acquired through mother to child transmission although 
the possibility of transmission through sexual abuse or healthcare practices cannot be 
ignored (Brookes et al, 2004; American Academy of Pediatrics, 1999; Frederick et al, 
1994). In the absence of antiretroviral treatment the vertical transmission of HIV is 
reported to be as high as 40% in Africa (Chakraborty, 2005; Wiznia et al, 1996). These 
very high rates in Africa may be attributed to breastfeeding, poor obstetric management 
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as well as limited access to antiretroviral therapy. The timing of transmission depends 
on a number of factors largely related to the mother’s immune status (Tardieu,1998) 
 
Infection of the infant may take place in-utero and is thought to occur transplacentally. 
In-utero infection is associated with poor prognosis and increased risk of spontaneous 
abortion (Chakraborty, 2005; Wiznia et al, 1996). The HI virus has been isolated in 13-
20 week aborted foetuses including in specimens of neural tissue (Falloon et al, 1989). 
 
Intrapartum transmission of HIV which is thought to occur in two thirds of cases of 
mother-to-child transmission, can occur due to maternofoetal transfusion of blood during 
labour or through contact of infant mucous membranes with maternal blood and other 
secretions during delivery. Risk factors for intrapartum transmission include prolonged 
rupture of membranes, invasive procedures, high maternal viral load at the time of 
delivery and vaginal delivery (Chakraborty, 2005; Wiznia et al, 1996). Severe maternal 
vitamin A deficiency has also been found to increase the risk of transmission (Brown 
and Lourie, 2000). 
 
Post partum infection of infants through breast feeding is estimated to occur in 12-14% 
of cases. HIV has been detected in breast milk and colostrum. Infection is thought to 
occur due to prolonged exposure of the infant’s oral and gastrointestinal tracts to 
infected breast milk. Infants are at greater risk of infection if the mother has cracked 
nipples or a breast abscess (Chakraborty, 2005) as well as if breastfeeding is 
interspersed with formula feeding. Mothers who choose to breast feed their infants 
should therefore be advised about exclusive breastfeeding (Coutsoudis et al, 2001). 
 
2.3.2 Testing 
The diagnosis of HIV infection in infants is evolving rapidly. In South Africa more sites 
are gaining access to polymerase chain reaction (PCR) testing which allows for accurate 
and early detection of HIV antigens, rather than having to wait until the child is 15 
months old before performing an antibody test. In the absence of PCR testing serologic 
testing using enzyme-linked immunosorbant assay (ELISA) may be done. Although 
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much cheaper and more readily available, ELISA tests only detect the presence of HIV 
antibodies and are unable to distinguish whether these are maternal antibodies or not. 
The test may therefore yield false positive results in infants below 15-18 months who still 
have maternal antibodies in their bloodstreams (Falloon et al, 1989). 
 
In their advocacy statement, the African Network for Care of Children Affected by 
HIV/AIDS (ANECCA) provide detailed guidelines for the accurate diagnosis of HIV in 
children in Sub-Saharan Africa taking possible clinical and financial constraints into 
account. Improved access to antiretrovirals, makes it imperative that infants are 
diagnosed as early as possible so that they can access treatment as soon as possible 
(ANECCA, 2005). Obstacles to early diagnosis such as limited laboratory facilities and 
expertise as well as the high cost of tests must be overcome (ANECCA, 2005).  
 
2.3.3 Clinical Presentation and Progression 
In their comprehensive overview of paediatric HIV infection Wiznia et al (1996) describe 
the natural history of children perinatally infected with HIV. Rapid progressors are 
described as children who present with AIDS by their first birthday. They usually present 
clinically very early in their lives, often before five months of age. These infants present 
with pneumocystis carinii pneumonia, failure to thrive, hepatitis, diarrhoea, 
neurodevelopmental delays and encephalopathy. Slow progressors on the other hand 
are relatively much healthier in infancy and have a better five year prognosis. This 
bimodal clinical presentation is also described by Chakraborty (2005) and by Bobat et al 
(1998) in their South African study as well as by Spira et al (1999) in their report on the 
natural history of HIV infection, in children in Rwanda. 
 
HIV in children causes a broad spectrum of diseases which have been well described in 
the literature (Chakraborty, 2005; Cooper et al, 2004; Coovadia and Meyers, 2001; Spira 
et al 1999; Bobat et al, 1998; Wiznia et al 1996). Only the neurological complications of 
paediatric HIV will be discussed in detail in the following section of this literature review. 
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2.3.4 Antiretrovirals 
Antiretroviral therapy has been used consistently in the management of HIV infected 
children in the developed world for well over a decade. The aims of antiretroviral therapy 
are to reduce the plasma viral load to undetectable levels and maintain good 
immunological status of the child in order to prevent disease progression and 
opportunistic infections. The combination of reverse transcriptase inhibitors and 
protease inhibitors has been pivotal in reducing HIV morbidity and mortality in 
Westernised countries (Chakraborty, 2005). 
 
Reverse transcriptase inhibitors prevent HIV from transcribing itself from RNA to proviral 
DNA. This process is necessary for the virus to integrate into the host cell nucleus. A 
number of nucleoside, nucleotide and non-nucleoside reverse transcriptase inhibitors 
have been developed and are an integral part of HAART regimens. Protease inhibitors 
prevent the formation of mature competent virions which are capable of leaving the host 
cell after replication of the virus in the host nucleus has occurred. Protease inhibitors are 
extremely effective and their use has revolutionised antiretroviral therapy (Pratt, 2003). 
 
Highly Active Antiretroviral Therapy (HAART) is a combination of three (or more) 
antiretroviral drugs, usually two nucleoside reverse transcriptase inhibitors with either a 
non-nucleoside reverse transcriptase inhibitor or a protease inhibitor. Although 
extremely effective these drugs are associated with a number of side effects which must 
be monitored by clinicians (Pratt, 2003). 
 
 Access to antiretroviral drugs and the potential of going on a highly active antiretroviral 
regime is only starting to be realised in South Africa and other African countries. The 
South African government began its antiretroviral roll-out programme in April 2004. This 
programme has been slower to gain momentum than planned and has been fraught with 
political controversy. The UNAIDS report of December 2005 estimates that fewer than 
10% of people in Sub-Saharan Africa who need antiretrovirals are currently receiving 
them. Concerns have been raised that the widespread use of antiretrovirals in 
developing countries will result in resistance due to poor adherence. This would limit the 
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drug choices available in the future to these populations. Until recently the high cost of 
drugs was the main factor limiting access to antiretrovirals in sub-Saharan Africa, but 
now that drug prices have come down considerably, a lack of infrastructure and trained 
personnel are probably the major constraints. A number of models for distributing 
antiretrovirals in an effective and sustainable manner are currently being explored 
(Wood, 2005). In South Africa antiretrovirals are being phased in with tertiary hospitals 
gaining access first. As more personnel are trained and facilities are upgraded the 
programme is being expanded to include smaller hospitals and clinics. 
 
The best age at which to initiate HAART in children has been a topic of some debate 
over the past few years. The decision to initiate HAART is a complex one and should 
only be taken in consultation with the child’s caregivers (Wiznia et al, 1996). The 
Working Group on Antiretroviral Therapy suggests that HAART be started in the 
presence of moderate immunodeficiency as defined by age corrected CD4 counts. 
Chakraborty (2005) advocates “aggressive, multidrug therapy, as early in infection as 
possible” in order to suppress viral replication and prevent the emergence of resistant 
viral strains. Luzuriaga and Sullivan (2002) argue that antiretroviral therapy should be 
started within the first few months of life wherever possible. They base their argument 
on the premise that HIV can be accurately diagnosed in the first few weeks of life, that 
there is no way of determining which children will be rapid progressors, and finally that 
several antiretroviral regimes have been proven to be safe, effective and well tolerated 
in infants and young children. Current practice in most African countries, including South 
Africa is to start HAART only once the child’s CD4 count has dropped to below 20% 
(Dept of Health, South Africa, 2005). South African children are thus facing significant 
immunocompromise before being able to start HAART. Newly revised World Health 
Organisation guidelines propose starting treatment of children earlier, at CD4<25%, in 
order to optimise long term outcomes (ANNECCA, 2005).  A study conducted on adults 
in South Africa supports this proposal. Badri et al, 2006, found that delaying the initiation 
of HAART until the CD4 count was < 200µL resulted in increased morbidity and 
mortality. They suggest that criteria for commencing HAART, in resource poor settings, 
be amended. 
 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
14 
The impact of HAART on the neurodevelopment of HIV positive infants will be discussed 
below. 
     
2.4 HIV and the Developing Nervous System 
Central nervous system involvement in HIV infected children was first described in the 
early 1980’s, soon after AIDS had been identified (Epstein 1985). The neurological 
syndrome described, together with neuropathological findings, confirmed that HIV was a 
neurotrophic virus (Belman et al, 1992). Many questions about the natural progression 
and the pathogenic mechanisms of HIV related CNS disease in children remain 
unanswered (Rausch and Stover, 2001). 
 
Neurological complications and resultant developmental delay are seen frequently in 
HIV positive children, especially in younger children who have been infected perinatally 
(Raskino et al, 1999; Nozyce et al, 1994; Belman, 1992). The stage of brain 
development at which HIV infection occurs varies between children and so the clinical 
presentation will differ too (Belman, 1990). 
2.4.1 Neuropathology 
The central nervous system (CNS) in HIV positive children may be affected by invasion 
by HIV directly or by opportunistic infections such as meningitis or by both (Fragoso et 
al, 1999; Davies et al, 1992). Children under the age of three years are more likely to 
show evidence of CNS involvement compared to children who have survived over six 
years of age (Blanche et al, 1990). 
 
The CNS is a viral reservoir for HIV (Kolson, 2002). HIV is found in cerebrospinal fluid at 
the time or soon after seroconversion (Spector et al, 1993; Davies et al, 1992; Epstein et 
al, 1987; Goudsmit et al, 1986; Ho et al, 1985; Resnick et al, 1985). HIV has been 
isolated in the brains of HIV infected patients during autopsy (Boni et al 1993; Davies et 
al,1992; Navia et al, 1986; Sharer et al, 1986) as well as in the CNS of aborted foetuses 
(Lyman et al, 1990). Increased levels of HIV DNA are found in brain tissue of patients 
who have encephalopathy (Sei et al, 1995). 
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HIV infected monocytes cross the immature blood brain barrier. The most frequently 
infected cells within the brain are the macrophages (Tardieu, 1998; Ensoli et al, 1997; 
Wiley et al, 1986). Macrophages in the white matter, the basal ganglia and around the 
blood vessels are the most vulnerable to infection. Monocytes, lymphocytes and 
astrocytes may also become infected but to a lesser degree (Tardieu, 1998; Wilfert et al, 
1994; Tardieu, 1992). 
 
Neuronal death, due to apoptosis, is thought to be due to the release of toxic products 
by infected macrophages. Infected macrophages secrete pro-inflammatory cytokines 
and other soluble factors such as HIV proteins which are toxic to nearby neurones 
(Kolson,2002) . Neurones and oligodendrocytes do not appear to be directly infected by 
the HI virus (Tardieu, 1998). 
 
Calcification of the basal ganglia is a common finding in HIV infected children (Tardieu, 
1998; Schmitt, 1991; Lenhart and Wiley, 1989; Belman, 1988; Belman, 1986). It may 
range from small vessel calcipherites to large calcific parenchymal deposits (Belman et 
al, 1988). Calcification of the white matter, especially in the frontal lobes has also been 
noted (Belman et al, 1988). 
 
Neuroradiological findings show cerebral atrophy (Falloon et al, 1989; Belman et al, 
1988) and enlargement of the ventricles and subarachnoid space (Tardieu, 1998) as 
well as the abovementioned calcification. Lateral as well as anterior corticospinal tract 
degeneration has been described (Belman et al 1988). Neuronal loss in the frontal 
cortex of patients with AIDS dementia has been described (Everall et al, 1991). 
 
According to Falloon et al (1989) the encephalopathy that results may be due to the 
following: 
• Release of toxins by infected macrophages leading to impaired neuronal function. 
• Dysfunction of the blood-brain barrier due to HIV infection of the endothelial cells. 
• Possible HIV infection of neuronal and glial cells leading to demyelination or 
neuronal damage (neuronal infection has not been conclusively documented). 
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• Blockage of binding of neuroleukin to neurones by the HIV envelope glycoprotein. 
• Damage to neural tissues caused directly by the HIV envelope glycoprotein. 
 
The discrepancy between the severity of the ensuing encephalopathy and the relatively 
small viral load in the CNS suggests that factors other than direct cellular damage may 
play a role in determining developmental outcome. 
 
There has been some debate as to whether or not astrocytes are directly involved in HIV 
infection of the CNS. Tornatore et al (1994) postulate that astrocytes could serve as a 
reservoir for HIV in the developing CNS, thus  facilitating infection of mononuclear and 
microglial cells. Alternatively the astrocytes may release cytokines capable of recruiting 
macrophages across the blood brain barrier or increasing replication in infected 
monocytes. Epstein et al (1993) suggest that infected macrophages initiate neurotoxicity 
which is amplified through interactions with astrocytes. They found that astrocyte-
macrophage interaction produces cytokines which cause astroglial proliferation and 
neuronal death. These findings explain why relatively low numbers of infected 
macrophages can produce progressive and devastating neurological impairment. In an 
in vitro study, Ioannidis et al (1995) demonstrated that HIV-1 can productively infect 
infant microglia and that infection can be maintained for a long period of time. The 
release of cytokines, such as tumour necrosis factor, and neurotoxins by infected 
microglia and multinucleated giant cells was confirmed in this study. According to 
Schmidtmayerova et al (1996) HIV-1 infected monocytes are able to recruit uninfected T 
cells and monocytes to sites of active viral replication or inflammation, mainly the brain 
and lymph nodes, thus enhancing the spread of infection. 
 
Wiley et al (1991) report neocortical damage in HIV positive adults with encephalitis. 
They demonstrated thinning of the neocortex with associated loss of large cortical 
neurones. The fact that they were unable to associate these changes with the presence 
of HIV antigens suggests that neocortical damage may be an indirect effect of HIV 
infection of the CNS. 
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De Carli et al (1993) found evidence of CT abnormalities in HIV infected children even 
prior to any clinical signs of encephalopathy. The most common finding was ventricular 
enlargement followed by cortical atrophy, leukoaraiosis and cerebral calcification. The 
degree of calcification seen on CT scans of young vertically infected children has been 
shown to correlate with the degree of cognitive dysfunction and aberrant behaviour in 
these children (Brouwers et al, 1995). The authors of the above two studies recommend 
the use of routine CT scans in HIV infected children to monitor presymptomatic brain 
disease and identify children at risk. 
 
Tardieu et al (2000) found that encephalopathy was most prevalent in children under 
one year of age and equalled the prevalence in adults by the time the children were 
seven years of age. Infants who present with encephalopathy before one year tend to 
have signs of neurodevelopmental involvement at birth as well as decreased birth 
weight and head circumference. They hypothesise that early onset encephalopathy has 
different neuropathologic origins to later onset encephalopathy. Early encephalopathy 
may be related to pathologic events during late foetal life. This is very significant as the 
last few months of gestation are the period of fastest brain growth. McGrath et al (2006) 
found that the risk of neurodevelopmental delay was highest amongst infants who were 
already HIV infected at birth. Any attempt to reduce the onset of encephalopathy should 
therefore focus on the last months of pregnancy (Smith et al, 2000). 
 
The current understanding of the neuropathology of paediatric HIV infection suggests 
that therapeutic intervention should be aimed at sustaining the immune activation of 
microglia, repairing the integrity of the blood-brain barrier and providing protection from 
neurotoxic agents to minimise neuronal damage (Epstein and Gelbard, 1999). 
2.4.2 Clinical Manifestations of Neurological Involvement 
A characteristic encephalopathy has been described in a number of studies related to 
infants and children infected with HIV (Chase et al, 1995; Spitaels, 1994; Pavlakis et al, 
1994; Nozyce et al, 1994; Fowler, 1994; Blanche, 1990; European Collaborative Study, 
1990; Diamond et al, 1990; Falloon et al, 1989; Ultman et al, 1986, 1987, 1996; Belman 
et al 1985, 1988, 1992, 1996; Epstein 1985, 1986;).  
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Encephalopathy may be one of the first clinical signs of HIV infection (Falloon, 1989). It 
initially presents with developmental delays, loss of milestones and deterioration in 
intellectual abilities. The developmental delay may progress to include pyramidal tract 
signs, ataxia, abnormal muscle tone and pseudobulbar palsy (Tardieu, 1998; Belman 
1992; Falloon et al, 1989). Acquired microcephaly is common in infants (Falloon et al 
1989). Ultimately the encephalopathy may result in spastic quadreparesis with dystonic 
posturing and regression of motor milestones (Tardieu, 1998). The development of 
severe encephalopathy in infancy has been correlated with serious systemic disease 
and an increased and early mortality (Llorente et al, 2003; Pearson et al, 2000; Belman, 
1992). The presence of hepatosplenomegaly, splenomegaly and lymphadenopathy in 
the first three months of life increases the risk of HIV encephalopathy and  death 28-fold 
(Laufer et al, 2000). Children who present with AIDS defining illnesses in the first two 
years of life are at risk of also having significant neurodevelopmental delays which may 
be attributed to HIV encephalopathy (Chase et al, 2000; Pearson et al, 2000; Belman et 
al, 1996; Nozyce et al,1994). 
  
A clinical description of the natural progression of the encephalopathy has been 
generally adopted with the following clinical pictures being described: 
• Subacute progressive: where the child fails to attain new milestones and starts to 
lose previously attained milestones 
• Plateau: no new milestones are attained, but there is no regression 
• Static: the child continues to attain milestones but at a much slower rate than 
normal (Pizzo P and Wilfert C, 1994). 
 
In her overview of CNS disorders related to paediatric HIV infection Belman (1992) 
notes that there are a number of other factors apart from encephalopathy that may result 
in neurodevelopmental delay in HIV infected children. These factors include: 
• Metabolic and endocrinologic disturbances resulting from HIV infection 
• Maternal illness, malnutrition and substance abuse during pregnancy 
• Complications due to prematurity 
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• CNS complications due to underlying medical conditions 
• Psychosocial stressors, including poverty, maternal illness, changing caretakers, 
chronic illness and frequent hospitalisations 
• Iatrogenic problems due to toxic or metabolic complications of therapy (Belman, 
1992). 
 
Neuropsychological measures are good predictors of disease progression, even better 
than CD4 counts. Poor muscle tone is also significantly associated with poor outcome, 
as is poor strength and decreased muscle bulk (Pearson et al, 2000). 
 
More recent studies by Smith et al (2000) and McGrath et al (2006b) have focussed on 
the impact of the timing of HIV infection on the neurodevelopment of HIV infected 
infants. Infants who are infected in utero present with clinical signs of 
neurodevelopmental delay earlier on and progress more rapidly. McGrath et al (2006) 
postulate that the difference in clinical presentation neurodevelopmentally could be 
explained by differences in the timing of infection with HIV when the developing central 
nervous system is at different stages of organisation. Early infection is more likely to 
result in motor delays as abnormal myelination could affect projection fibres as well as 
association and commissural connections. Later infection is more likely to result in 
cognitive delays as commissural connections and the connections with poles of cerebral 
lobes are more affected. 
 
A lower CD4 count and a high viral load are associated with increased severity of 
disability, growth failure and slower attainment of milestones in perinatally infected 
infants and young children (Pearson et al, 2000; Belman et al, 1996; Pollack et al, 1996; 
Chase et al, 1995; Fowler, 1994). 
 
2.5 Facets Of Development Affected 
Not many studies have attempted to identify the facets of development most affected by 
HIV. More research is needed in this area to establish which areas of development are 
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most affected. The following section provides an overview of the lessons learnt from 
previous studies on neurodevelopment in HIV infected children. 
2.5.1 Paediatric HIV and Cognitive Development 
HIV infected infants have cognitive delay and deficits in neuropsychological functioning 
due to CNS impairments. Mental retardation and acquired microcephaly are common 
findings in children with HIV encephalopathy (McGrath et al, 2006a; Fragoso et al, 1999; 
Belman et al, 1996; Henry et al, 1996; Fowler, 1994; Belman et al, 1988; Epstein et al, 
1986; Belman et al, 1985; Ultmann et al, 1985). Deficits in visual scanning, academic 
achievement and psychomotor speed have been found (Cohen et al, 1991). School- 
going children with AIDS have memory and visuopraxic impairments. However in the 
early stages of infection only minimal impairment of executive functions has been noted 
(Bisiacchi et al, 2000). Cognitive developmental skills such as comprehension and 
puzzle performance are less severely affected indicating that cognitive deficits increase 
with increasing age (Drotar et al, 1997). Children infected in utero appear to be the most 
severely affected (Brouwers et al, 1995; De Carli et al, 1993). 
 
The cognitive deficits described in HIV positive children exist independently of 
environmental and social risk factors (McGrath et al, 2006; Chase et al, 2000; Knight et 
al, 2000; Henry et al, 1996). 
 
 
2.5.2 Paediatric HIV and Motor Development 
Motor development is compromised from an early stage in HIV positive infants and 
children may start presenting with motor impairments in the first few months of life 
(Potterton and Eales, 2001; Chase et al, 1995; Nozyce et al, 1994). Children’s motor 
development, coordination, muscle tone and muscle strength are consistently affected 
by HIV infection (Pearson et al, 2000; Drotar et al, 1997; Chase et al, 1995). Dystonia, 
ataxia and tremor indicate extrapyramidal and cerebellar involvement (Chase et al, 
1995; Belman et al, 1988). Diaparesis with mild spasticity and progressive long tract 
signs may be seen (Fragoso et al, 1999; Belman et al, 1996; Belman, 1992; Belman et 
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al, 1988; Belman et al, 1985). Children with encephalopathy often present initially with 
low tone which progresses to increased tone with hyperreflexia (Mitchell, 2001). 
 
Children who present with motor delays early on are at greater risk of disease 
progression (Pearson et al, 2000). Muscle strength is decreased in children infected with 
HIV (Blanchette et al, 2001; Pearson et al, 2000), which may be a factor contributing to 
the fact that gross motor development is often more affected than fine motor 
development (Baillieu, 2005; Potterton and Eales, 2001; Parks and Danoff, 1999 )   
2.5.3 Paediatric HIV and Speech and Language Development 
The neuropathology of language deficits in HIV infected children is not well understood 
(Wolters et al, 1995). Language is affected later in life than gross motor development 
and is thought to be a reflection of both the chronicity of the disease as well as direct 
CNS involvement (Bisiacchi et al, 2000; Msellati et al, 1993). Chronic otitis media is 
extremely common in children who are HIV positive and while this may explain language 
delay due to impaired hearing to some extent it cannot account for all the deficits in 
speech and language experienced by these children (Layton and Scott, 2000). 
 
 HIV infected children have been found to have both receptive and expressive language 
delay, with expressive language being affected earlier and to a far greater extent  
(McClowry, 2000; Coplan et al, 1998; Tardieu et al, 1995; Wolters et al, 1995; 1997;  
Pressman, 1992; Pizzo et al, 1988; Epstein et al, 1986). The clinical impairments 
progress from mild expressive dysfunction in non-encephalopathic children, to severe 
expressive and receptive dysfunction in encephalopathic children. Both verbal and non-
verbal language are affected (Wolters et al, 1997). Verbal language skills are strongly 
related to motor function and therefore any motor deficits including those in motor 
planning, and muscle coordination may impact on oro-motor skills and lead to feeding 
problems as well as articulation and speech difficulties (Wolters et al, 1997). 
 
All aspects of development are adversely affected by paediatric HIV infection. 
Expressive language and gross motor development appear to be the most severely 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
22 
impaired. Further studies on the relative severity of developmental impairment are 
needed, particularly in developing countries. 
 
Evolving knowledge on the pathology of CNS involvement in children infected with HIV 
has underpinned a number of clinical studies over the last two decades. Clinical studies 
on the impact of HIV on the development of young children will be discussed in the 
following section. 
 
2.6 Clinical Studies 
Clinical studies relating to paediatric HIV and neurodevelopmental delay will be 
discussed. The studies will be grouped together in terms of when they were conducted 
as this makes it easier to see the evolution of knowledge on the topic over time. The 
studies done in Africa will be discussed separately as they raise issues of particular 
relevance to this study that need to be highlighted. 
2.6.1 Clinical studies from the developed world 
The first studies of HIV infected children and neurodevelopment emerged from three 
study sites, the University of Medicine and Dentistry in New Jersey, Albert Einstein 
College of Medicine in New York and the State University of New York. Two distinct 
groups of researchers co-authored nine of the first published articles produced on this 
topic between 1985 and 1988 (see table 2.1). The above factors must be borne in mind 
before attempting to extrapolate the findings of these studies to other parts of the world. 
 
These preliminary studies were mainly descriptive in nature and none of them compared 
HIV positive children to a control group. Most had very small sample sizes ranging 
between four to 18 children (Epstein et al, 1986, 1988, Ultmann et al 1985, Belman et al, 
1985, 1986). Epstein et al (1986) included 36 children in their study and Belman et al 
(1988) had a sample size of 68 children, making the findings of these studies more 
credible, although none of the authors discussed the power of their studies. The 
abovementioned studies also covered a very broad age range from six weeks to 13 
years which makes it difficult to compare the findings of various studies. There is also 
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little consistency in the assessment tools used in the different studies. The Denver 
Developmental Scale in conjunction with the Bayley Scales of Infant Development 
(BSID) was used by Ultmann et al (1985, 1987) and by Belman et al (1985). Belman et 
al (1988) relied on hospital records and parents for developmental histories and did not 
specify how they assessed motor development. Epstein et al (1986) considered 
evaluation of milestones sufficient in infants less than 15 months of age and used the 
BSID for children over 15 months. Epstein et al (1985) report on four case studies but do 
not specify whether or not standardised assessments were used. The lack of 
consistency in the method of assessment makes it difficult to draw meaningful 
conclusions from the above findings. 
 
All of the early studies reviewed highlighted the presence of neurological complications 
in children who are HIV positive. Epstein et al (1985) concluded that a progressive 
encephalopathy was an early feature of AIDS in children. Ultmann et al (1985) noted 
that developmental delays were worse in children with AIDS than in children with Aids 
Related Complex (ARC). They propose that these developmental abnormalities could be 
due to neurological, social or medical factors. Belman et al (1985) documented 
neurological involvement in all the children in their study (n=18). The severity of 
involvement varied but the most frequent manifestations included acquired 
microcephaly, encephalopathies and pyramidal tract signs. In 1986, Belman et al 
showed a 61% incidence of calcification of the basal ganglia in children who had AIDS. 
The study by Epstein et al (1986) confirmed his earlier findings (Epstein et al, 1985) and 
those of Belman et al (1985). It also showed a correlation between pathologic findings 
and clinical presentation and postulated that the encephalopathy described in children 
could be due to the direct effects of HIV on the developing nervous system. Ultmann et 
al (1987) described similar neurodevelopmental findings to previous studies and 
identified the need for sensitive standardised tests to be used in future studies. They 
also highlighted the fact that many other factors may influence developmental progress 
in HIV positive children. Ultmann et al (1987) advocated that all children with AIDS 
should have regular developmental assessments. In 1988, Belman et al published the 
largest longitudinal study to date (n=68) which delineated the clinical characteristics of 
CNS involvement in children with symptomatic HIV infection. 
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By the end of the 1980s the clinical presentation of HIV related encephalopathy had 
been well documented and described. The studies however represented a limited 
sample in terms of culture, socioeconomic status and geographical setting. These 
factors may themselves influence childhood development and therefore the results of 
these studies can not be extrapolated to different parts of the world The emphasis of 
research now shifted to establish the prevalence of neurological involvement, the time of 
onset of clinical symptoms as well as the natural progression of neurological 
impairments. Although most of the studies were still based in the United States, more 
centres became involved and some European studies were also undertaken. 
 
The age range of the studies done in the 1990’s was narrower with most researchers 
focussing on the first two years of life with some extending to four years (Belman et al, 
1996; Chase et al, 1995; Gay et al, 1995; Nozyce et al, 1994; Blanche et al, 1990; The 
European Collaborative Study, 1990). The fact that these studies focussed on children 
of similar ages makes it easier to compare their findings and draw conclusions. 
 
With more studies focussing on younger children the issue of early accurate diagnosis 
became more pertinent. Blanche et al (1990) tested for HIV antibodies to confirm their 
diagnosis. In children younger than 15 months clinical diagnostic criteria used by the 
CDC were used to make a diagnosis, thus no asymptomatic children under 15 months 
of age were included in the study which could have led to possible bias. The sample 
was likely to under-represent the children who were slow progressors and still clinically 
well. The European Collaborative Study followed children born to HIV positive mothers. 
They were tested for HIV at 18 months and those who had antibodies were considered 
HIV positive and compared to those who had seroreverted. This meant that the 
assessors were, in theory, blind to the HIV status of the children until they were 18 
months old. The reality is that the clinical signs of HIV infection are often very obvious, 
and therefore true blinding is difficult to achieve. This methodology was also used by 
Nozyce et al (1994) and Belman et al (1996) who tested for HIV antibodies at 15 and 18 
months. Schmitt et al (1991) do not specify how diagnosis of HIV was made despite the 
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fact that all their subjects were under a year old. Lobato et al (1995) also do not discuss 
the diagnostic measures used in the six centres involved in their study. 
 
A trend began to emerge with more researchers using standardised developmental 
assessment tools with the majority of studies making use of the Bayley Scales of Infant 
Development (,Belman et al, 1996; Pollack et al,1996; Henry et al, 1996; Chase et al, 
1995, Gay et al, 1995; Nozyce et al, 1994). Unfortunately some studies still made use of 
non standardised tests and questions of validity and reliability were seldom raised 
(Schmitt et al, 1991; Blanche et al, 1990; The European Collaborative study, 1990). 
 
Despite some methodological differences between the studies the findings relating to 
neurological complications and HIV infection were fairly consistent. In their longitudinal 
follow-up study Blanche et al (1990) identified encephalopathy in one third of their HIV 
positive sample in the first year of life. The European Collaborative Study had similar 
results with 31% of the HIV positive children in their sample presenting with neurological 
complications. Lobato et al (1995) conducted a large cross-sectional multicentre 
surveillance study and diagnosed HIV encephalopathy in 10% of their HIV infected 
children and in 23% of children with AIDS. Chase et al (1995) compared a group of HIV 
infected children to a group of HIV exposed but uninfected children under 30 months of 
age, and identified developmental delay in 50% of HIV infected children compared to 
18% of seroreverter children. Nozyce et al (1994) and Belman et al (1996) both found 
severe encephalopathy in almost all children with symptomatic AIDS. Both these studies 
compared HIV positive children to HIV negative children and followed children up from 
birth to two years of age. The severity of neurological involvement appeared to be 
associated with the severity of clinical disease. Gay et al (1995) found that HIV positive 
infants under two years of age were developmentally delayed compared to their HIV 
negative controls even when the effects of HIV were not confounded by prenatal 
maternal drug use. Belman et al (1996) concluded that exposure to HIV in utero did not 
negatively impact on the developing CNS if the child did not become infected with HIV. 
 
Pollack et al (1996) conducted a longitudinal follow up study of HIV positive infants, HIV 
exposed infants and HIV negative infants under the age of two years. They established 
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a correlation between HIV viral load and both neurodevelopment and linear growth. 
They found that infants with more pronounced growth failure had the most marked 
cognitive and motor delay. The sample size of infected children in this study was small 
and the authors acknowledge that maternal drug use and nutrition were possible 
confounding factors. In their study Henry et al (1996) controlled for the effects of 
psychosocial and environmental risk factors and still found that HIV positive children 
were significantly developmentally delayed compared to an HIV negative control group. 
They confirmed that the degree of cognitive delay was related to the level of immune 
system function (CD4 count). The age range in this study was very broad (one to nine 
years) and the sample size was relatively small with no power calculation given, the 
results should therefore be interpreted with caution.  A number of other authors began to 
do comparative studies on neurodevelopment that also controlled for factors which may 
negatively impact on development (maternal education, prenatal drug exposure, minority 
status, birth conditions) and found that HIV positive infants still demonstrated early and 
marked cognitive and motor delay which may be early indicators of HIV disease 
progression (Chase et al, 2000; Knight et al, 2000). 
 
The quality of these studies was considerably better than those done in the 1980’s with 
use of control groups, larger sample sizes and standardised assessments. The results 
of these more recent studies are therefore more credible and can be generalised to 
other populations of HIV infected children.  
 
Emphasis now shifted to establishing the effect of the timing of infection on the 
neurological development of the child. Early infection with HIV, while still in utero, was 
found to be related to more severe neurodevelopmental delay with more rapid 
progression (McGrath et al, 2006; Smith et al, 2000). The reasons for these findings 
have been discussed in section 2.4.1 on neuropathology. 
 
Neuropsychological functioning was found to be an independent risk factor for death in 
HIV infected adults (Ellis et al, 1997). Pearson et al (2000) found that 
neuropsychological and motor function (especially reduced muscle mass) were useful 
indicators of disease progression in infants, children and adolescents and could be used 
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to predict long term outcomes, including longevity. Missmer et al (2000) found that 
growth parameters, immune status as well as social factors were important predictors of 
functional status in HIV infected children. Llorente et al (2003) found that BSID scores in 
the lower quartile were independent predictors of mortality after adjusting for treatment, 
clinical category, gestational age, viral load and CD4 percentage. 
 
As children infected with HIV are gaining access to better treatment options they are 
surviving beyond early childhood and even into adolescence (Sullivan and Luzuriaga, 
2001). This has meant that the focus of research in developed countries has shifted 
from the very young child to include children of school going age. More studies are now 
being done on the cognitive and behavioural problems experienced by these children in 
school. Receptive and expressive language impairments are also being more fully 
investigated in this group of older, verbal children (McClowry, 2000). 
  
McClowry (2000) presented an overview of the literature and described the language 
and cognitive disorders found in school age children and confirmed that expressive 
language is more affected than receptive. This study highlighted issues of relevance for 
speech and language pathologists. Mellins et al (2003) suggested that the high rate of 
behavioural problems, particularly Attention Deficit Hyperactivity Disorder, experienced 
by HIV infected children, older than three years, are not as a result of HIV infection. 
They concluded that other biological and social factors such as poverty, family 
disruption, trauma, parental drug use and mental illness are likely to contribute to 
behavioural issues. Smith et al (2006) conducted cognitive assessments on HIV positive 
and HIV exposed children in a large, multicentre, longitudinal study. They found that 
children who had an AIDS defining illness early on in childhood were at risk for static 
encephalopathy and cognitive delay in pre-school and early school years. 
 
Nozyce et al (2006) investigated behavioural and cognitive function of 274 clinically and 
immunologically stable antiretroviral-experienced HIV infected children. The age range 
in this study was broad (2-17 years) which necessitated the use of a number of different 
assessment tools. Children enrolled in this study were found to be four times more likely 
to present with behavioural problems and were at risk for cognitive and developmental 
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delay. There was no control group in this study and scores were compared to 
established childhood norms. 
 
The findings of these studies highlight the fact that developmental issues are going to be 
a lifelong concern for children infected with HIV and that cognisance needs to be taken 
of this, especially with respect to planning educational services for these children. 
Developing countries have yet to experience the full impact of HIV positive children in 
school but can anticipate challenges in the future as more children gain access to 
HAART and survive to school going age. 
 
Very little research has emerged from developing countries other than Africa during this 
time period. One study from Brazil (Fragoso, 1999) aimed to identify neurologic 
involvement in a cohort of HIV infected adolescents and children. Unfortunately this was 
a retrospective study and no formal neurodevelopmental assessment tools were used. 
The very low rate of neurological involvement identified (less than 10%) should therefore 
be viewed with some circumspection. The studies conducted in Africa will be discussed 
in section 2.6.2. 
 
A summary of the most important studies done on the impact of HIV on the development 
of children in the developed world is presented in table 2.1. 
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Table 2.1 Summary of Neurodevelopmental studies in the developed world. 
Authors Country Sample 
(n) 
Age range Measures Main Findings 
Belman et 
al 1985 
USA 6 6m-5yrs DDST 
BSID I 
Stanford Binet 
All children had developmental or 
neurological involvement. 
Ultmann 
et al 1985 
USA 16 10m-6yrs DDST 
BSID I 
Stanford Binet 
All children delayed, especially in 
language and cognitive abilities 
Epstein et 
al 1985 
USA 4 10m-11yrs CT scan 
Neurological 
examination 
All 4 children had neurological 
deterioration 
Epstein et 
al 1986 
USA 36 2m-11yrs BSID I 
Stanford Binet 
Progressive encephalopathy due to 
primary infection of brain with HIV 
Ultmann 
et al 1987 
USA 16 6m-6yrs DDST 
BSID I 
Variable Neurodevelopmental courses 
Belman et 
al 1988 
USA 68 6wks-13yrs BSID I 
Stanford-Binet 
Preschool 
language scale 
Kaufman 
Assessment 
Battery for 
Children 
90% of children had evidence of CNS 
dysfunction. Severity of dysfunction 
and neurologic course was variable. 
Blanche et 
al 1990 
France 94 1m-9yrs Neurological 
examination 
One third of patients had severe 
immuno-supression and 
encephalopathy early on, the majority 
had less clinical symptoms. 
European 
collaborati
ve study 
1990 
8 
European 
centres 
39 HIV + 
164 HIV - 
Birth-4yrs Neurological 
examination 
Lower prevalence of developmental 
delay than previously reported (31%) 
Nozyce et 
al 1994 
USA 21 HIV+ 
65 sero-
reverted 
95 HIV- 
Birth-2 yrs BSID HIV symptomatic children at greater 
risk for developmental impairments. 
HIV exposed, uninfected children not 
at risk for developmental delay.  
Chase et 
al 1995 
USA 24 HIV + 
27 sero-
reverted 
4m-30m BSID  Early and persistent delay is common 
in HIV + children. Exposed, uninfected 
children are not at risk. 
Lobato et 
al 1995 
USA 
Multi-
centre 
1811 Birth-13 yrs Record review HIV encephalopathy is common and 
associated with increased morbidity 
and mortality 
Gay et al 
1995 
USA 126 Birth-2yrs BSID Rate of development in first 24 months 
slower in HIV infected children. 
Belman et 
al 1996 
USA 32 HIV + 
99 sero-
reverters 
116 HIV- 
Birth-2yrs Neurological 
examination 
Neurological deterioration associated 
with severe clinical disease. HIV 
exposed, uninfected children not at 
risk.  
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Pollack et 
al 
1996 
USA 22HIV+ 
42 Sero-
reverters 
27HIV- 
Birth-2yrs BSID Developmental delay associated with 
decreased linear growth in HIV 
infected children. Growth and 
development associated with HIV viral 
load. 
Chase et 
al 2000 
USA 114HIV + 
481 HIV- 
4m-30m BSID II Cognitive and motor delays and 
declines in HIV infected children are 
important markers of disease 
progression, independent of other risk 
factors. 
Smith et al 
2000 
USA 114 Birth-30m BSID II Early infected children are at greater 
risk for developmental impairment than 
those infected later. 
Pearson 
et al 2000 
USA 831 Birth-16yrs BSID II 
McCarthy 
scales of 
children’s 
abilities. 
Wechsler 
intelligence 
scale. 
Wechsler adult 
intelligence 
scale. 
Neuropsychological and motor 
outcomes can predict long term 
outcomes (eg longevity) in HIV 
infected children. 
Missmer 
et al 2000 
USA 65 Mean 5.5yrs Functional 
Status II 
Growth parameters, immune status 
and social factors are important 
predictors of functional status. 
Blanchette 
et al 2000 
USA 25 HIV+ 
25HIV - 
Mean 24.7m 
Mean 18.5m 
BSID II 
CT scan 
CT abnormalities were associated with 
developmental delay 
Macmillan 
et al 2001 
USA 147HIV+ 
383 drug 
exposed 
Birth-30m BSID II HIV infection associated with slow 
neurodevelopment and decreased 
head growth. 
Llorente et 
al 2003 
USA 157 4m-30m BSID II BSID scores at 4m independently 
predict  mortality. 
Smith et al 
2006 
USA 117 HIV+ 
422 HIV- 
3yrs-7yrs McCarthy 
scales of 
children’s 
abilities 
An early AIDS defining illness 
increased the risk of static 
encephalopathy during pre-school and 
early school age years. 
Nozyce et 
al 2006 
USA 274 2yrs-17yrs Conner’s 
Parent Rating 
scale. 
Wechsler –
intelligence 
scale for 
children III 
Wechsler Pre-
school and 
primary scales 
of intelligence. 
Stable HIV + children had more 
behavioural problems and lower 
developmental and cognitive scores 
than established norms. 
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2.6.2 Clinical studies from Africa. 
Despite the fact that Sub-Saharan Africa has the highest prevalence of paediatric HIV 
infection in the world (UNAIDS, 2005), very little research into the neurological 
complications of HIV in children has been done in Africa. 
 
In the 1990’s a small number of studies relating to neurodevelopmental delay in African 
children infected with HIV was published. Spitaels (1994) documented two case studies, 
Vetter et al (1996) and Emodi and Okafor (1998) reported on general clinical 
manifestations of HIV in children and Msellati et al (1993) conducted a prospective 
cohort study which assessed neurological development in HIV positive children. Boivin 
et al (1995) compared HIV positive children to their negative counterparts and followed a 
small group of HIV positive children up for a two year period, Drotar et al (1997) 
compared HIV infected infants to uninfected and sero-reverter infants in a prospective 
study of 18 months. 
   
The ages of the children included in these four studies varied widely. Emodi and Okafor 
(1998) and Vetter et al (1996) included children from birth to 16 years of age in their 
studies. Spitaels (1994) presented two case studies one of a 10 month old and one of a 
two and a half year old. Msellati et al (1993), Boivin et al (1995) and Drotar et al (1997) 
followed children up from birth to 18 months or two years of age. The fact that these 
studies included children of such different ages makes it difficult to compare their 
findings. 
 
A second problem arising from the research in Africa is that few of the studies explain 
how the diagnosis of HIV in children younger than 15 months was made. All authors 
appear to have relied, to some extent on clinical diagnosis which means that the findings 
for children under 15 months should be interpreted with caution as false positive and 
negative diagnoses are possible. 
 
Most of the authors did not use standardised developmental assessments although 
Msellati et al (1993) did draw up their own tool based on existing tools. Unfortunately 
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they do not specify whether or not this was validated prior to commencing the study. 
Boivin et al (1995) used the Denver Developmental Screening Test and Drotar et al 
(1997) used the Bayley Scales of Infant Development. The differences in assessment 
methods mean that significant comparisons between studies cannot easily be made. 
 
The two children assessed by Spitaels (1994) both presented with delayed milestones 
and changes in tone and neither had focal neurological signs. Vetter et al (1996) did not 
assess patients for neurological signs specifically, they did however note that meningitis 
with neurological sequelae was very common among HIV infected children. Emodi and 
Okafor (1998) identified neurological complications in only 9.5% of their patients. This 
figure could be low relative to other studies because this was a retrospective study 
which relied on clinical notes. Neurodevelopment was not routinely assessed and 
therefore may often have been missed by the examining doctors. The age range of this 
study (birth to 16years) was also much wider than other studies which detected a higher 
prevalence of neurological involvement (Nozyce et al, 1994; Msellati et al’ 1993; 
Belman, 1992) 
 
The large prospective cohort study conducted by Msellati et al (1993) identified 31% of 
infants in their study as being developmentally delayed at 12 months of age, and by the 
time the children were 18 months of age this had risen to 40%. These findings are 
similar to the findings of the European Collaborative Study (1990) which found 31% of 
infants infected with HIV had neurological complications. Msellati et al (1993) recognise 
that factors related to disease chronicity as well as direct neurological involvement may 
contribute to the developmental delay seen in these children. Boivin et al (1995) 
assessed 14 asymptomatic HIV positive children using the Denver Developmental 
Screening test and concluded that HIV affects the CNS of infected children even before 
the children become symptomatic. Drotar et al (1997) compared HIV positive children to 
seroreverted children and uninfected children and concluded that HIV infection results in 
early motor and cognitive delay that is not attributable to environmental and biological 
risk factors. 
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A study done in South Africa comparing HIV positive to HIV negative children (Potterton 
and Eales, 2001) found that 40% of HIV positive children under 12 months of age 
presented with developmental delays. This study made use of the Neurodevelopmental 
Assessment Score (Goodman et al, 1985), which although valid and reliable and 
designed for use on South African children, is a screening tool and did not provide much 
insight into the extent of delay experienced. 
 
The most comprehensive studies of neurodevelopment and paediatric HIV to emerge 
from Africa have been done in Tanzania by one group of authors. McGrath et al (2006b) 
studied the timing of mother to child transmission of HIV and the neurodevelopment of a 
large sample of Tanzanian children in a longitudinal follow-up study from birth to 18 
months. They found that HIV positive children performed worse on tests of 
neurodevelopment than HIV negative children and were more likely to be 
developmentally delayed by 18 months of age. Children who were already infected at 
birth were at greater risk of developmental delay. This study made use of the Bayley 
Scales of Infant Development II. The authors of this study stress that regular 
developmental assessments of all HIV infected children should be carried out in order to 
plan for medical, rehabilitative, educational and psychological interventions. In their 
secondary analysis of the same cohort, McGrath et al (2006a) investigated the impact of 
double blinded, placebo controlled, multi-vitamin supplementation trials on the 
neurodevelopment of children born to HIV positive mothers. Multivitamin 
supplementation was not associated with better mental scores, but did improve motor 
scores between six and 18 months of age. The authors of this study caution that vitamin 
supplementation is not an alternative to antiretroviral therapy and should be used in 
combination with usual HAART regimes. 
 
Only one study relating to HIV and school going children in Africa could be found 
(Bagenda, 2006). This study examined the neurologic and neuropsychologic functioning 
of long-surviving, antiretroviral-naïve children in Uganda. The children were between six 
and 12 years of age and were assessed using the Kaufman Assessment Battery and the 
Wide Range Achievement- third edition. HIV infected children did not differ significantly 
in neurologic and cognitive assessments when compared to age and gender matched 
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controls. This study highlights the fact that there is a subgroup of HIV infected children 
of school going age who do well, despite not being on HAART and that their needs 
should not be neglected. The sample size of HIV infected children in this study was 
relatively small (n=28) and further studies are required to confirm these findings. 
 
There remains a huge need for studies on the neurodevelopmental complications of HIV 
in developing countries and especially in Sub-Saharan Africa where the prevalence of 
paediatric HIV remains very high and where antiretrovirals are not yet universally 
accessible. Intervention studies are urgently needed to establish the best way to 
manage these children in the long term. 
 
A summary of the studies on neurodevelopmental delay in HIV positive children 
conducted  in Africa is presented in table 2.2. 
Table 2.2 Neurodevelopmental studies conducted in Africa. 
Authors Country Sample  
(n) 
Age Measures Main Findings 
Msellati et 
al, 1993 
Rwanda 50 HIV+ 
136 HIV- 
32 HIV 
unknown 
6m-24m Neurological 
examination 
HIV + children more likely to be 
developmentally delayed than 
HIV- children. Delay is related to 
stage of HIV infection. 
Boivin et al, 
1995  
Zaire 14 HIV+ 
36 HIV- 
Birth-
24m 
DDST HIV infects the developing CNS, 
even in asymptomatic children. 
Drotar et al, 
1997 
Uganda 79 HIV+ 
241 Sero-
reverters 
116 HIV- 
6m-24m BSID HIV results in motor and cognitive 
delay that is not attributable to 
environmental risk factors. 
Emodi and 
Okafor, 
1998 
Nigeria 63 Birth -
16yrs 
File review Less than 10% of children 
presented with neurological signs. 
Potterton 
and Eales, 
2001 
South 
Africa 
30 HIV + 
30HIV - 
Birth-
12m 
Neurodevelopmental 
assessment score 
Developmental delay is common 
and presents early in HIV infected 
infants 
McGrath et 
al, 2006 
Tanzania 327 6m-18m BSID II Developmental delay is highest 
amongst children already infected 
with HIV at  birth 
McGrath et 
al, 2006 
Tanzania 327 6m-18m BSID II Maternal multivitamin 
supplementation can reduce the 
risk of developmental delay 
Bagenda et 
al, 2006 
Uganda 28 HIV+ 
42 Sero-
6-12yrs Kaufman 
Assessment Battery 
Antiretroviral naïve HIV infected 
children, did not differ significantly 
in neurologic and cognitive 
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reverters 
37 HIV- 
for Children 
Wide Range 
Achievement III 
functioning when compared to a 
control group. 
  
2.7 Paediatric HIV and Growth 
Malnutrition is common in children infected with HIV. This can be as a result of reduced 
calorie intake due to poverty or poor feeding practices, or can be due to the effect of the 
virus on the gastrointestinal system which results in malabsorption. Chronic diarrhoea, 
vomiting and oral candiasis are also contributory factors. Malnutrition affects the growth 
of HIV positive children. Children with growth failure may have decreased weight for 
height (wasting) and decreased height for age (stunting). Malnutrition initially causes 
wasting, while stunting is associated with prolonged malnutrition (Wiznia et al, 1996; 
Chantry and Moye, 2005). 
 
Wasting may result from failure to gain weight or from loss of weight and indicates that 
there is decreased fat or tissue mass relative to what is expected for a child of that 
height or length. Wasting can have a very rapid onset, but can also recover very quickly 
under favourable circumstances (WHO, 1986). Stunting is an indication of slow skeletal 
growth and is often associated with poor socio-economic conditions, chronic or repeated 
infections as well as inadequate nutrition. Stunting takes a long time to correct once 
adverse circumstances have been corrected as skeletal growth is a slower process than 
growth in body mass. Head circumference and arm circumference measurements are 
usually considered as proxies for height and weight and are therefore frequently omitted 
in studies on growth in children (WHO, 1986). 
 
Until recently growth was routinely recorded on growth charts from the NCHS (National 
Centre for Health Statistics in the United States). Although the NCHS growth charts 
represent children in the USA the World Health Organisation has endorsed their use 
around the world based on evidence that growth patterns of pre-school children from 
different ethnic backgrounds are in fact very similar (Chantry and Moye, 2005). WHO 
growth charts for breast fed infants are now available for height and weight and should 
be used in future studies (WHO Bulletin August 2006). Anthropometric measures may 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
36 
be expressed as z-scores which signify the distance in standard deviation scores above 
or below the reference median z-score of 0.0 which is the 50th percentile for a specified 
age and sex (Chantry and Moye, 2005). 
 
In HIV infected children weight, height and head circumference may all be affected 
within the first six months of life. The association between HIV and malnutrition is bi-
directional. Malnutrition can cause more rapid progression of HIV disease, and HIV 
causes worsening malnutrition through its direct impact on the gastrointestinal system. 
Certain antiretroviral drugs can contribute to malnutrition by causing diarrhoea and 
vomiting. Regular monitoring of weight, height and head circumference is recommended 
in all HIV infected children (Chantry and Moye, 2005; Nachman et al, 2002; Coovadia 
and Meyers, 2001; Bobat et al, 1998). In a child who is not meeting his growth 
milestones, vitamin and micronutrient deficiencies should be considered as well (Mintz, 
1999). 
 
Growth delay is a direct effect of paediatric HIV infection. Growth hormone levels in HIV 
infected children are usually normal. Causes for poor growth in HIV infected children 
may be due to decreased sensitivity to circulating growth hormone, decreased sensitivity 
to insulin-like growth factors or to the fact that the release of cytokines as a result of HIV 
infection may lead to ineffective action of growth hormone (Newell et al, 2003; Lepage et 
al, 1991; Laue et al, 1990). 
 
A number of studies have investigated growth deficiencies in children infected with HIV. 
Nathan et al (2003) reported stunting, but not wasting in a sample of institutionalised 
HIV positive African children. Spira et al (1999) found that failure to thrive in the first few 
months of life was associated with increased risk of death or progression to AIDS in HIV 
infected infants in Rwanda. Bobat et al (2001) investigated the growth of HIV infected 
children born in Durban, South Africa. They found that HIV positive infants exhibited 
early and sustained low mean length-for-age and weight-for-age z scores but weight-for-
length was within normal limits. The authors of this study concluded that HIV infected 
children have early and sustained stunting, but not wasting. Children with rapidly 
progressing disease are stunted and wasted and have a poor prognosis. 
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There is an association between growth and neurodevelopmental delay in HIV positive 
children especially in children with advanced stages of the disease (Pollack et al, 1996). 
Infants with the most severe growth delay had significant cognitive and motor delay 
even if this only became apparent later (Pollack et al, 1996). Wiznia et al (1996) report a 
strong correlation between poor weight for age and decreased cognitive function and a 
low CD4 count. Missmer et al (2000) found that a decreased height for age z-score was 
a strong predictor of decreased functional status, suggesting that height may be used as 
an indicator of disease severity.  
 
Acquired microcephally has been noted by a number of authors and is usually due to 
impaired brain growth and cerebral atrophy secondary to encephalopathy (Mitchell, 
2001; Macmillan, 2001; Mintz, 1999). Cortical atrophy is associated with disease 
progression and neurodevelopmental delay (Llorente et al, 2003; Pearson et al, 2000). 
 
Growth parameters are important markers of disease progression in HIV infected 
children and may be predictive of neurodevelopmental status. Height and weight should 
be routinely monitored in children infected with HIV. 
 
2.8 Effect of HAART on Neurodevelopment. 
As new treatment options become available and children in developed countries have 
easier access to HAART, concerns have been raised about the long term effects of 
these drug regimens on the development of children (Brady et al, 1996). These issues 
are important for Sub-Saharan Africa and other developing countries where more 
children are slowly gaining access to antiretroviral medication. 
 
The first study to be done on the effect of antiretrovirals on neurodevelopment was 
conducted by Pizzo et al (1988). They found that continuous infusion of zidovudine in 
children with symptomatic HIV infection resulted in a marked improvement in 
neurodevelopmental function in children who were encephalopathic prior to treatment. 
Despite the small sample size and concerns about long term toxicity, especially 
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myelosuppression, this study raised great hopes for the future management and 
possible reversal of encephalopathy. 
 
Wolters et al (1997) conducted a follow up study on children with symptomatic HIV 
disease who were initially antiretroviral naive. They found that cognitive scores remained 
stable at six and 24 months after starting antiretroviral therapy but that both expressive 
and receptive language scores deteriorated at six and 24 months despite antiretroviral 
therapy. Raskino et al (1999) investigated the effect of different nucleoside antiretroviral 
regimes on neurologic, neurocognitive and brain growth outcomes in children. They 
concluded that combination therapy (zidovudine and didanosine) was superior to 
monotherapy for most CNS outcomes evaluated. In their retrospective study Sanchez-
Ramon et al (2003) claim that antiretroviral therapy was responsible for reversing 
neurologic changes in some patients and delayed onset of progressive encephalopathy 
if commenced prior to onset of neurologic symptoms. In 2005, Jeremy et al investigated 
whether the addition of a protease inhibitor would improve neuropsychological 
functioning in antiretroviral therapy experienced children. They found no significant 
improvements except for a slight improvement in vocabulary scores. This study did not 
investigate the effects on motor function.  
 
Resino et al (2006) conducted a retrospective study of 113 children who had six years of 
follow up after commencing antiretroviral therapy. All children had received mono- or 
dual-nucleoside therapy prior to starting HAART. They concluded that long-term HAART 
was able to restore CD4 counts and control viral loads in HIV infected children as long 
as it was started before the onset of severe immuno-suppression. Children who 
commenced HAART with CD4 counts of greater than 25% achieved counts of over 30% 
quickly and were able to maintain them. 
 
The studies reviewed present a case for cautious optimism on the protective and 
restorative effects of antiretrovirals on the CNS. Future studies need to be done on 
narrower age ranges and need to monitor functional as well as clinical outcomes.    
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2.9 Paediatric HIV and the Family 
Paediatric HIV is a multigenerational disease. The diagnosis of a child as HIV positive 
almost always means that at least the mother, and possibly the father, is infected as 
well. This makes HIV very different from other chronic childhood diseases. Families 
affected by HIV are also more likely to be poor and are often inhibited from accessing 
the services and support which they require due to the stigmatisation of HIV. They may 
also have limited access to health care (Deacon et al, 2005; Sher, 2005). Families 
affected by HIV also experience multiple losses which add to the psychosocial burden 
and emotional distress experienced by the family (Orner, 2006; Katapa, 2004; Lewis et 
al,1996; Lewis et al, 1994; Sherwen and Boland, 1994; Reidy et al, 1991). 
 
Many studies have identified stigma as one of the main concerns facing HIV infected 
mothers and their children (Silver et al, 2003; Antle et al, 2001; Hackl et al, 1997). The 
stigma attached to HIV makes it difficult for HIV positive mothers to form meaningful 
relationships with people outside the immediate family. Many mothers reported being 
lonely and having no friends (Antle et al, 2001). Stigma exists not only at a social level 
but also within the health care system and mothers reported feeling humiliated and 
ostracised when trying to access health and social care. Silver et al (2003) reported that 
mothers who perceived themselves to be stigmatised were more likely to be depressed 
and to report lower levels of parenting self-efficacy.  
 
Two studies conducted in Africa identified a number of concerns expressed by 
caregivers of HIV infected adults. Some of the issues identified by the caregivers of 
adults infected with HIV as being problematic were; stigma, lack of/cost of transport to  
clinics, lack of training, poverty, loneliness and lack of acknowledgement of themselves 
as caregivers by health care workers and non-governmental organisations (Orner, 2006; 
Katapa, 2004). Care-giving also impacted negatively on employment and social life. 
Caregivers expressed the problem of the cost of transport to clinics for on going medical 
care. Katapa (2004) makes the point that “home-care” in developing countries is 
different to that in developed countries as it merely means that the patient is being sent 
home to be cared for by their family and does not imply the provision of continued 
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professional medical care within the home. Within this context the need for training and 
empowerment of caregivers becomes imperative. These studies are of importance as 
they were conducted in developing countries. 
 
In their extensive review Richter et al (2004) highlight the fact that adult caregivers of 
HIV infected and affected children have needs of their own which must be addressed in 
an attempt to prolong the length of time that they are able to care for the children as well 
as to improve their ability to care for children. They advocate programmes that provide 
psychosocial and emotional support to help families and children deal with the multiple 
stresses and losses that they face. 
 
Reidy et al (1991) highlighted the fact that children who are HIV positive require 
nurturing as well as care necessitated by their illness. This places an increased burden 
on the primary caregiver of the child, who may themselves be HIV positive. HIV is a 
progressive chronic illness which requires long term family involvement and 
commitment. As the disease progresses the child will present with severe acute signs 
and symptoms which require frequent and intensive medical intervention. Caring for a 
child with HIV is a time consuming and burdensome activity. Caregivers are beset with 
constant concerns over the child’s health and worries about what the future may hold, 
they often feel inadequate as they are unable to meet the child’s needs and lack 
confidence in their own parenting abilities (Adler, 2000; Weiner et al, 1994; Reidy,1991). 
Linsk and Mason (2004) investigated the stresses on grandparents and other relatives 
caring for children affected by HIV, and found that the caregivers infected with HIV 
themselves, experienced the most stress. 
2.9.1 Parenting Stress 
Being the parent of any child is inherently stressful to a certain degree (Deater-Deckard 
and Scarr, 1996; Abidin, 1992). Some level of parenting stress is normal. Abidin (1992) 
argued that there is no linear relationship between parenting stress and good parenting 
and that some parents may disengage from their children completely and experience 
very little parenting stress. A number of studies investigating the factors that may 
influence the levels of stress experienced by caregivers have been conducted. 
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Ostburg and Hagekull (2000) investigated the predictors of parenting stress in a 
population of 1081 Swedish mothers of healthy children. They found that high work load, 
low social support, perception of the child as ‘difficult’, negative life events, child 
caretaking hassles, more children in the family and high maternal age were directly 
related to increased levels of parenting stress. No buffering effects of social support 
were found. This study is valuable in that it was well carried out and very 
comprehensive. However the sample of mothers was well educated and from a highly 
developed country with extraordinary social “safety nets” and care should therefore be 
taken before applying these findings to other socioeconomic and cultural contexts. 
Quittner et al (1990) also found no moderating effects for social support in their study on 
chronic parenting stress. 
 
Schor (2003) favours the family stress model developed by Conger in 2000. According 
to this model children’s outcomes are strongly influenced by how well their families 
function. Stresses within the family, including stress brought about by ill health, can 
disrupt parenting and can lead to short term and long term poor outcomes. The 
development of effective interventions to improve family functioning may lead to 
significant benefits for children and their families. Cadman et al (1991) conducted a 
large epidemiologic study in Canada and found that families of children who had chronic 
health problems are not necessarily dysfunctional compared to families with healthy 
children, although they may experience moderately elevated psychosocial problems. 
They urge clinicians not to assume that a family will have increased levels of 
psychosocial problems simply because they have a child with a chronic health problem. 
However, having a child with a disability or a chronic health condition has repeatedly 
been shown to increase parenting stress (Esdaile and Greenwood, 2003; Ultmann et al, 
2002; Dyson, 2001; Button et al, 2001; Ong et al 1998; Bithony et al, 1995). Dyson 
(2001) examined parental stress and family functioning in families with children with 
handicaps. She found that parental stress was independent of economic and social 
constraints and that levels of stress did not affect family functioning. She suggests that 
to lessen stress, intervention should focus on increasing child competencies, caretaking 
of the child and changing parental perception of the child as it was these areas which 
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contributed most to parental stress.  Abidin and Wilfong (1989) found that parents of 
young children seek appropriate health care for their children regardless of their 
parenting stress levels. Stanton (1999) conducted a comprehensive review of family 
functioning and outcomes in children with neurological disorders. She concluded that 
family functioning does influence outcome in certain cases but that more research needs 
to be done in this area.  
 
Esdaile and Greenwood (2003) found that having a child with a disability led to elevated 
stress scores in both mothers and fathers and that there was no gender difference in 
levels of stress. The impact of having a disabled child on the father is not often 
considered and they suggest that programmes should address the needs of both 
mothers and fathers. Deater-Deckard and Scarr (1996) also found very similar levels of 
stress between mothers and fathers in their sample of non-referred parents of healthy 
children. 
 
 A number of studies have been done to try and determine what factors have the most 
effect on parenting stress. Button et al (2001) found that the level of impairment in 
disabled children was a significant predictor of stress in mothers of children with cerebral 
palsy, however the amount of partner support the mother received did not influence 
parenting stress levels. These findings are in contrast to those of McKinney and 
Peterson (1987) who found that mothers with less spousal support had higher levels of 
parenting stress. Silver et al (1998) concur with Button et al (2001) in finding that 
parents of children with greater functional limitations experience higher levels of parental 
distress.  A study conducted in Malaysia by Ong et al (1991) found that mothers of 
children with cerebral palsy who had greater care-giving demands and required more 
frequent hospitalisation were more stressed. Mothers with lower levels of education also 
experienced more parenting stress in their study. It would appear that there are a 
number of factors which influence parenting stress and that there is no clear consensus 
on which are the most important. Individual family assessment therefore remains 
important and generalisations should be avoided. 
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In response to the complexity of caregiver burden, Raina et al (2004) have developed a 
complex multidimensional model to explain this concept. The concept of caregiver 
burden is broader than that of parenting stress and encompasses aspects of formal and 
informal caregiving within a comprehensive model. The five constructs included in the 
proposed model are:  
• Background and context. This includes socioeconomic status of the family which 
can be determined using measures of parental education, occupation and 
income. The authors of the proposed model hypothesise that higher socio-
economic status will be associated with fewer child behaviour problems, less 
caregiving demands and better psychosocial and physical health; 
• Child characteristics. Behaviour problems and level of disability will be assessed. 
Better scores in these areas are expected to be associated with improved 
caregiver self-perception and better physical and psychological health; 
• Caregiver strain. Factors considered under this construct are care giving 
demands and perception of formal care. Fewer caregiving demands are expected 
to be associated with higher scores on measures of self perception. Caregivers 
who report formal care as being more family centered are anticipated to have 
better psychological and physical health; 
• Intrapsychic factors. Factors such as mastery and self esteem are expected to be 
associated with higher perceived levels of social support, better family functioning 
and higher use of stress management stategies.   
• Coping/ supportive factors and health outcomes. These factors will measure 
informal support derived from family and friends as well as stress management. 
The authors hypothesize that higher scores will be associated with better 
psychological and physical health of the caregivers (Raina et al, 2004).  
 
This multidimensional model will allow researchers to investigate the direct relationships 
between constructs and outcomes as well as the indirect effects through intervening 
constructs. This will help to determine the most relevant factors impacting on caregiver 
health and well being and possibly assist in planning family centred services (Raina et 
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al, 2004). This model is still being tested and will provide valuable insights into caregiver 
burden and the factors which influence it. 
 
Parenting stress has traditionally been investigated with the mother as the primary 
caregiver. As society goes through rapid transformation one can not assume that the 
biological mother will always be the primary caregiver (Schor, 2003). The following 
sections will explore the parenting stress of mothers, grandmothers and fathers caring 
for children infected or affected by HIV.  
2.9.2 Mothers 
It is important to note that many of the HIV positive mothers included in the following 
studies have children who are not necessarily HIV positive (Goldstein et al, 2005; Silver 
et al, 2003; Marcenko and Samost, 1999; Hackl et al, 1997; Faithfull, 1997; Black et al, 
1994b). The issues raised in these studies are similar to those expressed by HIV 
positive mothers with HIV positive children, however they have the additional concern 
for their child’s health and well being (Shambley-Ebron, 2006). 
 
Goldstein et al (2005) investigated psychological distress and substance abuse among a 
large sample of parents living with HIV. They found that custodial parents who were HIV 
positive themselves were significantly more likely to be emotionally distressed, this 
being even more significant in mothers. HIV positive mothers were overburdened and 
often unable to meet their own health care needs. Greater perceived parental distress 
was associated with medical non-adherence and more missed clinic appointments. 
Parental distress was not associated with increased number of children in the household 
which is in contrast to the hypothesis originally put forward by the authors. Mothers who 
are HIV positive face the dual challenge of being a patient and a caregiver (Hackl et al, 
1997).   
 
DeMarco et al (2002) found that mothers who were HIV positive themselves tended to 
“silence” their own needs and attend to the needs of their children and others first. This 
included physical and health needs as well as psychological needs. This practice of 
“silencing self” ultimately placed an increased burden on the mothers and meant that 
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they did not readily seek the help they need even when it is available. Mothers who 
experienced difficulty in caring for their children due to ill health experienced high levels 
of psychological disturbance (Silver et al, 2003). These findings are corroborated by 
Shambly-Ebron (2006) who conducted an in depth qualitative study on self-care and 
mothering in HIV positive African American women. She also found that mothers would 
put the needs of their children and others in their care above their own. The mothers in 
this study valued their role as mothers very highly and found that it helped to create a 
“life of meaning”. Black et al (1994) found that mothers who were HIV positive were 
more receptive to an intervention programme aimed at optimising their child’s 
developmental progress than HIV negative mothers.  
 
Young mothers with HIV appear to enjoy their children in infancy but find their increased 
levels of activity as their motor development improves more challenging. Mothers 
described their toddlers as “bad” or “mean” rather than typical or normal (Abdalian and 
Wright, 2000). 
 
Varga et al (2005) conducted a study in Johannesburg where they investigated the 
psychosocial consequences of mothers receiving their babies HIV diagnosis at four 
months rather than waiting until twelve months. Most mothers preferred the early 
diagnosis as it meant they did not have to deal with the uncertainty and fear of an 
unknown diagnosis. However in the case of sero-discordant couples, the early diagnosis 
placed enormous stress on the mother who was still dealing with the birth of her child 
and now had to face issues of disclosure and stigma as well. Careful counselling and 
support are advocated in the event of early diagnosis of HIV in infants.  
 
Mothers of HIV infected children experience chronic sorrow, from the time of their child’s 
diagnosis and for the rest of the child’s life as she faces the challenges and illnesses 
which paediatric HIV inevitably brings (Antle et al, 2001). A need exists for support 
groups which address the needs of HIV positive mothers within the context of their 
family (Hansell et al, 1998). Mothers who are HIV positive also express the need for a 
“one-stop” clinic where all the health needs of themselves and their children can be met 
(Marcenko and Samost, 1999; Hackl et al, 1997). 
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Very few studies were found in which both the mothers and their children were HIV 
positive. The needs of this group require further investigation, particularly in the context 
of developing countries where paediatric HIV is still so common.  
2.9.3 Grandmothers 
As the biological mothers of HIV infected children become incapacitated or die due to 
their own infection the care of the children is often transferred to the grandmothers. This 
is particularly common in Africa where institutions for care of orphans are few and far 
between and where traditionally care of orphans falls on surviving relatives (Richter et 
al, 2004). This situation, although preferable to institutionalisation, places additional 
stresses on aging caregivers and raises a new set of concerns. The stigmatisation and 
isolation experienced by HIV affected families may compound the problems and 
stresses experienced by grandmother caregivers (American Academy of Pediatrics, 
1999; Joslin and Harrison, 1998; Caliandro and Hughes, 1998). Grandmothers’ own 
health problems may complicate the problems inherent in parenting. Grandparents tend 
to neglect their own health as they prioritise the health care and nurturing needs of their 
grandchildren. The health of elderly caretakers is at risk of being compromised as they 
assume a caretaking role, which involves multiple tasks, at a time of their lives when 
their own health needs are increasing (Linsk and Mason, 2004; Schor et al, 2003). The 
parenting role assumed by grandmothers often occurs in the context of grieving for 
multiple family members including grandchildren, sons and daughters (Joslin and 
Harrison, 1998) 
 
Musil (1998) investigated the parenting stress of grandmothers caring for their 
grandchildren. She found that grandmothers who were the primary caregivers had 
significantly high parenting stress levels on the PSI-SF compared to grandmothers who 
did not have primary care of their grandchildren. She suggests that additional research 
into the psychosocial health of grandmother caregivers will provide valuable insight and 
provide direction for developing programmes to support grandmother caregivers in 
meaningful ways. This study provides some fuel for thought in a country where more 
and more children are being cared for by their grandmothers. 
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2.9.4 Fathers 
Not many studies have investigated the impact of having an HIV positive child on fathers 
and male caregivers. Strug and Burr (2003) investigated the service needs of male 
caretakers of HIV infected and affected children. Not many HIV services cater 
specifically for the needs of male caretakers. They found that men requested help with 
accessing finance, housing and transport as priorities, and then parenting and emotional 
support. Forty three percent of services surveyed offered parenting skills training, but 
these seldom employed male staff or made an effort to address the concerns of male 
caretakers specifically. Men requested support groups for men caring for HIV infected 
children. In their study on parenting stress and psychosocial adjustment of fathers caring 
for HIV positive children Weiner et al (2001) reported high levels of parenting stress and 
psychological distress. Fathers in this study also requested gender-specific support 
groups as well as parenting skills and assistance with disease management and 
planning for the future. Antle et al (2001) urge that the parenting preparation of fathers 
be considered in programmes for families affected by HIV. 
 
The needs of fathers and other male caregivers caring for children infected with HIV 
have not been well explored and further studies need to be conducted in order to gain 
better insight into the challenges faced by this small, but growing, group. 
 
Parenting stress is a complex issue which is confounded by many psychosocial factors. 
Caregivers of HIV positive children are at risk of increased levels of parenting stress. 
The parenting stress of caregivers of HIV positive children in developing countries has 
not been fully explored. 
 
The following section will briefly discuss the context of paediatric HIV in South Africa. 
 
2.10 Socioeconomic Context of Paediatric HIV in South Africa  
Decades of apartheid left the health system in South Africa plagued by racial disparity 
and inequality. Addressing these issues posed an immense challenge to the new 
democratic government in 1994 (Saloojee and Pettifor, 2005). A number of social and 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
48 
economic reforms aimed at alleviating the worst consequences of apartheid and 
hopefully leading to improved child health and well-being were initiated soon after the 
ANC came into power (Cameron, 2003). These measures included providing free 
access to health care for all children under six years of age and pregnant women, 
increasing access to social grants and providing primary health care that was both 
accessible and affordable to all (Saloojee and Pettifor, 2005). Despite these efforts the 
divide between rich and poor continues to increase and the health and well-being of the 
majority of children in South Africa remains sub-optimal (Romani and Anderson, 2002). 
HIV has played a large contributing role to this unfortunate state of affairs and has 
placed an enormous burden on existing health care facilities. Saloojee and Pettifor 
(2005) report that more than 40% of deaths of children under five are due to AIDS and 
that in-hospital mortality rates have more than doubled in the last ten years. 
 
Cameron (2003) found that a large cohort of infants born in South Africa in 1990 failed to 
gain weight as rapidly as expected in the first year of life and that differences between 
white and black children persisted into childhood and early adolescence. These findings 
again highlight the worrying disparity between the well-being of black and white South 
African children and the fact that the economic and social changes made since the end 
of apartheid have not been sufficient to overcome these. Richter et al (2004) and 
Williamson (2000), also acknowledge that nutrition, as well as access to health care, are 
factors that need to be addressed in the bid to meet the needs of vulnerable children in 
South Africa, including those infected with HIV. 
 
The number of children orphaned by HIV/AIDS in South Africa is expected to continue to 
rise for a number of years, as is the number of child-headed households (Skinner et al, 
2004). At present 10% of children in South Africa have lost at least one parent by the 
time they are nine years old (Brookes et al, 2004). Orphaning in the context of HIV is 
often preceded by a period of time where children become the caregivers for their dying 
parents and younger siblings. This is often a time of immense emotional and financial 
stress for children and parents alike (Loening-Voysey, 2002). In Sub-Saharan Africa the 
burden of caring for children orphaned by HIV has largely been met by the extended 
family, this may place financial burdens on the family and lead to exploitation and abuse 
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of orphans (Lau and Muula, 2004). The stresses of grandmothers assuming care for 
their orphaned grandchildren has been previously discussed in this review. 
 
Poverty in South Africa remains a serious and complex challenge which is inextricably 
linked to the spread of HIV (Loening-Voysey, 2002; Barbarin and Richter, 2001; 
Barbarin and Khomo, 1997). Barbarin and Khomo (1997) in their extensive study on 
economic status and social capital in South African townships found that the poorest 
families in Soweto were those headed by single mothers who did not attend high school, 
living in households of six people or more, and who were unemployed. They also found 
that the presence of a grandmother in these households was more of a mediating factor 
for hunger than the presence of a male partner. They attribute this to the fact that 
grandmothers may bring a small but important income to the family if they receive a 
pension. 
 
2.10.1 Poverty and child development 
Poverty has the potential to impact negatively on early childhood development (Lima et 
al, 2004; Schor et al, 2003; Linver et al, 2002; Catherwood, 1999). Emerson (2004) 
noted that even in developed countries, poverty was associated with poor parental 
health and well-being and consequently poorer parenting practices and that the 
experience of poverty is often associated with poor child heath and well-being. Duncan 
et al (1994) state that the length of time a child is exposed to poverty is an important 
factor to take cognisance of, while Burgess et al (2004) argue that the timing of 
exposure to poverty is also important with children born into a poor household being at 
greater risk than those exposed to poverty at a later stage of their childhood. A number 
of studies have investigated ways in which to possibly mediate the effects of poverty on 
the development of young children. These studies have mainly been conducted on poor 
people living in wealthy countries, we should therefore take care not to assume 
automatically that their findings will apply to our context in South Africa where people’s 
experiences of poverty may be very different.  
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Schor et al (2003) report that parents are central to paediatric care. The health and well-
being of children are inextricably linked to their parents’ physical, emotional and social 
health as well as their social circumstances and child rearing practices. There is 
enormous diversity among families and this impacts on child rearing practices and the 
way in which families and individual parents respond to stress. Child health is strongly 
related to family income. The findings of this study are of relevance in South Africa 
where unemployment remains unacceptably high with the potential to impact seriously 
on child health and development. 
 
In a large prospective study done in northeast Brazil, Lima et al (2004) found that poor 
performance in the first year of life on the BSID was related to environmental conditions 
associated with poverty. Children who had more stimulating homes performed better 
especially in the mental developmental indices of the BSID. Poor motor development 
was associated with extreme poverty for example mud floors that mothers were not 
happy to put their infants on. Biological factors did not influence development as much 
and only accounted for 6% and 5% of the variance in mental and motor development 
respectively. This study is of relevance to South Africa due to the similarities in socio-
economic status of this study cohort and the majority of South Africans. Lima et al 
(2004) conclude by stating that health professionals should advocate for policy aimed at 
reducing poverty and for programmes that strengthen social capital and provide low cost 
sustainable interventions that promote psychosocial development. This approach 
supports the findings of Dunst et al (1986) who found that supportive social networks 
were associated with better personal well-being, more positive attitudes and positive 
parent-child play opportunities and child behaviour and development in families with a 
disabled or developmentally at-risk child. 
 
Linver et al (2002) aimed to identify ways to mediate the effect of low income on the 
development of young children. They found that providing stimulating activities in the 
home mediated the impact of poverty on child development and that decreasing parental 
distress and improving parenting practices mediated the relationship between income 
and children’s behavioural problems. Huston et al (1994) report that high quality day 
care has a mediating effect on the intellectual development and early school 
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performance of children from very poor families. Richter et al (2004) propose that the 
expansion and improvement of early childhood care and education centres at a national 
level could potentially benefit a large number of vulnerable children. 
 
Poverty remains a serious concern in South Africa with the potential to impact negatively 
on the development of South African children. Around the world HIV is a disease 
exacerbated by poverty. The most vulnerable members of a community are hit hardest 
by this disease (Adler, 2000; Foster and Williamson, 2000; Dutra et al, 2000). Children 
in South Africa are therefore extremely vulnerable as they face exposure to both poverty 
and HIV.  
 
2.11 Rehabilitation and HIV 
2.11.1 A Role for Physiotherapy? 
As the life expectancy of people living with HIV has increased due to the availability of 
HAART so the rehabilitation needs of this population has increased (Nixon and Cott, 
2000). Many of the conditions to which HIV infected individuals are vulnerable result in 
impairments and disabilities which may benefit from rehabilitation. Despite this, very little 
research has been done into the role of physiotherapists in the long term management 
of people living with HIV. What research has been done has focussed mainly on the 
adult population and very little has been done on children. 
 
Some of the first reports to emerge on the rehabilitation needs of adults living with HIV 
came from the Departments of Physical Medicine and Rehabilitation at The Graduate 
Hospital, Philadelphia. O’Dell et al (1991) described the types and degree of disability in 
37 HIV positive people on discharge from acute hospitalisation. A significant number of 
subjects required assistance with ambulation, stair climbing, feeding and bathing. They 
concluded that significant physical disability exists in persons with AIDS discharged from 
hospital and advocate that rehabilitation professionals be consulted as rehabilitation 
may be of benefit. O’Connell and Levinson (1991) described the rehabilitation services 
utilised by 51 HIV positive patients. These services included therapeutic exercise, gait 
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aids, pain management, vocational assessment and counselling. Unfortunately they did 
not comment on how patients responded to these interventions. O’Dell and Dillon (1992) 
reviewed HIV-related disease, impairment, disability, and handicap pertinent to 
rehabilitation. They again conclude that current rehabilitation knowledge and practice 
could be applied to HIV-related disability in an attempt to improve quality of life. Despite 
this early recognition of the potential role for rehabilitation in the management of HIV 
infected individuals very few intervention studies have ever been done. 
 
The only areas where significant research has been done in the field of rehabilitation 
and HIV are in the fields of aerobic exercise and strength training in adults who are HIV 
positive. Both aerobic exercise and graded strength training have been shown to have 
significant positive effects on aerobic fitness and muscle strength respectively, as well 
as on overall quality of life (Nixon and Cott, 2000). 
 
Paediatric rehabilitation specialists world wide have been very slow to take up the 
challenge of paediatric HIV in any meaningful way. HIV has been known to cause 
neurodevelopmental delay for the last 20 years and yet not one intervention study 
examining the rehabilitation of these children could be found. Various authors have 
given anecdotal evidence for the need for rehabilitation for HIV infected children with 
neurodevelopmental delay (Mintz, 1999; McDougall, 1998; Cohen, 1991; Harris-Copp, 
1988) however none of them support their claims with any evidence-based literature. 
The clinical rationale that these authors use for motivating for rehabilitation of HIV 
positive children with neurodevelopmental delay are sound and they do highlight the 
need for further research and intervention studies in this area. 
 
Other areas of paediatric HIV that may benefit from rehabilitation have also not been 
thoroughly investigated. 
2.11.2 Intervention Frameworks 
The framework in which the rehabilitation of adults and children with HIV could be 
placed is well presented by Nixon and Cott (2000) in their article on reconceptualising 
HIV within a rehabilitation framework. They discuss how HIV can be viewed within the 
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context of the World Health Organisation’s International Classification of Impairment, 
Disability and Handicap (now the International Classification of Functioning, Disability 
and Health (ICF)). Their comprehensive overview of impairments suffered by HIV 
positive individuals and consequent disabilities and handicaps is well presented and the 
implications for practice, education and research are of importance for physiotherapists 
around the world. Unfortunately they do not pay much specific attention to paediatric 
HIV. Hwang and Nochajski (2003) also discuss HIV within the framework of the ICF, 
again more attention is paid to adult HIV. This study focuses more on the technical 
aspects of the ICF and pays less attention to the clinical aspects of HIV disease. Mitchell 
and Linsk (2004) stress that HIV should be viewed as a chronic, long term illness which 
warrants a multidimensional approach. 
 
The ICF recognises that health extends beyond the concept of disease. The main 
components of the ICF are body functions and structures, activities and participation. 
Impairments refer to any loss of body structure of function and may be temporary or 
permanent. An individual’s impairments may limit their activities and their ability to 
participate fully within their community (WHO, 2001). The ICF allows researchers and 
clinicians to identify the components of health rather than the consequences of disease 
and is broad enough to be used in a number of different clinical settings (WHO, 2001).    
 
Helders et al (2003) discussed the changes that have occurred in paediatric 
rehabilitation over the years from an impairment oriented model, through a functional 
approach and finally to a family-centred approach, and argue that paediatric 
rehabilitation has evolved into a dynamic discipline in its own right. They advocate 
careful standardised assessment and a system of rehabilitation for disabled children that 
is functionally based and family orientated. A number of studies have highlighted the 
need for a family-centred approach to the rehabilitation of children with chronic 
disabilities (O’Neil et al, 2001; King et al, 1999; Viscardis, 1998) This approach requires 
that the needs of the child are met within the context of their individual family and that 
any rehabilitation programme given, is designed for the individual child with input from 
the family. Programmes are designed to build on families’ strengths and support families 
in their natural caregiving and decision making roles. Parents and professionals are 
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seen as equals in a partnership to optimise care of the child. Interpersonal aspects of 
care are emphasised in this approach. Programmes designed in this way are more likely 
to be sensitive to the individual and cultural differences in families and to meet the 
needs of the child and the caregivers. Adherence to programmes that have been 
designed together is thought to be better than that in programmes imposed on the family 
by the practitioner (O’Neil et al, 2001; Coleman, 2001). 
 
Although HIV is not mentioned in these articles, the general approach advocated has 
definite relevance for the rehabilitation of HIV positive children with neurodevelopmental 
delay. Both the ICF and the concept of family centred intervention, stress the importance 
of looking at the child within their family and social context and designing interventions 
that look beyond the impairment level. 
2.11.3 Service Delivery 
Possible methods of service delivery to children with developmental delays will now be 
discussed as well as some of the services which have been developed for children who 
do have neurodevelopmental delay as a consequence of HIV infection. 
 
A number of studies have been done to evaluate the best way of delivering 
developmental services to children with neurodevelopmental delay. Some controversy 
exists on the most effective way of providing developmental services and no single 
approach is suitable for all situations. Awareness of child development is increasing in 
developing countries and early intervention is advocated for children with low birth 
weight, developmental delays and children from disadvantaged backgrounds (Engle et 
al, 2007). 
 
Early child development programmes are directed towards improving growth and 
development of young children as well as to ameliorate the negative effects of risk 
factors. The most effective early intervention programmes provide learning opportunities 
for the children and their families, are targeted towards younger and moredisadvantaged 
children, are of longer duration and are integrated into other child and family health 
services (Engle et al, 2007). 
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Shannon (2004) investigated the barriers to family centred services, he concluded by 
urging professionals to evaluate each family’s needs individually and not to assume that 
early intervention is a priority for all families. Brinker et al (1994) found that attending 
early intervention programmes could increase levels of parenting stress and that high 
levels of parenting stress were in turn related to poor cognitive outcomes. 
 
Wasik et al (1990) and Loeb et al (2004) both found that high quality day care improved 
young children’s cognitive abilities. Both studies were done on children from poor 
communities in well resourced countries. Wasik et al (1990) compared children in day 
care to children who received home stimulation programmes while Loeb et al (2004) 
compared children in day care to children in family care. The possible reasons for the 
advantages of day care include the fact that at day care the child’s activities are the 
primary focus whereas at home the caregiver has a lot of other tasks and responsibilities 
and structured play activities with the child are not often a priority. The results of these 
two studies need to be interpreted with care as the stimulation and facilities at all day 
care centres are not equal. 
 
Black et al (1994), Powell et al (1998) and Eickmann et al (2003) investigated the use of 
home stimulation programmes for children with developmental delay. All three studies 
used the Bayley Scales of Infant Development as their developmental outcome  
measure. Black et al (1994) found no difference in cognitive or psychomotor 
development between children in a control and an intervention group despite biweekly 
home visits from birth to 18 months of age. The children in this study all had drug 
abusing mothers, half of whom were HIV positive. The study was conducted in a poor 
inner city area. In contrast Powell et al (1989) and Eickmann et al (2003) found that 
development improved with increasing frequency of home visits. The aim of both the 
interventions in both these studies was to provide skills and knowledge to mothers to 
promote their children’s development within the limited resources of the family. Both of 
these studies were done in developing countries, namely Jamaica and Brazil. Eikmann 
et al (2003) acknowledge that the once weekly visits that they provided are not 
sustainable in the long run, they do however urge that more projects that include 
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mothers and that can be carried out by community workers supervised by health care 
professionals, be initiated. They also stress that poverty alleviation be a part of any 
project aimed at promoting child development and that the most vulnerable children are 
selected out for intervention. 
 
Although no individual intervention studies could be found on the management of 
developmental problems in HIV infected children, a number of authors call for the 
establishment of holistic family centred services that address complex psychosocial 
aspects as well as developmental components (New et al, 2006; Barnard and Muller, 
2004; Strug and Burr, 2003; Barnet and Whiteside, 2002; DeMatteo et al, 2002; Prado et 
al, 2002; Kmita et al, 2002;; Coscia et al, 2001; Boland, 2000; Salisbury, 2000; Himid et 
al,1998; Woodruff, 1994; Cohen, 1991; Hopkins et al,1989; Crocker,1989). Strug and 
Burr (2003) and DeMatteo et al (2002) emphasise that these services should include 
specific support for fathers and other males who find themselves in the role of primary 
caregivers. Hopkins et al (1989) and Coscia et al (2001) stress that parenting workshops 
and training should be included in the programme. Coscia et al (2001) argue that these 
interventions may mediate the environmental risk factors such as poverty. 
 
Hansell et al (1998) warn that improving social support does not necessarily improve 
coping and stress management in caregivers of HIV positive children. Prado et al (2002) 
confirm that participation in psychosocial interventions is often low. They found that HIV 
positive mothers were more likely to engage in these programmes if they perceived a 
need for the intervention, they had high stress levels and low social support and if they 
established a “therapeutic alliance” with the service provider from the outset. The 
therapeutic alliance was the strongest independent predictor of engagement. They 
therefore encourage interventionists to prioritise the establishment of rapport with 
patients early on in the intervention process. Cost effectiveness, equity and cultural 
sensitivity should be considered when planning a new service (Scott et al, 2005; 
Desmond et al, 2002; Farmer et al, 2001). 
 
A number of authors have identified the need for comprehensive, holistic services for 
children infected with HIV, which should include developmental services. Paediatric 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
57 
rehabilitation specialists have not been optimally involved in the long term management 
of children with HIV and neurodevelopmental delay, especially in developing countries. 
A need exists for studies that evaluate intervention programmes aimed at HIV positive 
children with neurodevelopmental delay. 
 
2.12 Conclusions 
Paediatric HIV remains a serious health challenge in South Africa where the epidemic 
has not yet reached its peak.  
 
HIV is known to be neurotrophic and to cause neurological damage through a number of 
pathological mechanisms. This results in a well described encephalopathy which causes 
developmental complications early on in childhood. All facets of development are 
negatively affected by paediatric HIV independent from other environmental and 
biological risk factors. This has been demonstrated in studies from around the world, 
including a limited number from Africa. 
 
Paediatric HIV is a multigenerational disorder and impacts heavily on the entire family. 
Increased stresses are placed on the primary caregiver and parenting stress is high. 
 
The role of physiotherapy as an intervention for children with developmental delay as a 
result of HIV infection has never been investigated. Any intervention which occurs 
should address the needs of the child within the context of the family and recognise 
cultural and social differences. The family should be partners in service planning and 
delivery. 
 
Children infected with HIV in South Africa generally live in poor socio-economic 
circumstances which impact negatively on all facets of development, but especially 
cognitive development. Interventions should aim to address these issues and policies 
are needed to improve conditions and developmental outcomes for all vulnerable 
children in South Africa, not only those infected with HIV. 
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Taking cognisance of these factors the main aim of this study was to determine whether 
a basic home stimulation programme had an impact on the neurodevelopmental status 
of HIV infected children. 
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Chapter 3 
MEASURING INSTRUMENTS and PILOT STUDIES 
In this chapter the measuring instruments used in this study will be discussed. Issues of 
suitability, reliability and validity are highlighted. The pilot studies done to ensure 
suitability of each measure are described. 
3.1 Bayley Scales of Infant Development II 
The Bayley Scales of Infant Development were first published in 1969 and have long 
been considered the gold standard in developmental assessments (Harris et al, 2005; 
Tieman et al, 2005). In 1993, the second edition of the Bayley scales (BSID II) was 
introduced in an attempt to address some of the concerns that were raised about the 
original version. The aims of the revision of the Bayley scales were to update the 
normative data, extend the age range, improve content coverage, update test materials 
and address gender and cultural biases that may exist, conduct reliability and validity 
studies and improve the clinical utility while preserving the basic qualities of the BSID 
(Bayley, 1993). 
 
The BSID II is an individually administered test that assesses current developmental 
status. The primary objective of the BSID II is to identify children who have 
developmental delay and to plan intervention strategies. The BSID II consists of three 
scales, the mental scale, the motor scale and the behavior rating scale. The mental 
scale assesses cognitive, language and personal-social aspects of development and 
includes items to evaluate memory, habituation, problem solving, early number 
concepts, generalisation, classification, vocalization, language and social skills. The 
motor scale assesses gross and fine motor development and includes assessment of 
movements associated with rolling, creeping and crawling, sitting, standing, walking, 
running jumping and climbing, as well as grasp and fine motor coordination. The 
behavior rating scales assess the child’s behavior during the testing situation. Raw 
scores obtained in the mental and motor assessments are converted to standard scores 
which are age adjusted. These are the Mental Developmental Index and the 
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Psychomotor Developmental Index which have a mean of 100 and a standard deviation 
of 15 (Black and Matula, 2000). 
 
The mental and motor scales of the BSID II have been shown to have excellent 
reliability coefficients (an average of .88 and .84 respectively) as calculated using 
coefficient alpha (Bayley, 1993) and suggest that the BSID II is a highly reliable tool. 
Test-retest stability showed a high degree of stability over time and across age groups 
for mental and motor development (ranging from .77 to .91) (Bayley, 1993). Interscorer 
agreement was established by having an examiner and an observer score each child 
(n=51). Interscorer agreement was calculated by correlating the MDI score of the 
examiner with that of the observer. The same process was applied to the PDI. 
Interscorer reliabilities were .96 for the MDI and .77 for the motor scale. It was felt that 
the observer was at a disadvantage when scoring the motor scale as some items 
involve physical manipulation of the child to determine their abilities and the observer 
would not have experienced this directly (Bayley, 1993).The author provides evidence 
that the MDI and PDI scales of the BSID II have content, construct, predictive and 
discriminant validity. 
 
The Behavior Rating Scale has not stood up to rigorous psychometric testing to the 
same level as the MDI and PDI. It is therefore not included in any of the clinical studies 
discussed previously and was not included in this study.   
 
The norms for the BSID II were derived from a national, stratified random sample 
representing American infants between one and 42 months of age. One thousand seven 
hundred children were assessed, 100 in each of the 17 age groups between one and 42 
months. Gender, race, geographical region and parental education level were 
proportionally represented based on the figures from the 1988 US census (Bayley, 
1993). 
 
The BSID II was tested by the research team on a sample of 35 HIV positive children. In 
relation to the normative sample, these children had a mean MDI of 79.6 and a mean 
PDI of 81.1, approximately 1.3 standard deviations below the normative sample. The 
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standard deviations observed with these children showed far greater variance than the 
normative sample, the motor scale had a standard deviation of 27.2 and the mental 
scale had a standard deviation of 19.8. Bayley warns that not all HIV positive children 
will necessarily perform in a similar manner due to the presence of different 
developmental risk factors (Bayley, 1993).  
 
Despite its wide use in research and clinical practice some concerns about the BSID 
have been raised over the years. One of the issues raised is the concern that final 
scores on the BSID can vary considerably depending on where in the test the examiner 
chooses to start administering items. Mayes (1997) found that scores were inflated if 
testing began at the child’s chronological age (as recommended in the testing manual) 
and were skewed in the opposite direction if testing started at the lowest item set. Mayes 
(1997) proposes that examiners test upward until the child fails all items and downward 
until the child passes all items and not to follow the basal and ceiling guidelines in the 
manual. Administering the test in this way would increase the administration time. 
Gauthier et al (1999) also addressed the issue of where to start with administering the 
test. They agree that small variances in testing procedure can influence a child’s end 
score significantly. They recommend that testing of all full term infants be started at the 
child’s chronological age and that the examiner should not use clinical discretion in 
determining the starting point. Following this simple directive ensures that results 
obtained are meaningful and comparable. 
 
A number of authors have identified concerns over the stability of the BSID in assessing 
high risk infants. Niccols and Latchman (2002) found that the BSID was sensitive to 
changes in development in high risk infants during the first two years of life The findings 
of their study support the clinical validity of the BSID. They do however warn that BSID 
scores obtained in the first year of life should not be used in an attempt to predict future 
performance later in life, especially in infants with non-typical development. This 
cautionary note is reiterated by Harris et al (2005) who found that the BSID 
demonstrated only modest stability over time when administered to a group of high risk 
infants 
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The BSID was normed on a sample of typical American children. Raw scores obtained 
on the mental and motor scales are converted to age adjusted standard scores, the 
mental developmental index and the psychomotor developmental index. The scoring 
manual for the BSID only allows for MDI and PDI scores from 50 to 150. It is therefore 
not possible to assign a developmental index score for a child with a very low raw score. 
As the BSID is often used with children with developmental delay a need for describing 
scores below 50 was identified. Robinson and Mervis (1996) used statistical modeling to 
extrapolate MDI and PDI scores between 30 and 50. They recommend that any child 
who scores below 30 be assigned a score of 29. These scores can be used to monitor 
children’s progress and assess the impact of intervention but examiners must remember 
that MDI and PDI scores below 50 are estimated and not based on actual data (Black 
and Matula, 2000).  
 
Richter et al (1992) recognized the need to identify developmental assessment tools 
which were appropriate and valid assessments of developmental progress in South 
African children. The first version of the Bayley Scales of Infant Development (BSID I) 
was administered to a large group (n=722) of South African children from both urban 
and rural areas (Richter et al, 1992). The local sample was modeled on the American 
standardization sample. The South African children performed consistently well on the 
BSID I and in fact in many instances better than their American counterparts. This was 
particularly evident in the younger children under 12 months of age, where South African 
children achieved significantly higher scores than the American standardization sample 
in both mental and motor scores. Rural South African children tended to score lower 
than urban children in both motor and mental development. Richter et al (1992) found 
the original materials in the BSID to be appropriate for use with South African children 
and suggest that they can be used without modification. 
 
African children have previously been described as having precocious gross motor 
development (Capute et al, 1985). The pattern of  precocious developmental 
performance in the first year found by Richter et al (1992) was also found by Aina and 
Morakinyo in 2005 when they normed the BSID on 128 Nigerian children. Unfortunately 
they do not state whether they use the BSID I or the BSID II. In this study children in all 
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age groups performed better in psychomotor assessments than in the mental 
assessments. The highest mean MDI was in the 16 week age group and the lowest was 
in the 30 month age group. The highest PDI mean score was in the eight week age 
group and the 10 month age group had the lowest mean PDI. All age groups had mean 
MDI and PDI scores which were well above the minimal normal developmental index 
score as stipulated by the author of the test (Aina and Morakinyo, 2005). The sample 
size of 128 used by Aina and Morakinyo (2005) is too small to draw conclusive, 
generalisable results for the rest of Africa. 
 
The BSID II has not been normed on South African children although it has been used 
for research purposes in South Africa as well as other African countries and other 
developing countries (Aina and Morakinyo, 2005; Cooper and Sandler, 1997). Results 
from the BSID I have been shown to correlate strongly with results from BSID II (Bayley, 
1993). Due to these factors and because of the study design in this study it was decided 
that re-norming the BSID II on South African children would not be necessary. However 
it must also be acknowledged that many social and political changes have occurred in 
South Africa since the BSID I was normed. Changes in the socio-political environment 
could have influenced child development so it was decided to conduct a pilot study in 
order to identify whether the BSID II was still a valid and appropriate developmental 
assessment tool for urban black South African children. 
3.1.1 Training and pilot study  
No specific qualification is required prior to using the BSID. However it is recommended 
that testers are experienced in the field of paediatrics and should have experience in 
administering and scoring paediatric developmental assessments. The researcher and 
research assistant for this study attended a one week training workshop on the BSID II 
conducted by a clinical psychologist from Baylor University, USA, who had extensive 
experience using the BSID clinically and as an outcome measure in a number of 
different research projects. 
 
Each item of the BSID was discussed and possible problems in administration were 
highlighted. The BSID was administered to a number of normal (n=3) and at risk (n=5) 
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children in order to practice and to assess the suitability of the tool in the South African 
context. The children all responded well to the test items and all the healthy children 
scored within the normal range of the test for mental and motor development. 
 
Once the training week was completed and the researcher and research assistant were 
confident with the administration and scoring of the BSID II, it was decided to undertake 
a further pilot study to confirm that the BSID II was indeed a suitable tool for use on high 
risk, urban, black South African children. Twelve children (10% of sample size of main 
study) were assessed using the BSID II. The researcher performed all assessments 
while the research assistant observed the testing and scored the children independently. 
A sample of convenience was used. Children were drawn from the paediatric follow up 
clinic at CH Baragwanath hospital. They thus came from similar socioeconomic and 
cultural backgrounds to the children who were included in the main study.  
 
The following inclusion criteria were used: 
• Children who had had a hospital admission for an upper respiratory tract 
infection. 
• Children who had tested HIV negative on Elisa or PCR (depending on age) during 
admission. 
• Children who were now declared healthy and free of impairments by the 
assessing doctor. 
• Children who were less than 42 months of age. 
 
Children were assessed seated on their mother’s laps or at a small table on a child sized 
chair. The guidelines for administering the BSID II were followed. The mental scale was 
administered before the motor scale. Testing commenced at the child’s chronological 
age. 
Results 
The children all appeared to enjoy the testing and responded well to most of the testing 
equipment. The scores obtained by the children can be seen in table 3.1 
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The mean MDI for this group of children was 96.2 (± 12.7) with a range of 83-120. The 
mean PDI was 101.2 (± 14.88) with a range of 80-132.  
 
Table 3.1 Age, MDI and PDI of children in Pilot Study 
  Age 
(months) 
MDI PDI 
3 101 103 
5 97 109 
6 120 132 
8 88 117 
11 83 87 
12 93 97 
15 85 85 
17 90 94 
21 106 108 
24 84 80 
30 118 110 
37 89 93 
 
All of the children except one achieved mental and motor scores within the normal range 
for the BSID II. One child had scores in the accelerated development category for 
mental and motor development, one for motor development only and one for mental 
development only. 
 
The scores of the researcher and the research assistant were very close, having a 98% 
agreement for MDI and 96% for PDI. Although the researcher conducted all the 
assessments in the main study it was necessary for the research assisstant to have a 
thorough understanding of how the BSID ll was scored and how to interpret the results 
in order to be able to plan the intervention programme. 
 
Based on the findings of this pilot study and on the work of Richter et al (1992) it was 
concluded that the BSID II remained an appropriate tool for assessing development in 
South African children.  
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3.2 Parenting Stress Index- Short Form 
Conceptualisation and measurement of parenting stress present a formidable challenge 
and many research models have viewed stress differently. These factors make research 
in this area complex and challenging (Reitman et al, 2002). 
 
The Parenting Stress Index was developed by Abidin in 1978 as a screening and 
diagnostic assessment tool. It is a 120 item self-administered Likert scale which yields 
information about the magnitude of stress in the parent-child dyad. The PSI has proven 
reliability and validity but is considered time consuming for use in research or as a 
screening tool (Reitman et al, 2002; Pearson and Chan, 1993) 
  
The Parenting Stress Index/Short form (PSI/SF) is a direct derivative of the original 
Parenting Stress Index, with all items being contained in the original version with 
identical wording. It is a 36 item, self administered questionnaire. Parents score each 
item presented on a five point Likert scale ranging from “strongly agree” to “strongly 
disagree”. Values of one to five are allocated for each response and added to give a 
total stress score and three sub-scale scores, higher scores indicate higher levels of 
stress (Abidin,1995). 
 
The PSI/SF was developed in response to clinicians and researchers identifying the 
need for a concise, easy to administer version of the PSI which could be administered in 
a limited amount of time. A number of researchers who analysed the PSI indicated that 
a three way factor analysis would be the best way to describe the data (Abidin, 1995). 
Based on their suggestions a short version which consisted of a total score and three 
sub-scales was developed. The three sub-scales were labeled Parental Distress, 
Parent-Child Dysfunctional Interaction and Difficult Child (Abidin, 1995). The process of 
factor analysis is described in detail in the test manual. 
 
The Total Stress score gives an indication of the overall level of parenting stress that the 
individual is experiencing. The total stress score is a reflection of stress experienced 
within the role of being a parent and does not reflect other life stresses. Parents who 
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experience a Total Stress score of greater than or equal to 90 are experiencing clinically 
significant levels of stress and should be referred for counseling (Abidin, 1995). 
 
The Parental Distress score indicates the level of stress a parent is experiencing in his 
or her role as a parent, as a function of a number of personal factors inherent to 
parenting. The component factors associated with the Parental Distress subscale 
include, impaired sense of parenting competence, stresses associated with restrictions 
in other life roles, conflict with partner, lack of social support and the presence of 
depression. When the Parental Distress subscale scores above the 90th centile 
therapeutic intervention that aims at improving parent’s self esteem and sense of 
competence as a parent may be the most beneficial to both the parent and the child 
(Abidin, 1995). 
 
The Parent-Child Dysfunctional Interaction (P-CDI) subscale focuses on the parent’s 
perception of whether or not their child meets their expectations and whether their 
interactions with their child affirm them as a parent. Parents who score high in this 
subsection feel alienated and rejected by their children. A risk of child abuse exists for 
parents who score above the 95th centile in this subscale and immediate referral is 
recommended (Abidin, 1995). 
 
The Difficult Child subscale probes some of the behavioral issues children may have 
which make them easier or more difficult to handle. These may be inherent 
characteristics of the child or may be learnt oppositional and non-compliant behavior. 
Children over two years of age are more likely to exhibit behavioral problems that are 
learnt rather than younger children whose behavior is more likely to be due to 
temperament or physiological disturbances such as colic. Regardless of the cause 
parents who produce high scores in this subscale require professional assistance 
(Abidin, 1995).  
 
Test-retest reliability was established on a sample of 270 parents over a six month 
period. The total stress score was .84 with the subscale sores of .85, .68, and .78 for 
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PD, P-CDI and DC respectively. In order to test validity of the scale the author correlated 
the PSI/SF to the full length PSI and found a high correlation of .94 (Abidin, 1995). 
 
Reitman et al (2002) evaluated the PSI/SF in a low socio-economic, primarily African 
American population. They found that the PSI/SF had very good to excellent internal 
consistency and that the three factor model was marginally better than a single factor 
model. A series of multiple regression analyses examined the relationship of various 
psychosocial and demographic factors with the PSI/SF. The Difficult Child subscale was 
associated with a measure of child oppositionality, the Parental Distress subscale was 
associated with self reported psychological symptoms and low income and the Parent-
Child Dysfunctional Interaction subscale was associated with self reported psychological 
symptoms as well as low income and education. The findings of this study support the 
generalisability of a three factor measurement of parenting stress (Reitman et al, 2002). 
 
The PSI/SF has been used in a number of studies, conducted around the world, and 
authors have found it to be clinically useful as well as psychometrically sound (Feldman 
et al, 2004; O’Neil et al, 2001; Button et al, 2001; Musil et al, 1998; Deater-Deckard et 
al, 1996). Studies using the PSI/SF could not be found from African countries. 
 
3.2.1 Translation and Pilot Study 
In order to ensure that the PSI-SF could be self administered by the majority of 
caregivers in the study sample it was decided to translate it into Zulu and Southern 
Sotho. These are the two most commonly spoken languages in Soweto where the study 
was conducted (Barbarin and Khomo, 1997). 
 
Permission was obtained from the original author of the PSI/SF to translate the scale. 
The author stipulated what procedure should be followed and this is outlined below. 
 
The questionnaire was translated by professional, home language translators into Zulu 
and Southern Sotho. 
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These translations were then back-translated into English by two individuals whose  
mother tongue was Zulu and Southern Sotho respectively. 
This back translation was then sent to the original author and he checked them for 
accuracy and to ensure that the concepts being tested remained stable during 
translation.  
Comments were sent back to the researcher. The Southern Sotho translation was 
accepted by the author, however a few changes were requested for the Zulu translation. 
The researcher met with the translators and discussed possible alternatives.  
 A second Zulu translation was produced with minor changes. 
The second version was then back-translated again and the back-translation 
resubmitted. 
This version was approved and both the Zulu and Southern Sotho translations of the 
PSI/SF were adopted by the original author and Psychological Assessment Resources 
as official versions. (See appendix V for PSI/SF and translations). 
 
Testing 
The translated versions of the PSI-SF were tested in a pilot study to ensure test-retest 
reliability and to determine whether they were easily understood by caregivers of 
children living in Soweto. 
 
The testing took place at Chris Hani Baragwanath hospital where the study was to be 
conducted. A sample of convenience was used. 
 
The PSI/SF was handed out by a physiotherapist to caregivers of young children whom 
she was treating. A physiotherapy assistant who spoke both Zulu and Southern Sotho 
fluently was available to translate any questions the caregivers had and the instructions 
if necessary. 
The questionnaire was given to 10 Zulu and 10 Southern Sotho speaking caregivers of 
children admitted to the medical wards. Caregivers completed the questionnaire in the 
ward and then returned it to the physiotherapist. 
The PSI/SF was re-administered to the same group of caregivers five days later. 
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The total scores can be seen in table 3.2. 
 
Table 3.2 Test re-test scores for Zulu and Southern Sotho translations  
Southern Sotho PSI/SF Total Zulu PSI/SF Total 
Test Re-test Test Re-test 
51 50 87 87 
92 90 63 62 
85 85 146 146 
119 111 49 46 
62 61 46 42 
140 140 51 42 
109 104 52 51 
48 45 110 105 
113 108 118 110 
86 91 91 89 
 
Results 
The Zulu and Southern Sotho translations of the PSI-SF showed very high test-retest 
reliability over a five day period for the Total Stress scores (Zulu r= .995, S Sotho r= 
.993). 
 
The means and standard deviations for the total PSI/SF scores obtained in this pilot 
study are found in table 3.3 
 
Table 3.3 Means and Standard Deviations for Test Retest scores of translated PSI/SF 
Southern Sotho PSI/SF Zulu PSI/SF 
Test Re-test Test Re-test 
90.5(± 30.4) 88.5 (±29.7) 81.3 (± 34.8) 78.0 (± 35.2) 
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Discussion 
None of the caregivers required assistance with completing the PSI-SF and only 
occasional questions were asked. Caregivers reported that the questionnaire was easy 
to understand and that most of the questions were relevant to their situations as parents. 
 
Some of the issues raised included queries about question six “I am unhappy with the 
last purchase of clothing I made for myself”. Two mothers in the pilot study could not 
remember when they had last bought new clothing for themselves as they relied on 
handouts from family members or charity. This problem was not encountered in the 
main study. A few mothers also asked about question 33 “Think carefully and count the 
number of things that your child does to bother you”. The choices for this question start 
with the option of “1-3” things, some caregivers asked what they must choose if their 
child did nothing that bothered them. It was explained that they should choose the option 
“1-3”. 
 
Questions with a different format were somewhat confusing (Q22, Q32 and Q33). 
Questions 22 and 32 require that the respondent select one of five statements that best 
describes them. The layout of these two questions is different from the rest. It was 
decided that these two questions as well as question 33, described above, should be 
explained individually to all caregivers prior to commencing the test. 
 
Most caregivers took between 20 and 30 minutes to complete the questionnaire. 
 
The very high Total Stress scores obtained by this group of caregivers was of concern, 
although one would expect high levels of parenting stress in caregivers of hospitalized 
children. A small unpublished pilot study done on the parenting stress of parents of 
typically developing South African children compared to children with cerebral palsy 
found that the parenting stress levels of South African parents with healthy children was 
within normal limits, mean= 69.4 (Haniff et al, 2005).  
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Conclusion 
Based on the findings of this pilot study and on the literature reviewed, it was decided 
that the PSI/SF was an appropriate outcome measure to use to assess the parenting 
stress of caregivers of children in Soweto, South Africa. 
 
3.3 Household Economic and Social Status Index (HESSI) 
The Household Economic and Social Status Index (HESSI) was used to collect 
demographic information in this study. The HESSI was developed and standardized in 
Soweto, South Africa and has been used to collect demographic data for the longitudinal 
“Birth to Twenty” study (Barbarin and Khomo, 1997). It is therefore ideal to use to collect 
data from caregivers of children living in Soweto. No pilot study was considered 
necessary prior to using this questionnaire. Barbarin and Khomo (1997) recognized that 
financial resources alone are not an accurate measure of poverty in developing 
countries. They developed the HESSI to include measures of food adequacy, shelter, 
utilities, durable consumer goods, accumulated assets, social status, education, 
occupation and family structure in order to provide a more holistic picture of the socio-
economic conditions in which people live. This questionnaire may lack economic 
specificity but it does highlight factors which have a direct bearing on child development 
and is sensitive to socio-economic variations at the lower end of the economic scale. 
This is important in developing countries where poverty is widespread and decisions 
need to be made about how best to allocate limited resources (Barbarin and Khomo, 
1997). 
3.4 Conclusion 
Based on the literature reviewed and the pilot studies conducted it was decided that the 
BSID II was the most appropriate developmental assessment tool for use in this study. 
 
The PSI/SF was translated into Zulu and Southern Sotho and proved to have good test- 
retest reliability. It was decided to use this tool to measure parenting stress even though 
it has not been used extensively in developing countries as yet. 
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The HESSI was considered to be an appropriate tool for assessing socio- economic 
status in the study population as it was developed in Soweto, South Africa and focuses 
on socio economic factors which may impact on child development.   
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Chapter 4 
METHODS 
In this chapter the methodology for this study is presented. The study design and 
subject recruitment is described and the study procedure will be discussed. 
 
It should be noted that when this study was designed antiretroviral therapy was not 
available in government hospitals in South Africa. Four months after data collection 
commenced the South African government made antiretrovials available in a limited 
number of sites, including at Harriet Shezi clinic where this study was conducted.  This 
introduced a confounding variable to this study but did present the opportunity to 
investigate the interaction between HAART and the intervention provided in this study, 
as well as the impact of HAART on the neurodevelopmental status of the children in the 
study. 
 
4.1 Location 
This study was conducted at the Harriet Shezi Children’s Clinic at Chris Hani 
Baragwanath Hospital in Soweto, South Africa. This is an outpatient clinic which 
provides follow up care for HIV positive children. The clinic is staffed with doctors, 
nurses and counselors. A social worker and a dietician visit the clinic on a regular basis.  
 
4.2 Ethical Considerations 
Ethical clearance for this study was obtained from the Committee for Research on 
Human Subjects at the University of the Witwatersrand. (Clearance certificate M03-05-
68) See Appendix l. 
 
Permission to conduct the study was obtained from the relevant authorities at Chris Hani 
Baragwanath Hospital. Informed, written consent, for themselves and the child was 
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obtained from the primary caregiver of each child prior to him/her being enrolled in the 
study. 
 
According to the guidelines of the Committee for Research on Human Subjects at the 
University of the Witwatersrand, a contribution to transport costs was made to the 
caregivers at each visit to the clinic. Although the children in the control group did not 
receive any intervention they continued to receive all the services usually available at 
the clinic. There were no rehabilitation services offered at the clinic. At the end of the 
study period all children were given a home management programme, regardless of 
which group they were in, and were referred for further rehabilitation if this was 
considered necessary. All children were given a small book at the end of the study to 
thank them for their participation. 
 
4.3 Study Design  
The design for this study was a randomized, controlled clinical trial. The study was 
pragmatic in nature. 
 
4.4 Subjects 
Subjects were drawn from a paediatric HIV clinic (Harriet Shezi clinic) at Chris Hani 
Baragwanath hospital. The caregivers of all children who met the inclusion criteria were 
asked to participate in the study. 
 
Inclusion criteria: 
• children with vertically transmitted HIV 
• children under 2 and a half years old on entry to the study 
• children who attend the paediatric HIV clinic with their primary caregiver 
 
Exclusion criteria: 
• children with clinically evident congenital abnormalities 
• prematurity (< 37 weeks) 
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• children resident in an institution 
• children already receiving physiotherapy 
 
During the course of the study children were excluded from developmental assessment 
if they presented with an oxygen saturation of less than 85%, cyanosis or a temperature 
of over 38 degrees Celsius. These were criteria set by the clinic to screen children who 
needed to be fast tracked through the system and see a doctor as soon as possible. An 
appointment to do the developmental assessment was then given for the following 
week. 
 
 
4.5 Materials and Measurements 
Bayley Scales of Infant Development II 
The BSID II is the most widely used developmental assessment tool in paediatric 
research (Long and Cintas, 1995). Scores are obtained in three areas, cognitive, motor, 
and behavioral. The raw scores obtained in the motor and cognitive areas are then 
converted to standard scores. Validity and reliability have been well established on a 
number of study samples, including on children infected with HIV (Black and Matula, 
2000). 
Parenting Stress Index- Short Form  
The Parenting Stress Index (PSI/SF) contains 36 items across 3 subscales that are 
reported to have good reliability (Abidin 1995). The 3 subscales are “Parental Distress”, 
“Parent-Child Dysfunctional Interaction” and “Difficult Child”. Items are rated on a 5 point 
scale from “strongly agree to “strongly disagree,” with higher scores indicating higher 
levels of stress. The PSI/SF provides a total stress score as well as 3 sub-scale stress 
scores. Evidence for test-retest reliability (Pearson correlations of .84 for the total stress 
scores and .68 to .85 for subscale scores) is given in the test manual (O’Neil et al 2001). 
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The PSI-SF was translated into Zulu and Sotho and these translations have been 
accepted by the original author as official versions as previously discussed. 
 
The BSID ll and the PSI/SF have been discussed in more detail in chapter three. 
CD4 Counts 
CD4 counts are routinely used to quantify the immune status of a patient. Children who 
attend Harriet Shezi clinic have their CD4 count taken as part of their baseline work-up 
when they first register with the clinic. Thereafter CD4 counts are done at 6 monthly 
intervals unless the child’s clinical condition deteriorates rapidly and further investigation 
is warranted. CD4 counts are used to determine eligibility for HAART and to monitor 
response to medication. 
 
Anthropometric Measurements 
Height/length and weight were measured routinely by the clinic nurses prior to the 
children seeing a doctor. Measurements were recorded in the child’s file. 
 
Children who could stand independently had their height measured using a wall 
mounted scale (Hottain Ltd, Crymych, Dyfed). The children stood against the measure, 
bare foot or in socks, with their heels against the wall, and had the horizontal plate 
lowered until it rested on top of their heads. Height was recorded in centimeters. 
 
Infants, and children who could not stand, had their length measured in supine on a 
“Morena Baby Measuring Mat”. Their heads were placed against the vertical board and 
the measurement was taken at the heel. Every attempt was made to keep the children 
well aligned on the mat until measurement was complete. Length was recorded in 
centimeters. 
 
Children who could stand had their weight measured on a Standing Digital Scale (Seca). 
Infants were weighed on a Tanita 1584 Baby Scale. Weight was recorded in kilograms 
to two decimal places. 
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Head circumference was measured using the tape measure in the BSID II kit. The 
researcher measured the head circumference all the children as this was not routinely 
measured at the clinic. The tape was placed around the head at the broadest part of the 
occiput. Three measurements were taken and the mean was calculated and recorded in 
centimeters. In the case were children had braids in their hair every effort was made to 
pass the tape measure under the braids and as close to the scalp as possible. Mean 
head circumference z-scores were calculated at each visit. This was done using NCHS 
growth tables and using the formula: observed head circumference minus mean 
population head circumference divided by the standard deviation of the population. 
Software for calculating head circumference z-scores and standard deviations was not 
available at the Medical Research Council of South Africa at the time this study was 
done. 
 
Oxygen saturation was measured using a Datex Ohmeda Saturation Monitor. This 
reading was not recorded but was noted to determine whether the children were well 
enough to be assessed developmentally. 
 
4.6 Home Management Programme 
A home management programme was given to each child in the experimental group. 
The main aim of the home programme was to optimise the child’s functional potential 
and to encourage age appropriate behaviour in normal movement patterns. The home 
programme was taught by a qualified physiotherapist. It was not possible to design a 
standardized programme for all the children as their needs and levels of function varied 
greatly. A broad outline of the aspects to be addressed was drawn up in consultation 
with clinical experts who have many years of experience working with children with 
neurodevelopmental delay (See appendix ll). Principles of Neurodevelopmental Therapy 
were followed when drawing up each programme and activities were chosen according 
to the child’s age and developmental level. This was done within the context of the 
needs and concerns expressed by the caregiver. The home programme given to each 
child was recorded in their file. 
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The intervention was structured around activities of daily living and developmentally 
appropriate play which could be incorporated into the family’s daily routine. It 
incorporated aspects identified as concerns by both the caregiver and the research 
assistant. Care was taken to ensure that the programme complied with the principles of 
Family Centred Intervention. Caregivers were encouraged to let their children play and 
interact with other children as much as possible and to use older siblings and other 
family members to reinforce the home programme. 
 
As speech and language are commonly affected in HIV positive children all children 
were given a small picture book to take home. Caregivers were encouraged to read to 
them every day or at least to tell them stories related to the pictures in the book. For the 
older children books were selected that could be used to reinforce emerging concepts of 
shape, number, colour and size. The children could return their book and exchange it for 
a new one at each visit. 
 
All caregivers of perambulatory children were asked not to use walking rings (baby 
walkers) as these are very popular despite their negative influence on the development 
of walking (Seigal and Burton, 1999). 
 
4.7 Procedure 
 
Most children attending Harriet Shezi Clinic are followed up at three monthly intervals. 
Children who are healthy and have CD4 counts of over 25% may only be seen every six 
months. Children who are ill, or who are starting HAART may be seen more regularly. 
 
The researcher did not want to put an extra burden on the caregivers so this study was 
designed to fit in with the clinic schedule. This was convenient for the majority of 
caregivers as they were not required to make extra visits to the clinic only to see the 
researcher. This also ensured that the intervention was sustainable beyond the duration 
of the study. 
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Pilot Studies 
Prior to commencement of the study, a pilot study was conducted using the PSI-SF. The 
research assistant and the researcher were trained in the administration of the BSID II 
by a child psychologist from Baylor University in the USA. The pilot studies have been 
described in detail in chapter three. 
Baseline data collection 
The files of all children booked to attend the clinic that day were screened by the 
researcher and research assistant. The caregivers of all children attending the HIV clinic 
who met the inclusion criteria were asked to participate in the study. If caregivers were 
interested in participating they were given the information sheet to read, which was 
available in Zulu, Sotho and English. Written informed consent was obtained from the 
caregivers for themselves and the children prior to any testing being done (See 
appendix IIl). Caregivers were asked to complete the biographical questionnaire in any 
of the abovementioned languages (See appendix IV). Children were assigned 
consecutive numbers as they joined the study and were then randomly allocated to 
either the control or experimental group using a computer generated random number 
table. The research assistant kept a record of which group each child was in, the 
researcher remained blinded to the group allocation of each child. 
Study procedure 
Session 1 (baseline) 
Height/length and weight as measured by the clinic sisters were recorded for all 
children.  
 
Head circumference was measured by the researcher. 
 
The child’s file was checked for their latest CD4 count and to determine whether the 
child was on antiretroviral therapy or not. 
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Caregivers were asked to complete the Parenting Stress Index-Short Form (See 
appendix V). This self administered questionnaire was available in English, Southern 
Sotho and Zulu. If the caregiver could not read but spoke English the research assistant 
read the items to them and allowed them to circle their response. A counsellor read the 
items to caregivers who could not read Zulu or Sotho and who did not understand 
English. 
 
All caregivers were asked to complete the Household Economic and Social Status Index 
(HESSI) (See appendix VI). As with the PSI-SF a counsellor helped if the caregiver 
could not understand English.  
 
The BSID was administered by the researcher who was blinded as to whether the child 
was in the control or experimental group. The BSID was administered with the child 
seated on the caregiver’s lap at a table or seated at a child sized table on a small chair if 
the child was older. Testing was conducted in an area of the clinic away from the main 
waiting room in order to try and minimize distractions. The Mental Scale was 
administered before the Motor Scale as recommended in the testing manual. Testing 
was started at the child’s chronological age for both the Mental and the Motor Scales. 
 
Children in both groups were referred to the social worker or dietician if appropriate. Any 
questions which the caregivers asked about their child’s developmental status were 
answered. 
 
Children in the experimental group were given individual home programmes by the 
research assistant. Each home programme was based on the concerns and priorities 
expressed by the caregivers as well as the child’s performance on the BSID II. The 
reasons for potential developmental delay were explained to the caregivers with a very 
basic explanation that HIV itself can affect the baby’s brain and therefore their 
developmental progress. The impact of repeated illness, hospitalization and malnutrition 
on normal development was also explained. 
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The research assistant asked the caregivers if they were happy with the child’s 
development and whether there was anything in particular which they thought their child 
should be able to do which they could not yet do. The child’s performance on the test 
items was then discussed with the caregivers and areas of strength and weakness were 
highlighted. 
 
These assessments and intervention took place at routine clinic visits and there was 
therefore no extra cost to the caregiver.  
Session 2 (3 months) 
Children in the control and experimental group had their height/length, weight and head 
circumference measurements taken.  The most recent CD4 count was recorded from the 
children’s files. 
 
Children in the experimental group also had their home programmes updated by the 
research assistant. This was based on progress made since their last assessment as 
reported by their caregiver as well as clinical observation on the part of the research 
assistant. Children were given a new picture book. 
Session 3 (6 months) 
Growth (height/length, weight and head circumference) parameters were recorded for all 
children in both the control and experimental group. 
The most recent CD4 count was recorded from the children’s files. 
All caregivers completed the PSI/SF again. 
The researcher assessed all children using the BSID ll according to the procedure 
previously outlined. 
The research assistant updated the home programmes of the children in the 
experimental group. This was again done in consultation with the child’s caregiver and 
based on the results of their BSID ll assessment. Any additional concerns raised by the 
caregivers were addressed. 
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Session 4 (9 months) 
Growth parameters for all children in both the experimental and control groups were 
recorded. 
The most recent CD4 count was recorded from each child’s file. 
The experimental group had their home programme updated by the research assistant 
in consultation with the caregiver. 
Session 5 (12 months) 
Growth parameters were recorded for all children in both the experimental and control 
groups. 
The most recent CD4 count was recorded from the children’s files. 
All the caregivers completed the PSI/SF again. 
The researcher reassessed all children using the BSID ll. 
The research assistant updated the home programmes of the children in the 
experimental group in consultation with the caregivers. 
 
As this was the last visit all caregivers were given a home management programme for 
their children. Children who presented with neurological signs were referred to the 
physiotherapy department at Chris Hani Baragwanath hospital for further management. 
All children were given an age appropriate story book to thank them for participating in 
the study.  
Measures to reduce attrition 
Harriet Shezi clinic serves the communities of Soweto, Eldorado Park, Lenasia and 
Orange Farm. These communities are poor and most people rely exclusively on public 
transport which is costly. Attendance at out patient clinics is often sporadic and regular 
attendance is rare. 
 
In order to try and ensure that patients do not miss appointments the clinic has the 
following system in place: If a patient misses an appointment the caregiver is phoned 
the same afternoon and asked why they did not come. They are given a new 
appointment for the following week. If the caregiver does not have finances for transport 
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a counselor will do a home visit and provide money for a trip to the clinic, where the 
patient will also be seen by a social worker who will try to assist with finances. If the 
counselors are unable to contact the caregiver by phone an attempt is made to organize 
a home visit to ascertain if there are any problems preventing return for follow up. Home 
visits were not possible for families who did not live in Soweto due to time and financial 
constraints. 
 
The researcher benefitted from this system in that most patients were traced by the 
counselors, however if a subject continued not to come for follow up the research 
assistant would phone them and request them to come in. Messages could not be left 
for caregivers as confidentiality and privacy had to be maintained at all costs.    
 
 4.8 Statistical Analysis 
Statistical analysis was performed in consultation with the Medical Research Council of 
South Africa using STATA, Release 8.0, for Windows. Attendance at the clinic was 
monitored and the primary analysis of data was done using intention to treat analysis. 
Intention to treat analysis is considered to be the primary analysis of choice for 
randomised controlled trials, especially when the study is pragmatic in nature such as 
this one was (Herbert et al, 2005; Wright and Sim, 2003; Kruse et al, 2002; Fergusson et 
al, 2002; Hollis and Campbell, 1999; Newell D, 1992, Consort Agreement, 2001). 
Intention to treat analysis has the advantage of maintaining randomisation and 
minimising type 1 errors (Fergusson et al, 2002;Newell, 1992), however where there is a 
large loss to follow up some controversy exists on how best to deal with the missing 
data (Raghunathan, 2004). In this study all available data was analysed at each time 
point. 
 
The loss to follow-up in this study was high (24.5%) so a secondary per protocol 
analysis of the primary outcomes was performed in order to verify the results. The per 
protocol analysis only considers the data of those children for whom complete data sets 
are available, subjects who have missing data or who dropped out of the study are 
excluded from analysis. Per protocol analysis is usually favoured in explanatory trials 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
85 
(Herbert, et al 2005). (The results of the per protocol analysis are presented at the end 
of chapter five). 
   
A sample size of 49 children in each of the two groups had 90% power to detect a 10 
percentage point change in BSID scores, between the control and experimental groups, 
using a standard deviation of 15 (Bayley, 1993). A sample size of 50 children in each of 
the two groups (control and experimental) had 90% power to detect a decrease of 10.5 
percentage points in the PSI/SF scores of caregivers. A standard deviation of 15.9 was 
assumed and was calculated as a pooled standard deviation from 3 studies (O’Neil et al 
2001; Ong et al 1998; Bithoney et al 1995). A factor of 0.3 was used to make the 
statistics from the three studies comparable, that is to be able to compare statistics from 
the Parenting Stress Index to those from the Parenting Stress Index/Short Form.  Fifty 
children were therefore needed per group. A further twenty two children were recruited 
to allow for a 20% drop-out during the year of follow up. A total of 122 children were 
therefore assessed. Testing was done at the 0.05 level of significance. 
 
The data were summarised using means and standard deviations as descriptive 
statistics. Baseline data for the control and experimental group were compared using a 
two-sample t test with equal variance. 
 
With respect to the BSID II, PSI-SF, CD4 counts and growth parameters, the control and 
experimental groups were compared over time in an appropriate analysis of variance 
(ANOVA) for repeated measures.  
 
Stepwise regression analysis was conducted to determine which demographic and 
anthropometric variables were the best predictors of MDI, PDI and PSI/SF scores at 
each visit, as well as which factors were predictive of change in these scores over time. 
In order to get a comprehensive fit, a step-up model was used with automatic elimination 
procedures (Petrie, 1987). Of importance here was to derive good predictive equations 
and therefor the aim was to ensure that the coefficient of determination was as big as 
possible. Hence the p value for entry into the regression was set at 0.25. 
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The results of this study are presented in chapter five.   
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Chapter 5 
RESULTS 
In this chapter the results of this study will be presented and briefly commented on. The 
loss to follow up that occurred during the study will be presented and reasons for drop 
out will be explained. The baseline data will then be presented, thereafter the results for 
each outcome assessed over time will be presented. The factors which influenced 
developmental status and parenting stress at each visit will be described as well as the 
factors which influenced the amount of change that occurred over time. In chapter six 
the implications of all the results will be discussed in more detail. 
 
5.1 Loss to Follow-up 
One hundred and twenty two children and their caregivers were enrolled in this study. 
Only two caregivers approached, refused to participate in the study. Due to the nature of 
HIV disease in children a large drop-out of children was anticipated due to death and 
socio-economic factors. The following diagram represents the loss to follow up that 
occurred over the course of the study. 
 
 
 // Figure 5.1 follows on next page. 
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Figure 5.1 Loss to follow-up. 
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The methods to prevent loss to follow up at Harriet Shezi clinic were described in 
chapter three. Thirty children were lost to follow-up during the course of this study, this 
equates to 24.6% of the initial sample size, which although high is to be expected in a 
study of this nature. 
 Death of children. 
The main cause of loss to follow up in this study was due to death of the children (60% 
of children lost to follow-up). When the study commenced in February 2004 antiretroviral 
therapy was not available at government hospitals in South Africa and the mortality rate 
of HIV infected children was therefore high. All of the children who died did so after their 
first or second visit to the clinic, usually before or just after they were able to get on to 
HAART. More children in the experimental group died than in the control group. 
Transferred to other clinics. 
After April 2004 as HAART became available in South Africa more outlying hospitals 
and clinics gradually gained access to the medication. This meant that children who 
initially attended Harriet Shezi clinic because it was one of the first sites to dispense 
HAART, were gradually referred back to their closest hospital or clinic once they could 
receive their medication there. When children were thus referred, the caregiver was 
asked whether they were still prepared to come to Harriet Shezi to continue to 
participate in this study, however they would no longer be able to receive the other 
services at the clinic. Understandably, few caregivers were willing to do this. This 
accounted for the five children lost to follow up during the study due to being transferred 
elsewhere. 
Institutionalisation of children. 
Three children were placed in institutions during the course of the study. These children 
could no longer be part of the study because they no longer had a primary caregiver to 
do the home programme with them and fill in the PSI/SF. Although no longer part of the 
study, these children were followed-up and developmental advice was given to the 
caregivers from the orphanage who brought them to their clinic visits.  
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Change of caregiver 
One child had to be excluded from the study after her initial visit as she changed primary 
caregivers twice in six months. Her mother died and she was sent to her grandmother 
who died three months later. She was then sent to live with her aunt. 
Family moved out of area. 
Three children moved out of Gauteng during the study and no longer attended Harriet 
Shezi clinic. Two of the children moved with their mothers, the third child was sent to live 
with his grandmother in the Free State after his mother died. 
Untraceable. 
One child did not return to the clinic after his first visit. There was no contact number in 
the child’s file and when a counsellor from Harriet Shezi went to the address given in the 
file to find the family, she was unable to trace the child or the caregiver.  
Refused hospital treatment. 
One child did not return after the first visit as the mother decided to take her to a 
traditional healer and not to return to the hospital.  
 
5.2 Baseline Data 
5.2.1 Demographic information 
The demographic information for the experimental and the control groups at the start of 
the study is presented in table 5.1. Relevant information was extracted from the 
demographic questionnaire and the HESSI. The HESSI was not scored and analysed 
separately as many of the caregivers were not able to provide all the information 
requested, especially for items relating to the amount of rent paid and the cost of 
services for the household. Means and standard deviations or percentages were used to 
summarise the data.  The demographic data of the control and experimental groups 
were compared using a two sample t test with equal variance. 
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Table 5.1 Demographic information for experimental and control groups. 
 Experimental group 
n=60 
Control group 
n=62 
p value 
Age(months) 18.0 (±8.1) 19.0(±8.2) p=0.76 
Gender 
Male 
Female 
 
30 (50.0%) 
30 (50.0%) 
 
32 (51.6%) 
30 (48.4%) 
 
p=1 
Primary caregiver 
Mother 
Father 
Grandmother  
Aunt 
Other 
 
49 (81.7%) 
1 (1.7%) 
7(11.7%) 
2 (3.3%) 
1 (1.7%) 
 
55 (88.7%) 
1 (1.6%) 
4 (6.5%) 
0 (0%) 
2 (3.3%) 
 
p=0.54 
Age of caregiver 31.7 (±10.5) 29.8 (±8.4) p=0.27 
Educational level 
caregiver 
< Gr 5 
Gr 5-6 
Gr 7-9 
Gr 10-11 
Gr 12 
Tertiary 
 
 
1 (1.7%) 
0 (0%) 
9 (15.0%) 
32 (53.3%) 
16 (26.7%) 
2 (3.3%) 
 
 
2 (3.2%) 
2 (3.2%) 
9 (14.5%) 
30 (48.4%) 
16 (25.8%) 
3 (4.8%) 
 
p=0.87 
Number of adults in 
household 
 
3.2 (±2.0) 
Median= 3 
 
3.2 (±1.9) 
Median= 2 
 
p=0.99 
Number of children in 
household 
 
4.1 (±7.6) 
Median= 3 
 
3.0 (±1.9) 
Median= 2 
 
p=0.59 
Monthly income R1435 (±5098.88) R939,16 (±1893.83) p=0.52 
Housing 
-Shack 
-Room 
-Flat 
-Shared house 
-Own house 
 
13 (21.7%) 
9 (15.0%) 
4 (6.7%) 
10 (16.7%) 
24 (40.0%) 
 
13 (21.0%) 
7 (11.3%) 
0 (0%) 
14 (22.6%) 
28 (45.2%) 
 
p=0.30 
Amenities in home 
-Fridge 
-TV 
-Telephone/cell phone 
-Car 
-VCR 
-Washing machine 
-Microwave 
 
46 (76.7%) 
48 (80.0%) 
41 (68.3%) 
5 (8.3%) 
13 (21.7%) 
5 (8.3%) 
11 (18.3%) 
 
 
44 (71.0%) 
44 (71.0%) 
37 (59.7%) 
2 (3.3%) 
10 (16.1%) 
9 (14.5%) 
11 (17.7%) 
 
p=0.54 
p=0.30 
p=0.35 
p=0.27 
p=0.49 
p=0.40 
p=1 
(Values presented are means and standard deviations unless otherwise indicated) 
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The two groups were well matched for all demographic variables measured, with no 
significant differences found between the two groups. The study population was 
relatively young and the vast majority of children were still being cared for by their 
biological mothers, the majority of whom were in their twenties and thirties. The families 
in which the children lived were poor with little access to common household amenities. 
One third of families lived in their own houses which they did not share with other 
families. Only one third of caregivers had completed school (12 years). The reported 
income varied widely due to the fact that a few wealthier families chose to bring their 
children to this clinic despite having medical aid. This accounts for the very wide 
standard deviation observed for income levels. The number of children per household 
was also skewed due to one mother caring for 60 abandoned and orphaned children in 
her home, without being registered as an orphanage or having any state support. She 
and her mother were the only adults in the household and the child she brought to the 
clinic was her own biological child.  
5.2.2 Growth parameters 
The baseline anthropometric data for children in the experimental and control groups is 
presented in table 5.2. The data for the control and experimental groups is compared 
using a two sample student’s t test with equal variance. 
 
Table 5.2 Baseline anthropometric data for children in experimental and control groups 
 
 
Experimental group 
n=60 
Control group 
n=62 
p value 
Head circumference  
z-score 
 
-2.54 (± 1.3) 
 
-2.35 (±1.3) 
 
p=0.42 
Height for age 
z-score 
 
-3.01 (±2.1) 
 
-2.71 (±1.6) 
 
p=0.37 
Weight-for-age 
z-score 
 
-2.61 (±1.4) 
 
-2.17 (±1. 6) 
 
p=0.10 
Weight-for-height 
z-score 
 
-0.74 (±2.1) 
 
-0.57 (±1.2) 
 
p=0.59 
(Values are means and standard deviations) 
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The children in the control and experimental groups were well matched for head 
circumference, weight and height. Malnutrition and stunting were present in both groups 
of children with stunting being more apparent than wasting. Weight for height z-scores 
were within normal limits due to the fact that both variables were decreased. These 
baseline anthropometric measurements indicate that the children in this study, as a 
group, were malnourished and that all their growth parameters were suboptimal. 
5.2.3 CD4 counts and HAART 
The number of children receiving HAART at their initial visit is depicted in table 5.3. The 
data for the control and experimental groups was compared using a two sample 
student’s t test. 
 
Table 5.3 Number of children in experimental and control groups receiving HAART 
 Experimental group 
n=60 
Control group 
n=62 
p value 
CD4% 14.2 (±8.3) 14.5 (±9.4) p=0.86 
HAART 
No 
Yes 
 
n=52 (86.7%) 
n=8 (13.3%) 
 
n=52 (83.9%) 
n=10 (16.1%) 
 
p=0.8 
       (Values are means and standard deviations unless otherwise stated) 
 
The mean CD4% counts for both groups of children were very low, indicating that many 
of these children had severe immuno-suppression and would be eligible for starting 
HAART. The majority of the children were not receiving HAART at the start of this study 
as it was not yet available in South African hospitals. Those children who were on 
HAART were paying for it privately or were enrolled in drug trial studies. There was no 
difference in the number of children on HAART between the two groups at the start of 
the study (p= 0.8). 
5.2.4 Developmental status 
The developmental status of the children in the experimental and control groups at 
baseline is presented in table 5.4. Developmental status is presented as age corrected 
developmental indices, the Mental Developmental Index (MDI) and the Psychomotor 
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Developmental Index (PDI). The data for the control and experimental groups was 
compared using a two sample student’s t test with equal variance. 
 
Table 5.4 MDI and PDI for children in the experimental and control groups at baseline. 
 Experimental group 
n= 60 
Control group  
n=62 
 p value 
MDI 62.6 (±21.5) 68.5 (±22.1) p=0.14 
PDI 49.8 (±22.3) 57.4 (±24.8) p=0.08 
                     (Values are means and standard deviations unless otherwise stated) 
The children in both the experimental and control groups were extremely delayed in both 
mental and motor development at their initial assessments. Motor development was 
particularly severely affected with scores being extremely low. The PDI scores of the 
experimental group were lower than those of the control group, but not significantly so. 
 
The BSID allows for classification of children as having accelerated development, being 
within normal limits, having mild delay or severe delay. The breakdown for this sample 
at baseline is presented in table 5.5. 
Table 5.5 Developmental status of groups according to BSID classification at visit one. 
 MDI PDI 
 Experimental 
n=60 
Control 
n=62 
Total 
n=122 
Experimental 
n=60 
Control 
n=62 
Total 
n=122 
Accelerated (>115) 0% 0% 0% 0% 1.6% 1% 
Normal (85-115) 21.7% 25.8% 22% 8.5% 17.7% 12% 
Mild delay (70-84) 16.7% 32.2% 26% 18.5% 13% 15% 
Severe delay (<70) 61.6% 42% 52% 73% 67.7% 72% 
 
It is of concern to note that half the children had severely delayed mental development 
and almost three quarters had severely delayed motor development. Less than 25% of 
the children had normal mental development scores and only 12% fell into the normal 
category for motor development. The experimental group had more children in the 
severely delayed category for both mental and motor development than the control 
group. 
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5.2.5 Parenting stress 
The means and standard deviations of parenting stress levels for caregivers of children 
in the experimental and control groups as measured by the PSI/SF are presented in 
table 5.6. The data for the two groups was compared using a two sample student’s t test 
with equal variance. 
 
Table 5.6 Parenting stress of caregivers of children in experimental and control groups at 
baseline. 
 Experimental group 
n=60 
Control group 
n=62 
p value  
PSI/SF Total 104.1 (±20.0) 103. 7 (±19.2) p=0.92 
PD 37.5 (±9.3) 36.9 (±7.5) p=0.72 
P-CDI 33.2 (±8.6) 32.2 (±9.0) p=0.55 
DC 33.3 (±7.1) 34.6 (±7.4) p=0.31 
                      (Values are means and standard deviations unless otherwise stated) 
 
The parenting stress levels of both groups of caregivers were extremely high. Values of 
over 90 for total stress indicate clinically significant levels of stress. There was no 
difference between the two groups in terms of total stress scores, or any of the three 
subscale scores. All three of the sub-scales were elevated, indicating that parents 
experienced high levels of stress in all of the domains measured. The parental 
dysfunction (PD) subscale score was slightly higher than the rest. This could be 
attributed to the fact that most of the caregivers were the child’s biological mother and 
HIV positive themselves which could affect their own health related quality of life and 
emotional well being. 
 
5.3 Outcomes Over Time as Measured by Intention to Treat Analysis. 
This section presents the changes that occurred in each of the outcomes that were 
measured over the study period will be presented. CD4 counts and anthropometric 
measures (height, weight and head circumference) were performed every three months 
at each visit. Whether or not the child was on HAART was also documented at all five 
visits. MDI, PDI and PSI were measured at baseline, six months and twelve months. 
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Change in anthropometric scores as well as in MDI, PDI and PSI was assessed using 
repeated measures analysis of variance.  
5.3.1 HAART over time 
At each visit it was recorded whether or not the child was on HAART. The percentage of 
children receiving HAART at each visit is shown in table 5.7. The data for the two groups 
was compared using Fisher’s exact test. 
 
Table 5.7 Percentage of children in each group receiving HAART at each visit. 
 Experimental group Control group p value 
Visit 1. 13.3% 16.1% p=0.80 
Visit 2. 46.8% 34.6% p=0.23 
Visit 3. 65.1% 64.0% p=1 
Visit 4. 79.1% 77.6% p=1 
Visit 5. 86.1% 85.7% p=1 
 
The number of children receiving HAART increased steadily throughout the duration of 
the study. At no point was there a significant difference between the two groups in the 
number of children receiving HAART. The increase in number of children receiving 
HAART is a measure of the success of the rollout of antiretroviral therapy at Harriet 
Shezi clinic. 
 
5.3.2 Anthropometric outcomes over time. 
The height, weight and head circumference of each child were measured at every visit.  
. 
Head Circumference 
In table 5.8 the head circumferences of the children in the experimental and control 
groups at each visit are shown. 
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Table 5.8 Change in head circumference over time 
 Experimental group Control group Total 
Visit 1 n=60 
45.13(±3.12) 
n=62 
45.45 (±2.91) 
n=122 
45.29(±3.01) 
Visit 3 n=43 
46.68(±2.85) 
n=50 
46.85(±2.41) 
n=93 
46.77(±2.61) 
Visit 5 n=43 
47.91(±2.34) 
n=49 
48.07(±2.05) 
n=92 
47.99(±2.18) 
Total n=146 
46.41(±3.04) 
n=161 
46.68(±2.73) 
n=307 
46.55(±2.88) 
 
The absolute values for head circumferences of the two groups were very similar, with 
no significant differences found between groups over time (p=0.42).The head 
circumference of both groups of children increased significantly over time from baseline 
to 12 months follow up (p=0.00). 
 
The mean z-scores for the control and experimental groups are presented in table 5.9. 
 
Table 5.9 Mean head circumference z-scores over visits by group. 
 Experimental group Control group 
Visit 1 -2.54 -2.35 
Visit 2 -2.23 -2.12 
Visit 3 -2.02 -1.88 
Visit 4 -1.82 -1.73 
Visit 5 -1.53 -1.48 
 
Although they improved over the course of the study the head circumference z-scores 
for both the control and the experimental groups remained well below the international 
norm at the end of the study period (-1.53 and -1.48 respectively). 
Height 
The height-for-age- z-scores for the experimental and control groups at each visit are 
presented in table 5.10 
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Table 5.10 Change in height- for-age z-score over visits by group 
 Experimental group Control group Total 
Visit 1 n=60 
-3.01(±2.06) 
n=62 
-2.71(±1.60) 
n=122 
-2.86(±1.83) 
Visit 2 n=47 
-2.87(±1.54) 
n=52 
-2.61(±1.57) 
n=99 
-2.73(±1.56) 
Visit 3 n=43 
-2.76(±1.33) 
n=50 
-2.49(±1.25) 
n=93 
-2.62(±1.28) 
Visit 4 n=43 
-2.70(±1.36) 
n=49 
-2.27(±1.08) 
n=92 
-2.47(±1.24) 
Visit 5 n=43 
-2.40(±1.46) 
n=49 
-2.13(±1.06) 
n=92 
-2.25(±1.26) 
Total n=236 
-2.77(±1.61) 
n=262 
-2.46(±1.36) 
n=498 
-2.61(±1.49) 
 
 
The two groups had similar height-for-age z-scores which increased significantly for both 
groups combined over the year (p< 0.001). The children were stunted, with mean z-
scores of -2.86 for the combined group at the start of the study. Although the 
improvement over the year was significant the children remained stunted with mean z-
scores of -2.25 at the end of the follow-up period. There was no significant difference 
between the groups (p=0.22). 
 
Weight 
The weight-for-age z-scores for each group over time are presented in table 5.11. 
 
 
Table 5.11/ 
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Table 5.11 Change in weight-for-age over visits by group. 
 Experimental group Control group Total 
Visit 1 
n=60 
-2.61(±1.37) 
n=62 
-2.17(±1.56) 
n=122 
-2.39(±1.48) 
Visit 2 
n=47 
-2.42(±1.51) 
n=52 
-2.10(±1.50) 
n=99 
-2.25(±1.50) 
Visit 3 
n=43 
-2.05(±1.35) 
n=50 
-1.67(±1.22) 
n=93 
-1.84(±1.29) 
Visit 4 
n=43 
-1.87(±1.28) 
n=49 
-1.46(±1.13) 
n=92 
-1.65(±1.21) 
Visit 5 
n=43 
-1.55(±1.13) 
n=49 
-1.26(±1.12) 
n=92 
-1.39(±1.13) 
Total 
n=236 
-2.14(±1.38) 
n=262 
-1.76(±1.37) 
n=498 
-1.94(±1.39) 
 
Weight-for-age was below normal in both groups with a mean combined z-score for the 
two groups of  -2.39. The children did gain weight during the study period with the final 
mean weight-for-age z-score approaching normal at -1.39. There was a significant 
change in weight-for-age z-scores over the study period for the two groups combined 
(p<0.001). There was no significant difference between the two groups in terms of 
weight-for-age (p=0.08). 
 
The weight-for-height z-scores for the experimental and control groups at each visit are 
presented in table 5.12. 
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Table 5.12 Change in weight-for-height z-score over visits by group 
 Experimental group Control group Total 
Visit 1 n=60 
-0.74(±2.06)) 
n=62 
-0.57(±1.22) 
n=122 
-0.66(±1.68) 
Visit 2 n=47 
-0.83(±1.32) 
n=52 
-0.62(±1.38) 
n=99 
-0.72(±1.35) 
Visit 3 n=43 
-0.51(±1.07) 
n=50 
-0.27(±1.19) 
n=93 
-0.38(±1.14) 
Visit 4 n=43 
-0.31(±1.15) 
n=49 
-0.15(±1.08) 
n=92 
-0.22(±1.11) 
Visit 5 n=43 
-0.17(±1.14) 
n=49 
0.02(±1.07) 
n=92 
-0.07(±1.10) 
Total n=236 
-0.53(±1.46) 
n=262 
-0.33(±1.21) 
n=498 
-0.43(±1.34) 
 
The weight for height of both groups of children was within normal limits and was close 
to normal by the end of the study period. The weight-for-height z-score for the groups 
combined was -0.43 at the end of the study period which is 98% of the median. This 
reflects that the weight gain exceeded the growth in length of the children during this 
time period. There was a significant improvement in weight-for-height z-scores for the 
two groups combined (p<0.001) and there was no significant difference between the two 
groups (p=0.24). 
 
5.3.3 CD4% counts over time  
Each child’s most recent CD4% was noted at every visit. The change in CD4% for each 
group over the year is depicted in table 5.13. 
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Table 5.13 Change in CD4% over visits by group 
 Experimental group Control group Total 
Visit 1 n=60 
14.25(±8.32) 
n=62 
14.53(±9.36) 
n=122 
14.39(±8.83) 
Visit 2 n=47 
15.01(±8.38) 
n=52 
15.24(±9.88) 
n=99 
15.13(±9.15) 
Visit 3 n=43 
18.75(±11.57) 
n=50 
15.77(±8.44) 
n=93 
17.15(±10.06) 
Visit 4 n=43 
20.62(±11.13) 
n=49 
17.08(±7.82) 
n=92 
18.73(±9.63) 
Visit 5 n=43 
21.91(±10.21) 
n=49 
19.65(±7.59) 
n=92 
20.72(±8.95) 
Total n=236 
17.78(±10.26) 
n=262 
16.33(±8.83) 
n=498 
17.02(±9.56) 
 
 
The two groups were well matched in terms of their CD4% throughout the study period 
(p=0.64). The CD4% for both groups increased significantly over the one year follow-up 
period (p<0.001). The initial CD4% for both the experimental and control group was very 
low (14.25% and 14.53% respectively), as previously mentioned very few children were 
on HAART when enrolled onto the study. The CD4% at the end of the study was 
significantly improved for both groups (21.91% and 19.65% respectively). Many more 
children were on HAART by the end of the study period as seen in table 5.7. 
5.3.4 Developmental status over time 
Children were assessed with the BSID at visit 1 (baseline), visit 3 (six months) and visit 
5 (12 months). The changes in the mental developmental index (MDI) and the 
psychomotor developmental index (PDI) over time for each group of children can be 
seen in figures 5.14 and 5.15. 
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MDI  
The change in MDI for each group over time is represented in table 5.14. 
 
Table 5.14 Change in MDI over visits by group 
 Experimental group Control group Total 
Visit 1 n=60 
62.60(±21.51) 
n=62 
68.53 (±22.10) 
n=122 
65.61(±21.93) 
Visit 3 n=43 
61.63(±20.45) 
n=50 
69.38(±22.33) 
n=93 
65.80(±21.72) 
Visit 5 n=43 
69.30(±19.84) 
n=49 
64.31(±17.43) 
n=92 
66.64(±18.66) 
Total n=146 
64.29(±20.83) 
n=161 
67.51(±20.85) 
n=307 
65.98(±20.87) 
 
 
The MDI for both groups of children was extremely low initially. There was no significant 
difference between the two groups, with respect to MDI (p=0.27). The MDI also did not 
change significantly for the two groups combined over the period of one year (p=0.86). 
However the amount of change in the experimental group over the year (MDI=62.6 to 
MDI=69.3) was significantly greater (p=0.01) than the change seen in the control group 
(MDI=68.5 to MDI=64.3). In fact the control group deteriorated slightly over the year 
while the experimental group improved. Despite the fact that the children in the 
experimental group improved during the course of the study the mean MDI scores at the 
end of the study period indicate that the children still had significant delay in their mental 
development. 
PDI 
The change in PDI for each group over time is presented in table 5.15. 
 
Table 5.15/ 
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Table 5.15 Change in PDI over visits by group 
 Experimental group Control group Total 
Visit 1 n=60 
49.78(±22.25) 
n=62 
57.44 (±24.76) 
n=122 
53.67(±23.77) 
Visit 3 n=43 
59.26(±25.08) 
n=50 
63.20(±24.75) 
n=93 
61.38(±24.85) 
Visit 5 n=43 
70.49(±25.05) 
n=49 
65.86(±24.47) 
n=92 
68.02(±24.72) 
Total n=146 
58.67(±25.29) 
n=161 
61.79(±24.78) 
n=307 
60.31(±25.03) 
 
There was no significant difference between the two groups, with respect to PDI 
(p=0.57). The PDI scores of the two groups combined improved significantly over the 
one year period (p=0.00), however the amount of improvement over time in the 
experimental group (PDI=49.8 to PDI=70.5) was significantly more than in the control 
group (PDI=57.4 to PDI=65.9) (p=0.02). Although both groups showed some 
improvement in PDI scores over the study period, the mean PDI scores for both groups 
remained low, indicating that the children still had with significant motor delay at the end 
of the study period. 
 
The classification of the developmental status of the children according to the BSID II at 
visit five is presented in table 5.16. 
 
Table 5.16 Classification of groups according to BSID II scores at visit five. 
 
           MDI              PDI 
 Experimental 
n=43 
Control 
n=49 
Total 
n=92 
Experimental 
n=43 
Control 
n=49 
Total 
n=92 
Accelerated 2.3% 0% 1% 0% 0% 0% 
Normal 11.6% 12.2% 12% 34.8% 26.5% 30.4% 
Mild delay 48.8% 28.6% 38% 23.3% 18.4% 20.6% 
Severe delay 37.2% 59.2% 49% 41.9% 55.1% 48.9% 
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The proportion of children with severe delay according to their MDI scores was very 
similar to those seen at baseline (See table 5.5). Although nearly half the children were 
still classified as severely delayed in terms of their PDI scores this is an improvement on 
the 72% of children who fell into this category at visit one. Children in the experimental 
group were less likely to be severely delayed at visit five than children in the control 
group. A greater proportion of children scored within normal limits for PDI at the end of 
the study than at visit one, 30.4% as opposed to 12%. This improvement in motor 
function for the two groups combined could probably be attributed to the availability of 
HAART for all children who qualified for it by the end of the study period. 
 
5.3.5 Parenting Stress 
The PSI/SF was administered to the caregivers of the children at visit 1 (baseline), visit 
3 (6months) and visit 5 (12 months). Table 5.17 depicts the changes in total stress 
scores for each group over the study period. 
 
Table 5.17 Change in parenting stress over visits by group. 
 Experimental group Control group Total 
Visit 1 n=60 
104.13(±20.00) 
n=62 
103.77 (±19.18) 
n=122 
103.95(±19.51) 
Visit 3 n=43 
100.86(±24.96) 
n=50 
96.08(±21.19) 
n=93 
98.29(±23.00) 
Visit 5 n=43 
97.35(±24.12) 
n=49 
96.06(±21.49) 
n=92 
96.66(±22.64) 
Total n=146 
101.17(±22.80) 
n=161 
99.04(±20.75) 
n=307 
100.05(±21.74) 
 
The PSI total scores were well matched for the two groups (p=0.62). The PSI scores 
came down significantly during the course of the study with the scores at visit five being 
significantly lower than those at visit one (p<0.001). There was no difference in the 
amount of change that occurred in parenting stress between the two groups (p=0.57). 
Closer analysis revealed that of the three subscales of the PSI/SF there was a 
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significant decreases in Parental Dysfunction over time (p<0.001) as well as in Parent-
Child Dysfunctional Interaction (p<0.001) but no significant change in the Difficult Child 
subscale (p=0.08). The two groups were well matched for each of the three subscale 
scores over time with no significant differences between groups being noted. 
5.4 Variables that Predicted Outcomes. 
As a result of a step-wise regression analysis the variables that were predictors of each 
outcome were determined. As a result of the lenient p value set for entry into the 
regression (p=0.25), a number of variables entered each regression analysis. The three 
most important variables, as determined by the order in which they enter the regression, 
are highlighted in the discussion that follows each table. 
 
The factors that predicted MDI at visit one are shown in table 5.18a and 5.18b. 
Table 5.18a Order and significance of variables entering regression analysis for MDI at 
visit one (n=122). 
Begin with empty model p value 
Adding weight-for-age z-score 
Adding age 
Adding On HAART 
Adding gender 
Adding group 
P=0.0001 
p=0.0000 
p=0.0080 
p=0.0534 
p=0.1707 
 
Table 5.18b Variables predicting MDI at visit one (n=122). 
MDI Coefficient Std Error t P>│t│ 95%confidence 
interval 
Waz 
Age 
On HAART 
Female 
Control group 
Cons   
6.65 
-1.22 
-13.12 
-6.22 
4.50 
116.90 
1.15 
0.21 
4.59 
3.27 
3.23 
16.74 
5.76 
-5.91 
-2.85 
-1.90 
1.38 
6.98 
0.00 
0.00 
0.01 
0.06 
0.17 
0.00 
4.36       8.93 
-1.62      -0.81 
-22.21    -4.02 
-12.71    0.27 
-1.97      10.97 
83.69      150.12 
 
Many variables were predictive of MDI at visit one. The most important of these factors 
are seen in table 5.18b and accounted for 37.0% of the variance seen. The three most 
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important factors predicting MDI at this visit were weight for age z-scores, the age of the 
children and whether the children were on HAART. Children were more likely to have 
higher MDI scores if they had better weight-for-age z-scores, were younger and not on 
antiretrovirals. 
 
Table 5.19a and 5.19b shows the variables predictive of MDI at visit three. 
Table 5.19a Order and significance of variables entering regression analysis for MDI at 
visit three (n=93). 
Begin with empty model p value 
Adding weight-for-age z-score 
Adding age 
Adding height-for-age z-score 
Adding weight-for-height z-score 
Adding number of children 
Adding group 
Adding education level 
Adding housing 
Adding CD4 count 
p=0.0000 
p=0.1041 
p=0.1788 
p=0.0463 
p=0.1144 
p=0.1726 
p=0.1847 
p=0.1500 
p=0.1825 
 
 
Table 5.19b/ 
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Table 5.19b Variables predicting MDI at visit three (n=93). 
MDI Coefficient Std. Error t P>|t| 95% Confidence 
Interval 
Waz 
Age 
Haz 
Whz 
No. children 
Control group 
Education 
caregiver 
Grade 5-6 
Grade 7-9 
Grade 10-11 
Grade 12 
Tertiary 
Housing 
Room 
Flat 
Shared house 
Own house 
CD4% 
Cons 
-24.37 
-0.17 
20.22 
22.17 
-0.55 
9.23 
 
 
7.23 
30.16 
35.45 
33.71 
38.96 
 
-2.05 
12.75 
5.40 
-8.25 
0.28 
48.18 
 
-10.65 
0.27 
6.44 
7.77 
0.34 
4.00 
 
 
23.03 
19.12 
18.74 
18.94 
21.35 
 
6.71 
13.93 
6.28 
5.20 
0.21 
22.63 
 
-2.29 
-0.62 
3.14 
2.85 
-1.65 
2.31 
 
 
0.31 
1.58 
1.89 
1.78 
1.82 
 
-0.31 
0.92 
0.86 
-1.59 
1.35 
2.13 
0.02 
0.54 
0.00 
0.01 
0.10 
0.02 
 
 
0.75 
0.12 
0.06 
0.07 
0.07 
 
0.76 
0.36 
0.39 
0.11 
0.18 
0.04 
 
-45.57   -3.16 
-0.70      0.37 
7.40       33.04 
6.70       37.64 
-1.22      0.12 
1.26       17.21 
 
 
-38.64    53.11 
-7.94     68.25 
-1.87       72.78 
-4.02      71.43 
-3.57      81.49 
 
-15.41     11.30 
-14.99     40.48 
-7.11       17.91 
-18.60     2.11 
-0.13       0.68 
3.12       93.25 
 
At visit three a large number of variables were again predictive of MDI and together 
explained 44.4% of the variance seen. The three most important variables predicting 
MDI were weight-for-age z-score, age of the child and height-for-age z-score. Low 
weight-for-age was predictive of better MDI scores, this is in contrast to the finding at 
visit one where children with greater weight-for-age z-scores performed better. Younger 
children performed better and children with a greater height-for-age z-score also did 
better. 
 
The variables predicting MDI scores at visit five are shown in tables 5.20a and 5.20b. 
 
 
Tables 5.20a and 5.20b /  
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Table 5.20a Order and significance of variables entering regression analysis for MDI at 
visit five (n=92). 
Begin with empty model p value 
Adding weight-for-age z-score 
Adding CD4 count 
Adding group 
Adding on HAART 
Adding number of children 
Adding gender 
p=0.0000 
p=0.0058 
p=0.0640 
p=0.0662 
p=0.1626 
p=0.1888 
 
Table 5.20b Variables predicting MDI at visit five (n=92). 
MDI Coefficient Std Error t P>|t| 95% confidence 
interval 
Waz 
CD4% 
Control group 
On HAART 
No. children 
Female 
Cons 
7.29 
0.33 
-7.35 
-9.30 
-0.41 
-4.38 
85.54 
1.49 
0.20 
3.36 
4.86 
0.27 
3.01 
7.95 
4.90 
1.66 
-2.19 
-1.92 
-1.54 
-1.32 
10.76 
0.00 
0.10 
0.03 
0.06 
0.13 
0.19 
0.00 
4.33         10.25 
-0.06        0.71 
-14.04     -0.66 
-18.96      0.35 
-0.94        0.12 
-10.96      2.19 
69.72       101.36 
 
At visit five higher weight-for-age z-scores, higher CD4% counts and being in the 
experimental group were the three most important predictors of better MDI scores. A 
number of other factors as seen in table 5.20b contributed to predicting MDI scores at 
this visit. These factors accounted for 35.71% of the variance seen in MDI scores. 
 
 
The variables influencing PDI at visit one are presented in tables 5.21a and 5.21b. 
 
Tables 5.21a and 5.21b / 
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Table 5.21a Order and significance of variables entering the regression analysis for PDI at 
visit one (n=122). 
Begin with empty model  p value 
Adding weight-for-age z-score 
Adding age 
Adding on HAART 
Adding gender 
Adding  group 
Adding CD% count 
Adding income 
p=0.0000 
p=0.0000 
p=0.0107 
p=0.0548 
p=0.1451 
p=0.1392 
p=0.1705 
 
Table 5.21b Variables predicting PDI at visit one (n=122). 
PDI Coefficient Std Error t P>|t| 95% confidence 
interval 
Waz 
Age 
On HAART 
Female 
Control group 
CD4% 
Income 
Cons  
8.73 
-1.04 
-12.07 
-6.35 
5.31 
0.29 
0.00 
91.03 
1.25 
0.21 
4.73 
3.33 
3.31 
0.20 
0.00 
7.76 
6.98 
-4.89 
-2.55 
-1.91 
1.60 
1.43 
1.38 
11.73 
0.00 
0.00 
0.01 
0.05 
0.11 
0.16 
0.17 
0.00 
6.25        11.21 
-1.46      -0.62 
-21.43    -2.70 
-12.95      0.25 
-1.26       11.88 
-0.11       0.69 
-0.00       0.00 
75.65      106.41 
 
The three most important predictors of PDI at visit one were weight-for-age z-score, age 
of the child and whether they were on HAART or not. Children who were not on HAART, 
were younger and had higher weight-for-age z-scores were more likely to have better 
PDI scores. A number of other factors contributed towards predicting PDI. Together they 
accounted for 45.94% of the variance seen. 
 
Variables predicting PDI at visit three are shown in table 5.22a and 5.22b. 
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Table 5.22a Order and significance of variables entering the regression analysis for PDI at 
visit three (n=93). 
Begin with empty model p value 
Adding weight-for-age z-score  
Adding HAART 
Adding CD4 count 
Adding gender 
p=0.0000 
p=0.0541 
p=0.0918 
p=0.2238 
 
 
Table 5.22b Factors predicting PDI at visit three (n=93). 
PDI Coefficient Std Error t P>|t| 95% confidence 
interval 
Waz 
On HAART 
CD4% 
Female 
cons 
9.57 
-9.62 
0.29 
-5.62 
83.16 
1.70 
4.71 
0.23 
4.58 
8.01 
5.63 
-2.04 
1.27 
-1.23 
10.39 
0.00 
0.04 
0.21 
0.22 
0.00 
6.19         12.94 
-18.98     -0.27 
-0.16        0.75 
-14.73      3.49 
67.25     99.07 
 
A combination of a number of variables was predictive of PDI scores at visit three. The 
three most important variables were weight for age z-score, whether or not the child was 
on HAART and their CD4 count. Children with a higher weight-for-age z-score, with a 
higher CD4 count and not on HAART achieved better PDI scores. The combination of 
factors shown in table 5.22b accounted for 36.11% of the variance in PDI scores at this 
visit. 
 
The variables predictive of PDI at visit five are shown in table 5.23a and 5.23b. 
 
Table 5.23a and 5.23b / 
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Table 5.23a Order and significance of variables entering the regression analysis for PDI at 
visit five (n=92). 
Begin with empty model p value 
Adding height-for-age z-score 
Adding CD4 count 
Adding  on HAART 
Adding weight-for-age z-score 
Adding weight-for-height z-score 
Adding income 
Adding gender 
Adding group 
p=0.0001 
p=0.0003 
p=0.0194 
p=0.0647 
p=0.0759 
p=0.1504 
p=0.2347 
p=0.2340 
 
Table 5.23b Variables predicting PDI at visit five (n=92). 
PDI Coefficient Std Error t P>|t| 95% confidence 
interval 
Haz 
CD4% 
On HAART 
Waz 
Whz 
Income 
Female 
Control group 
Cons 
-9.94 
0.70 
-15.51 
28.67 
-18.32 
-0.00 
-5.33 
-5.15 
90.27 
9.07 
0.25 
6.28 
15.48 
11.94 
0.00 
4.31 
4.30 
10.26 
-1.10 
2.82 
-2.47 
1.85 
-1.53 
-1.50 
-1.24 
-1.20 
8.80 
0.27 
0.01 
0.02 
0.07 
0.13 
0.14 
0.22 
0.23 
0.00 
-27.98     8.09 
0.21         1.20 
-27.98    -3.02 
-2.13        59.47 
-42.07      5.42 
-0.00        0.00 
-13.92      3.25 
-13.70      3.40 
69.86       110.68 
 
The three most important predictors of PDI at visit five were height-for-age, CD4% count 
and whether or not the child was on HAART. Children were more likely to have higher 
PDI scores if they had a greater height-for-age z-scores, higher CD4% counts and were 
not on HAART. These variables in combination with those in table 5.23b explained 
41.07% of the variance seen in PDI scores at this visit. 
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In general children who were not yet eligible for HAART (ie. had higher CD4 counts) and 
with better growth parameters appeared to do better in terms of motor performance at 
each of the three time points. 
 
Table 5.24a and table 5.24b show the variables that predicted parenting stress of 
caregivers at visit one. 
 
Table 5.24a Order and significance of variables entering the regression analysis for PSI at 
visit one (n=122). 
Begin with empty model p value 
Adding weight-for-age z-score 
Adding education level 
Adding number of children 
Adding number of adults 
Adding age of caregiver 
p=0.0070 
p=0.0168 
p=0.0419 
p=0.0551 
p=0.2282 
 
Table 5.24b Variables predicting PSI of caregivers at visit one (n=122). 
PSI Coefficient Std Error t P>|t| 95% Confidence 
interval 
Waz 
Education 
caregiver 
Grade 5-6 
Grade 7-9 
Grade 10-11 
Grade 12 
Tertiary 
No. children 
No. adults 
Age caregiver 
Cons  
-2.69 
 
 
15.87 
7.92 
19.94 
7.87 
3.07 
0.90 
-0.58 
0.23 
78.72 
1.15 
 
 
16.29 
11.15 
10.58 
10.86 
13.05 
0.34 
0.97 
0.19 
13.47 
-2.34 
 
 
0.97 
0.71 
1.88 
0.72 
0.28 
2.67 
-1.63 
1.21 
5.84 
0.02 
 
 
0.33 
0.48 
0.06 
0.47 
0.77 
0.01 
0.11 
0.23 
0.00 
-4.96      -0.41 
 
 
-16.41     48.16 
-14.17     30.00 
-1.04       40.92 
-13.64     29.38 
-22.15     29.56 
0.23       1.57 
-3.51      0.34 
-0.14      0.59 
52.03      105.42 
 
 Weight-for-age, educational level of the caregiver and the number of children in the 
household were the most important predictors of parenting stress at this visit. Caregivers 
of children with higher weight-for-age z-scores had lower stress levels, while those with 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
113 
higher levels of education experienced more stress. Caregivers were more likely to have 
increased parenting stress if there were more children in the household. The 
combination of factors seen in table 5.24b accounted for 23.03% of the variance seen in 
PSI/SF scores at this visit. 
 
Variables predicting parenting stress scores at visit three are shown in table 5.25a and 
table 5.25b. 
 
Table 5.25a Order and significance of variables entering the regression analysis for PSI at 
visit three (n=93). 
Begin with empty model p value 
Adding weight-for-age z-score 
Adding housing 
Adding education level 
Adding gender 
Adding number of children 
p=0.0062 
p=0.0153 
p=0.0465 
p=0.0458 
p=0.2168 
 
Table 5.25b Variables predicting PSI/SF scores at visit three (n=93). 
PSI/SF Coefficient Std Error t P>|t| 95% Confidence 
interval 
Waz 
Housing 
Room 
Flat 
Shared house 
Own house 
Education 
caregiver 
Grade 5-6 
Grade 7-9 
Grade 10-11 
Grade 12 
Tertiary 
Female 
No. children 
Cons 
-5.09 
 
-2.63 
-8.44 
19.53 
-2.80 
 
 
-37.35 
-12.62 
-14.25 
-29.09 
-24.02 
9.00 
0.44 
100.04 
1.74 
 
7.39 
15.20 
7.07 
5.61 
 
 
24.97 
21.14 
20.42 
20.59 
23.26 
4.32 
0.36 
21.69 
-2.93 
 
-0.36 
-0.56 
2.76 
0.50 
 
 
-1.50 
-0.60 
-0.70 
-1.41 
-1.03 
2.08 
1.24 
4.61 
0.00 
 
0.72 
0.58 
0.01 
0.62 
 
 
0.14 
0.55 
0.49 
0.16 
0.31 
0.04 
0.22 
0.00 
-8.54      -1.63 
 
-17.34     12.08 
-38.70     21.82 
5.46       33.59 
-13.97     8.37 
 
 
-87.03     12.34 
-54.68     29.44 
-54.89     26.40 
-70.08     11.88 
-70.31     22.26 
0.40      17.60 
-0.27      1.16 
56.88      143.20 
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At this visit weight-for-age, housing and educational level were the most important 
predictors of parenting stress. Decreased weight-for-age z-scores were associated with 
increased parenting stress at this visit. Caregivers who shared a house with others were 
more likely to have high parenting stress levels and a higher level of education was 
associated with lower levels of parenting stress. The combination of factors shown in 
table 5.25b accounted for 34.69% of the variance seen at this visit. 
 
The variables that predicted parenting stress scores at visit five are shown in table 5.26a 
and 5.26b. 
 
Table 5.26a Order and significance of variables entering the regression analysis for PSI at 
visit five (n=92). 
Begin with empty model p value 
Adding number of children 
Adding education level 
Adding CD4 count 
Adding housing 
Adding on HAART 
p=0.0019 
p=0.0267  
p=0.0680  
p=0.1903  
p=0.2384   
 
 
Table 5.26b / 
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Table 5.26b Variables predicting PSI/SF scores at visit five (n= 92). 
PSI/SF Coefficient Std Error t P>|t| 95% 
Confidence 
interval 
Children 
Education 
caregiver 
Grade 5-6 
Grade 7-9 
Grade 10-11 
Grade 12 
Tertiary 
CD4% 
Housing 
Room 
Flat 
Shared house 
Own house 
On HAART 
Cons 
1.03 
 
 
-27.13 
-48.46 
-49.46 
-62.99 
-53.53 
-0.27 
 
10.87 
1.93 
9.21 
-3.47 
7.75 
142.90 
0.36 
 
 
29.81 
22.15 
21.39 
21.45 
24.04 
0.26 
 
7.45 
15.11 
7.27 
5.86 
6.52 
21.17 
286 
 
 
-0.91 
-2.19 
-2.31 
-2.94 
-2.23 
-1.00 
 
1.46 
0.13 
1.27 
-0.59 
1.19 
6.75 
0.01 
 
 
0.37 
0.03 
0.02 
0.00 
0.03 
0.32 
 
0.15 
0.89 
0.21 
0.55 
0.24 
0.00 
0.31        1.76 
 
 
-86.47      32.12 
-92.55     -4.37 
-92.04     -6.88 
-105.70   -20.28 
-101.40   -5.66 
-0.79         0.26 
 
-3.97        25.71 
-28.14      32.00 
-5.26        23.68 
-15.14      8.19 
-5.24        20.74 
100.75     185.05 
 
The number of children in the household, the educational level of the caregiver as well 
as the CD4% count of the child were the three most important predictors of parenting 
stress at this visit. Caregivers who lived in households with more children had higher 
stress levels. Those with higher levels of education had lower stress levels. The higher 
the child’s CD4% count, the lower the caregivers parenting stress was. The factors 
shown in table 5.26b accounted for 32.45% of the variance in parenting stress scores 
seen at this visit. 
 
A number of factors influenced the amount of parenting stress experienced by 
caregivers. Housing, educational level as well as the number of children in the 
household all played a role as did anthropometric measures and CD4% counts of the 
child to a lesser degree. 
 
A further analysis was done to see which factors predicted a change in the children’s 
developmental status and the caregiver’s parenting stress levels from visit one to visit 
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five. Table 5.27a and table 5.27b show which factors predicted an improvement in MDI 
over time. 
 
Table 5.27a Order and significance of variables entering the regression analysis for 
change in MDI (n=92). 
Begin with empty model p value 
Adding age 
Adding group 
Adding income 
Adding on HAART 
p=0.0021 
p=0.0460 
p=0.0437 
p=0.1381 
 
Table 5.27b Variables predicting a change in MDI over time (n=92). 
Change in 
MDI 
Coefficient Std Error t P>|t| 95%Confidence 
interval 
Age 
Control group 
Income 
On HAART 
Cons 
0.98 
-10.10 
0.00 
8.94 
-16.31 
0.27 
4.34 
0.00 
5.96 
6.20 
3.63 
-2.33 
1.55 
1.50 
-2.63 
0.00 
0.02 
0.12 
0.14 
0.01 
0.44         1.51 
-18.73     -1.47 
-0.00        0.01 
-2.93      20.82 
-28.63     -3.98 
 
The children who were most likely to improve with respect to their mental development 
were those who were older, in the experimental group and came from households with a 
higher monthly income. A number of other factors contributed towards predicting an 
improvement in MDI scores over the study period, but accounted for only 19.98% of the 
variance seen. 
 
Variables predicting a change in PDI over time are presented in table 5.28a and 5.28b. 
 
 
Table 5.28a and 5.28b / 
 
 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
117 
Table 5.28a Order and significance of variables entering the regression analysis for 
change in PDI (n=92). 
Begin with empty model p value 
Adding age 
Adding group 
Adding on HAART 
Adding weight-for-height z-score 
Adding gender 
Adding education level 
Adding weight-for-age z-score 
Adding height-for-age z-score 
Adding housing 
Adding number of adults 
Adding number of children 
p=0.0004 
p=0.0060 
p=0.0257 
p=0.0390 
p=0.1802 
p=0.1724 
p=0.1951 
p=0.0056 
p=0.2312 
p=0.1496 
p=0.2021 
 
Table 5.28b Variables predicting change in PDI over time (n=92). 
Change in 
PDI  
Coefficient Std Error t P>|t| 95% Confidence 
interval 
Age 
Control group 
On HAART 
Whz 
Female 
Educational 
level 
Grade5-6 
Grade 7-9 
Grade10-11 
Grade 12 
Tertiary 
Waz 
Haz 
Housing 
Room 
Flat 
Shared house 
Own house 
No. adults 
No. children 
Cons 
1.66 
-12.76 
10.72 
17.63 
-11.06 
 
 
5.87 
-15.58 
-1.25 
-6.89 
-37.13 
-31.63 
19.63 
 
8.65 
-22.27 
-8.56 
-0.56 
2.42 
-0.48 
-12.23 
0.34 
4.04 
5.46 
7.14 
4.22 
 
 
26.77 
19.66 
19.05 
19.34 
22.18 
9.87 
6.62 
 
6.99 
14.57 
7.43 
5.28 
1.29 
0.38 
22.84 
4.90 
-3.16 
1.96 
2.47 
-2.62 
 
 
0.22 
-0.79 
-0.07 
-0.36 
-1.67 
-3.20 
2.978 
 
1.24 
-1.53 
-1.15 
-0.11 
1.87 
-1.29 
-0.54 
0.00 
0.00 
0.05 
0.02 
0.01 
 
 
0.83 
0.43 
0.95 
0.72 
0.09 
0.00 
0.00 
 
0.22 
0.13 
0.25 
0.92 
0.07 
0.20 
0.59 
0.98       2.33 
-20.81     -4.72 
-0.16      21.59 
3.41       31.86 
-19.46     -2.66 
 
 
-47.48     59.21 
-54.76      23.59 
-39.21     36.71 
-45.45     31.66 
-81.34     7.07 
-51.30     -11.95 
6.44       32.82 
 
-5.27      22.57 
-51.31     6.77 
-23.38     6.26 
-11.07     9.96 
-0.16       5.00 
-1.23      0.27 
-57.75     33.28 
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The children who were most likely to show an improvement in their psychomotor 
developmental index scores were children who were older at baseline assessment, in 
the experimental group and already on HAART at their initial assessment.  The factors 
presented in table 5.28b accounted for 49.82% of the variance seen. 
 
The most important factors that were common to both MDI and PDI improvement are 
children who were older at baseline assessment and in the experimental group. 
 
The variables that were predictive of a change in parenting stress over the study period 
are presented in table 5.29a and 5.29b. 
 
Table 5.29a Order and significance of variables entering the regression analysis for 
change in PSI over time (n=92). 
Begin with empty model p value 
Adding education level 
Adding number of adults 
p=0.0464 
p=0.0561 
 
Table 5.29b Variables predicting change in PSI over time (n=92). 
Change in 
PSI  
Coefficient Std Error t P>|t| 95% Confidence 
interval 
Educational 
level 
Grade5-6 
Grade7-9 
Grade10-11 
Grade 12 
 Tertiary 
No. adults 
Cons 
 
 
40.91 
50.99 
58.72 
59.48 
58.28 
-2.09 
-41.74 
 
 
27.10 
19.94 
19.34 
19.53 
22.12 
1.08 
19.41 
 
 
1.51 
2.55 
3.04 
3.05 
2.63 
-1.94 
-2.15 
 
 
0.13 
0.01 
0.00 
0.00 
0.01 
0.05 
0.03 
 
 
-12.96      94.79 
11.25      90.55 
20.28      97.17 
20.65      98.31 
14.30      102.25 
-4.23       0.06 
-80.34    -3.14 
 
 
A decrease in parenting stress levels over the study period was predicted by the 
educational level of the caregiver and the number of adults in the household. Caregivers 
with higher levels of education were more likely to experience a decrease in stress 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
119 
levels. The more adults there were living in the household the less likely parenting stress 
levels were to decrease. The factors in table 5.29b accounted for only 15.80% of 
variance seen.  
 
5.5 The Impact of HAART on Development. 
In order to determine the impact of HAART on the development of children in this study 
a sub-analysis of data was done. The MDI and PDI scores of all children who were not 
on HAART at visit one, but were on HAART by visit three were analysed separately. The 
results of the analysis of variance for MDI and PDI can be seen in tables 5.22 and 5.23 
respectively. 
 
Table 5.30 Changes in MDI over time for children starting HAART. 
 MDI Experimental 
group  n=23 
MDI Control group 
n=22 
MDI Total 
n=45 
Visit 1 (no HAART) 64.22 (± 19.76) 68.77 (± 20.38) 66.44 (± 19.97) 
Visit 3 (on HAART) 59.43 (± 19.57) 69.32 (±  23.49) 64.27 (± 21.90) 
Visit 5 (on HAART) 70.57 (± 19.94) 60.50 (± 16.85) 65.64 (± 18.98) 
 
There was no significant improvement in MDI scores for the two groups combined over 
time (p= 0.77). The group of children who were receiving HAART as well as the 
intervention programme improved over the study period (MDI=64.22 to MDI= 70.57) 
while the children in the control group who received HAART showed a decline in MDI 
scores over time (MDI=68.77 to MDI=60.50). The difference in the amount of change 
between the two groups was significant (p=0.003). These findings suggest that HAART 
did not have a positive impact on cognitive development in this short follow up period. 
 
 
Table 5.31 / 
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Table 5.31 Change in PDI over time for children starting HAART. 
 PDI Experimental 
group n=23 
PDI Control group 
n=22 
PDI Total 
n=45 
Visit 1 (no HAART) 46.65 (± 19.60) 52.86 (± 23.57) 49.69 (± 21.62) 
Visit 3 (on HAART) 57.87 (± 24.34) 58.36 (± 23.63) 58.11 (± 23.72) 
Visit 5 (on HAART) 71.74 (± 22.92) 55.18 (± 21.60) 63.64 (± 23.57) 
 
There was a significant improvement in PDI scores for the two groups combined over 
time, after starting HAART (p<0.001) with both the experimental and control groups 
showing an improvement. The amount of improvement seen in the experimental group 
was however significantly more than that seen in the control group (p<0.001). These 
findings suggest that HAART does have a positive impact on motor development and 
that this effect was enhanced by the addition of a developmental stimulation 
programme. 
 
Only 13 children enrolled on this study never received HAART during the study period. 
Due to the very small number of children in this sub-group statistical analysis of their 
developmental scores is inappropriate. For the sake of completeness their MDI and PDI 
scores at visit one and visit five are summarised in table 5.32. 
 
Table 5.32 MDI and PDI scores of children never on HAART. 
 Experimental group  
n=6 
Control group 
 n=7 
MDI visit 1 75.0 (± 24.4) 67.8 (± 21.0) 
MDI visit 5 80.0 (± 21.7) 77.7 (± 14.4) 
PDI visit 1 71.7 (± 22.5) 65.1(± 19.8) 
PDI visit 5 86.2 (± 17.6) 91.7 (± 17.4) 
                     (Values represented are means and standard deviations unless otherwise indicated) 
The children in both the experimental and control groups, who never received HAART, 
showed an improvement in MDI and PDI scores over time. There were no apparent 
differences between the two groups. PDI scores for both groups were within normal 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
121 
limits at the end of the study period. The CD4% counts for this group of children were 
higher than those of the children who were eligible for HAART. At visit five the mean 
CD4 count for the children not on HAART in the experimental group was 24.3% (±9.2) 
and 28.4% (±8.8) for children not on HAART in the control group. 
 
5.6 Per Protocol Analysis of Primary Outcomes. 
The loss to follow-up over the study period was high at 24.5%. It was therefore decided 
to do a secondary per protocol analysis of the primary outcome measures namely the 
Bayley Scales of Infant Development (MDI and PDI) and the Parenting Stress Index 
(Short Form) in order to ascertain whether the loss to follow-up impacted significantly on 
the results of the study. 
 
The per protocol analysis was done using only the data for the 92 subjects who 
completed the study and had complete data sets. The baseline values for these three 
outcomes for the 92 subjects were compared to those of the 122 subjects recruited into 
the study using a two sample students t test. Repeated measures analysis of variance 
was used to analyse the changes in MDI, PDI and PSI(SF) over time. 
 
Table 5.33 Comparison of baseline data for per protocol and intention to treat analyses. 
 Baseline  
n=92 
Baseline 
n=122 
p value 
MDI 66.33 (±21.1) 65.64 (±21.8) 0.81 
PDI 53.58(±23.5) 53.71(±23.7) 0.97 
PSI 105.60(±18.3) 103.95(±19.51) 0.88 
 
There was no significant difference between the baseline data of the total sample 
(n=122) and the sample of children with complete data sets (n=92). The children who 
were lost to follow up were therefore representative of the sample as a whole. 
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5.6.1 Outcomes over time. 
The changes that occurred in each of the primary outcomes that were measured over 
the study period will be presented. MDI, PDI and PSI were measured at baseline, six 
months and twelve months. Repeated measures analysis of variance was used to 
analyse changes over time. 
 
5.6.2 Developmental status over time 
Children were assessed with the BSID at visit 1 (baseline), visit 3 (six months) and visit 
5 (12 months). The changes in mental developmental index (MDI) and the psychomotor 
developmental index (PDI) over time for each group of children can be seen in tables 
5.34 and 5.35. 
 
MDI  
The change in MDI for each group over time as measued by the repeated measures 
ANOVA is represented in table 5.34. 
 
Table 5.34 Change in MDI over visits by group. 
 Experimental 
n=43 
Control 
n=49 
Total 
n=92 
Visit 1 64.4(±20.8) 68.3 (±21.3) 66.4(± 21.0) 
Visit 3 61.6(± 20.5)  69.9 (±22.2) 66.1(±21.7) 
Visit 5 69.3(±19.8)  64.3(±17.4) 66.64(±18.7) 
Total 65.1(±20.4) 67.5(±20.4) 66.4(±20.4) 
 
The MDI for both groups of children was extremely low initially. There was no significant 
difference between the two groups with respect to MDI (p=0.48). The MDI also did not 
change significantly for the two groups combined over the period of one year (p=0.90). 
However the amount of change in the experimental group over the year (MDI=64.4 to 
MDI=69.3) was significantly greater (p=0.01) than the change seen in the control group 
(MDI=68.3 to MDI=64.3). In fact the control group deteriorated slightly over the year 
while the experimental group improved. Despite the fact that the children in the 
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experimental group improved during the course of the study the mean MDI scores at the 
end of the study period indicate that the children still have significant delay in their 
mental development. 
 
 
PDI 
The change in PDI for each group over time is presented in table 5.35. 
 
Table 5.35 Change in PDI over visits by group. 
  Experimental 
n=43 
Control 
n=49 
Total 
n=92 
Visit 1 49.6(±22.0) 57.1(±24.4) 53.6(±23.5) 
Visit 3 59.3(±25.1) 63.8(±24.6) 61.7(±24.8) 
Visit 5 70.5(±25.1) 65.9(±24.5) 68.0(±24.7) 
Total 59.8(±25.5) 62.3(±24.6) 61.1(±25.0) 
 
 
There was no significant difference between the two groups with respect to PDI 
(p=0.57). The PDI scores of the two groups combined improved significantly over the 
one year period (p=0.00), however the amount of improvement over time in the 
experimental group (PDI=49.6 to PDI=70.5) was significantly more than in the control 
group (PDI=57.1 to PDI=65.9) (p=0.02). Although both groups showed some 
improvement in PDI scores over the study period, the mean PDI scores for both groups 
remained low, indicating that the children still presented with significant developmental 
delay at the end of the study period. 
 
5.6.3 Parenting Stress 
The PSI/SF was administered to the caregivers of the children at visit 1 (baseline), visit 
3 (6months) and visit 5 (12 months). Figure 5.36 depicts the changes in total stress 
scores for each group over the study period as analysed by repeated measures analysis 
of variance. 
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Table 5.36 Change in Parenting Stress over visits by group. 
 Experimental 
n=43 
Control 
n=49 
Total 
n=92 
Visit 1 105.9(±19.6) 105.3(±17.1) 105.6(±18.2) 
Visit 3 100.9(±25.0) 96.0(±21.4) 98.3(±23.1) 
Visit 5 97.4(±24.1) 96.1(±21.5) 96.7(±22.6) 
Total 101.4(±23.1) 99.1(±20.4) 100.2(±21.7)  
 
 
The PSI total scores were well matched for the two groups (p=0.55). The PSI scores 
came down significantly during the course of the study with the scores at visit five being 
significantly lower than those at visit one (p<0.001). There was no difference in the 
amount of change that occurred in parenting stress between the two groups (p=0.55). 
Closer analysis revealed that of the three subscales of the PSI/SF there was a 
significant decreases in Parental Dysfunction over time(p<0.001) as well as in Parent-
Child Dysfunctional Interaction (p<0.001) but no significant change in the Difficult Child 
subscale (p=0.08). The two groups were well matched for each of the three subscale 
scores over time with no significant differences being noted. 
 
5.6.4 Comparison of intention to treat analysis and per protocol analysis of results. 
As can be seen in table 5.37 the results for the analysis of variance for the primary 
outcomes did not differ whether the intention to treat or the per protocol approach was 
used. The fact that the results do not change depending on the method of analysis used 
indicate that the findings of this study can be interpreted with confidence (Wright and 
Sim, 2003). 
 
Table 5.37 / 
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Table 5.37 Comparison of primary outcomes using intention to treat and per protocol 
analyses. 
 
Intention to treat  Per protocol 
Mental Developmental Index 
Within group 
Between groups 
Change over time by group 
 
p=0.8558 
p=0.2674 
p=0.0108* 
 
p=0.8965 
p=0.4845 
p=0.0091* 
Psychomotor Developmental 
Index 
Within group 
Between groups 
Change over time by group 
 
 
p=0.0000* 
p=0.5714 
p=0.0185* 
 
 
p=0.0000* 
p=0.5707 
p=0.0191* 
Parenting Stress Index 
Within group 
Between groups 
Change over time by group 
 
p=0.0001* 
p=0.6202 
p=0.5709 
 
p=0.0001* 
p=0.5516 
p=0.5502 
 
The ANOVA results for the anthropometric measures were also very similar whether the 
data were analysed using the intention to treat or the per protocol method.  
 
5.7 Recalculation of sample size 
The loss to follow up in this study was higher than anticipated; the standard deviations 
for the MDI and PDI scores were also higher than expected. This means that the initial 
sample size calculation did not yield the anticipated power. Taking the actual loss to 
follow up and standard deviations obtained into account, the power yielded by the 
sample size of 60 subjects per group is in fact only 65% and not 90% as initially 
calculated. 
 
Conclusion 
The findings of this study confirm that children who are HIV positive are at risk for 
developmental delay from an early age. The children in this study had severe 
developmental delay as measured by the Bayley Scales of Infant Development II. The 
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anthropometric indices for the children in this study were also decreased at baseline. 
The children were at risk for wasting and stunting and had decreased head 
circumference z-scores. 
 
Caregivers of children infected with HIV tended to be poor and many had not completed 
12 years of schooling. They had very high levels of parenting stress. Parenting stress 
was influenced by housing and educational level as well as the number of children in the 
household. Parenting stress levels came down in both the control and experimental 
groups during the course of the study but remained high.  
 
The children in the experimental group showed a significantly greater improvement in 
both MDI and PDI scores than the children in the control group. The children who 
improved the most were those who were older at their baseline assessment and in the 
experimental group. Although the children in the treatment group did improve in terms of 
motor and cognitive development they remained very delayed at the end of the study. 
  
Children who went onto HAART during the course of the study showed a significant 
improvement in motor development but not in cognitive development. These findings 
suggest that HAART may have a greater influence on motor development than on 
cognitive development, at least in the short term. 
 
The results for the primary outcomes used in this study, namely the BSID II and the 
PSI/SF were very similar whether the results were analysed using an intention to treat 
analysis or a per protocol analysis. 
 
The implications of these findings will be discussed in more detail in chapter six.   
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Chapter 6 
DISCUSSION 
The results of this study will be discussed in more detail in this chapter. Each of the 
main outcomes assessed will be discussed as well as possible reasons for the changes 
that were seen. The demographic information of the sample will be discussed as well as 
the challenges that were encountered doing this research. A number of suggestions for 
future research and clinical management will be put forward. 
 
6.1 Prevalence and Extent of Developmental Delay. 
The baseline developmental scores of the children in this study were extremely low with 
78% of children having delayed cognitive development and 87% of children presenting 
with delayed motor development. This high level of developmental delay, is in keeping 
with findings from studies conducted in other parts of the world where prevalence rates 
of 50% or higher have been documented (Pollack et al, 1996; Chase et al, 1995; 
Belman et al, 1986; Epstein et al, 1986). 
 
The prevalence of developmental delay in this study is double that of the only other 
South African study conducted. The study by Potterton and Eales (2001) reported a 
40% prevalence in developmental delay. However the children in their study were all 
under 12 months of age and the assessment tool used was a screening tool only and 
possibly not as sensitive as the BSID II used in this study. Msellati et al (1993) and Gay 
et al (1995) reported an increase in prevalence of developmental delay with increasing 
age in the first 18 months of life, it is therefore possible that the prevalence reported by 
Potterton and Eales (2001) would have been greater had older children been included in 
their study. 
 
The mean values for MDI and PDI were extremely low at baseline for both the control 
and the experimental group. The mean MDI for the two groups combined was 65.61 
(±21.93). This value is considerably lower than the mean MDI obtained by Bayley (1993) 
when she tested 35 HIV positive children in the process of validating the BSID II (79.6 
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±19.8). The difference can be explained in part by the fact that the children in the 
validation sample in the USA all had access to antiretrovirals whereas only 14.5% of the 
children in this study were on HAART at baseline. The standard deviations for the study 
sample and Bayley’s validation sample are very similar and reflect the range of abilities 
present in children infected with HIV. The mean MDI for this study at baseline reflects 
that the majority of children could be classified as having severe cognitive delay 
(MDI<70). The mean PDI for the two groups combined at baseline, was 53.67 (±23.77). 
This value is extremely low and is again much lower than the mean PDI value obtained 
by Bayley in her validation sample (81.1 ±27.2). Differences in access to medication 
again probably account for these discrepancies, as well as possible socio-economic 
differences. The standard deviation for motor development is high, indicating large 
variability in motor performance in children who are HIV positive. 
 
Various other studies have not identified such low developmental scores. Chase et al. 
(2000) documented mean MDI scores between 81.9 and 96.8 in HIV infected children 
between four and 30 months of age who had access to antiretrovirals. Mean PDI scores 
in Chase’s study were between 78.2 and 97.7. Knight et al (2000) reported mean MDI 
scores of 76.1 and mean PDI scores of 79.8 in their small sample of HIV infected 
children, the data for this study being collected prior to the use of HAART.   
 
According to Chase et al (2000) MDI or PDI scores of two standard deviations below the 
mean (ie < 70) are important early markers of severe HIV-related CNS disease and are 
diagnostic of encephalopathy. Similarly a drop in MDI and PDI over time of 2 standard 
deviations indicates early CNS involvement and encephalopathy. Taking these findings 
into account implies that the children in this study are at risk of severe central nervous 
system involvement. The changes that occurred in MDI and PDI scores over the course 
of the study will be discussed later. 
 
Clinical implications. 
• Children infected with HIV are at risk of significant developmental delay. 
Developmental screening should be an integral part of services offered to children 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
129 
who are HIV positive. Caregivers should be made aware of the fact that 
developmental delay is a common finding in children who are HIV positive and 
should be asked about their child’s developmental progress at every clinic visit. 
• Developmental screening and intervention should be an integral part of services 
offered to children who are HIV positive. This could happen across all sections of 
health care delivery, primary, secondary and tertiary. 
Research implications. 
• Future studies could design and test a developmental screening tool that is 
efficient and reliable in detecting developmental delay in HIV positive children 
within the context of busy clinics in developing countries. 
• The third edition of the Bayley Scales of Infant Development which is now 
available should be tested on a large sample of South African children to 
establish whether it is still a reliable assessment tool in the South African context. 
  
6.2 Factors Predicting Developmental Delay 
As discussed in chapter two there are a number of factors which may contribute to 
developmental delay. Step-wise regression analysis was performed to determine what 
variables were predictive of MDI and PDI at each of the three assessment visits. A 
number of variables were significant at different time points.The relationship between 
variables and their relative importance changed over time as the children’s clinical 
picture changed. The regression analyses were characterised by very wide confidence 
intervals and were unable to account for more than 50% of the variance seen. Factors 
other than those assessed must therefore also have contributed to predicting the 
developmental status of children in this study. The factors that were most important in 
predicting developmental status will be discussed in more detail. 
6.2.1 Growth parameters 
Malnutrition as evidenced by wasting and stunting has previously been associated with 
poor neurodevelopmental scores in studies on children with HIV. Pollack et al (1996) 
found that children with the most marked growth delay had the lowest cognitive and 
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motor development scores. Wiznia et al (1996) reported a strong correlation between 
low weight-for-age and decreased cognitive function. However the children in this study 
were malnourished and stunted, but not wasted. Weight-for-age was found to be 
significantly related to MDI at each of the three assessments, those children with better 
weight-for-age z-scores obtained higher MDI scores. Weight-for-height and height-for-
age were related to MDI scores but were not as important as weight for age. These 
results confirm the link between growth parameters and MDI especially as reported by 
Wiznia et al in 1996. 
 
Weight-for-age z-scores were also strongly predictive of PDI scores at all three visits. 
Weight-for-height and height-for-age were not as consistently predictive of PDI as 
weight for age was. 
 
Growth parameters have previously been identified as being markers of disease 
progression (Bobat et al, 2001) as has developmental delay (Mintz, 1999). It is therefore 
not surprising that anthropometric status should be predictive of developmental status in 
HIV infected children. 
 
Head circumference was not a predictor of developmental status at any of the visits. 
This was surprising considering that head circumference has previously been linked to 
the extent of developmental delay by a number of authors (Mitchell, 2001; MacMillan 
2001; Mintz, 1999). This is discussed further in section 6.6. Head-circumference-for-age 
z-scores improved equally for both groups of children in this study over the study period.  
  
Muscle weakness was not tested in this study but it was noticed anecdotally during 
administration of the BSID II that performance in activities that require strength against 
gravity was particularly delayed, for example standing, walking, climbing stairs and 
jumping. Muscle weakness has been associated with poor motor function in children 
infected with HIV (Pearson et al, 2000; Blanchette et al, 2002) and could be a result of 
muscle atrophy secondary to malnutrition. Pearson et al (2000) found that decreased 
muscle bulk was an independent predictor of disease progression in HIV infected 
infants.  
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Clinical implications. 
• The nutritional status and weight gain of children infected with HIV should be 
carefully monitored and supplements should be given early on to try and prevent 
the wasting and stunting that was evident in this study sample. Children with 
decreased weight-for-age should be referred for developmental screening in 
order to pick up early delays and monitor CNS involvement. According to the 
South African Department of Health guidelines once encephalopathy is suspected 
children may be started on HAART regardless of their CD4 count. This may lead 
to decreased prevalence of the delays of cognitive function observed in this 
sample. 
Research implications. 
• The link between wasting, muscle strength and functional outcomes in children 
infected with HIV needs to be established through further research.   
6.2.2 Age 
Younger children achieved significantly better MDI scores at visit one  and three, but not 
at visit five. Younger age was predictive of better PDI scores at visit one only. This 
finding is in keeping with those of Msellati et al (1993), Gay et al (1995) and Blanchette 
et al (2002) who reported that developmental delay in children infected with HIV became 
progressively worse in the first 18 months of life. This is explained by the disease 
progression witnessed in children infected with HIV and the associated encephalopathy. 
The influence of age on developmental status over time in this study is confounded by 
the addition of the intervention programme and HAART. 
 
The items on the BSID in the early months require little strength against gravity and do 
not assess learned cognitive concepts such as shapes and colours. Typically developing 
African children in South Africa and Nigeria performed at a level superior to their 
American counterparts when tested with the BSID I before 12 months of age (Aina and 
Morakinyo, 2005; Richter et al, 1992). This early precocious development in African 
children has been well documented and could, in part, contribute to the fact that the 
children in this study performed better when they were younger. The items on the BSID 
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II may be less culturally specific in the younger item sets and this may explain why 
younger children in Africa score better in the younger age groups. 
 
Clinical implications. 
• Younger children should be very carefully monitored so that any changes in 
developmental status can be detected as early as possible and the appropriate 
referrals made timeously. 
Research implications 
• Further research needs to done in South Africa to determine the age of onset of 
developmental delay and which children are at the greatest risk of becoming 
delayed. 
  
6.2.3 Socioeconomic factors 
Family income was not a strong predictor of the cognitive developmental status of 
children in this study. It did however form part of the set of predictors at every visit. This 
could be due to the fact that most families had very similar levels of income and all 
experienced equivalent levels of hardship. Fifty percent of caregivers in this sample 
reported a monthly family income of R700 (±$100) or less which is well below the 
breadline in South Africa. The mean income for the group was R1183 which is only 
slightly above the breadline. Poverty has been shown to impact negatively on cognitive 
development and to a lesser degree on motor development as well (Lima et al, 2004; 
Schor et al, 2003; Linver et al, 2002). Despite the very high levels of poverty in South 
Africa which have persisted for many decades, young South African children have 
generally performed well on standardized developmental testing in the past (Richter et 
al, 1992). 
 
The educational level of the caregiver was part of the set of factors predicting MDI at 
each visit, although it was never one of the most important factors. Having a caregiver 
with a higher level of education was predictive of better MDI scores. The majority of 
caregivers in this study had been to school until at least grade ten. Caregivers with a 
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better level of education were probably better able to respond appropriately to the 
counseling and informal education provided at Harriet Shezi clinic. An education level of 
grade ten implies a reasonably high level of literacy and proficiency in English. However 
without a matriculation certificate (grade 12) these caregivers would find it difficult to 
enter the formal labour market, and thus their earning potential is limited. Chase et al 
(2000) found that HIV infected children whose mothers had less than nine years of 
formal education were more likely to get MDI scores of below 69. 
 
Housing was included in the set of factors predicting MDI and PDI at most time points. 
Improved housing was associated with better MDI and PDI scores, but interestingly 
having a house that was not shared with others did not always add additional predictive 
value over a shared house. An increased number of children in the household made a 
small negative contribution to MDI and PDI scores as did an increase in the number of 
adults in the household.  
Clinical implications. 
• Health care providers need to be more aware of the educational levels of the 
people in their care and make sure that they are giving information at an 
appropriate level. 
Research implications  
• Further research needs to be done to investigate the impact of socioeconomic 
factors on the ability of families affected by HIV to cope with the burden of 
disease they face. 
 6.2.4 CD4 counts and HAART 
CD4% was consistently predictive of better MDI and PDI scores. This is in keeping with 
the findings of other studies where low CD4% counts have been associated with more 
severe developmental delay, especially in the cognitive domain (Henry et al, 1996). If 
the children had been monitored for longer an even greater impact may have been 
noted as their CD4 counts continued to improve. 
 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
134 
The frequency of hospitalization was not assessed in this study. The very low mean 
CD4% counts at the beginning of the study period (14.39%) do however mean that the 
children were severely immunocompromised at this point and that they would have been 
prone to frequent illness and possibly periods of hospitalization. This general ill health 
could be a contributing factor to the low mean MDI and PDI scores obtained at visit one 
(MDI=65.61, PDI=53.67). Frequent hospitalization has been shown to impact negatively 
on developmental progress (Cooper et al, 2004; Fiser et al, 2000; Ultmann et al, 1985). 
 
It is evident from previous research that children assessed in the pre-HAART era (Knight 
et al, 2000) scored worse on the BSID than those who had access to HAART from an 
early age (Chase et al, 2000). As previously discussed the children in this study did not 
have access to HAART when the study started, only 14.5% of children being on HAART 
at their baseline assessment. Children in South Africa also only have access to HAART 
once their CD4 counts are below 20% of normal. Most authors suggest starting HAART 
in children before they become symptomatic (Chakraborty, 2005; Luzuriaga and Sullivan 
2002). This implies that children in South Africa are at considerable risk for severe CNS 
involvement before they are able to start on an appropriate treatment regime. This 
damage may be irreversible even if HAART is started at a later stage and may lead to 
lifelong cognitive and motor impairment. Being on HAART was frequently predictive of 
lower MDI and PDI scores in this study, indicating that developmental delay is occurring 
prior to starting HAART and that those children who qualify for HAART may already 
have significant impairments. 
Research implications. 
• As more children in South Africa gain access to HAART, studies should be 
conducted to monitor the long term effects of HAART on developmental 
outcomes of children who are HIV positive.  
• The impact of starting HAART at different stages of the disease process could 
also be investigated in order to establish a protocol that allows for the best long 
term outcomes. 
 
Clinical implications 
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• All healthcare professionals in South Africa should be aware of the criteria for 
initiating HAART in children, and should refer children infected with HIV to 
specialist clinics where they can be managed holistically and appropriately.  
 
The changes that occurred in developmental status over time will be discussed in 
section 6.3. 
 
6.3 Changes in Development Over Time. 
The children in the experimental group of this study showed a significantly greater 
improvement in both MDI and PDI scores over the study period when compared to the 
control group. These results indicate that a basic home management programme does 
have a positive effect on the neurodevelopmental status of children who are HIV 
positive. 
 
Although both the MDI and PDI improved significantly in the treatment group the scores 
reached at the end of the study were still well below the normal ranges (MDI 66.64; PDI 
68.02). This indicates that although the children improved they remained severely 
delayed and need further follow up and intervention. 
 
The children in the control group deteriorated in their MDI scores although their PDI 
scores improved over time. Many studies have shown that children infected with HIV 
show a gradual decline in cognitive and motor development over time, especially in the 
first 18 months of life (Blanchette et al, 2002; Gay et al, 1995; Msellati et al, 1993). The 
fact that the children in the control group also showed an improvement in their motor 
development could be due to a number of different factors. Only 16 % of the children in 
the control group were on HAART when they started the study, this had risen to 85. % 
by the time they completed the study. A number of studies have been done on the 
impact of HAART on neurodevelopment and although the results of all the studies are 
not conclusive and not all of them considered motor development, there does seem to 
be a positive effect of HAART on developmental status (Resino et al, 2006; Sanchez-
Ramon et al, 2003; Raskino et al, 1999; Pizzo et al, 1988). Children in the control group 
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also showed slight improvements in their weight-for-age, height-for-age, and weight-for-
height over the study period. These improvements in weight and growth could also 
contribute to the improved motor function observed at the end of the study. An increase 
in weight may mean that muscle bulk and muscle strength increased as well and 
contributed to the improved motor performance. Many of the children received nutritional 
support from the dieticians at Harriet Shezi clinic in the form of food supplements as well 
as education and dietary advice. Although the abovementioned factors may have 
contributed to the improvements in motor development seen in the control group they 
were not sufficient to prevent the deterioration in cognitive development seen in this 
group of children. 
6.3.1 Factors predicting change in neurodevelopmental status. 
The children who showed the greatest amount of improvement in their MDI scores over 
time were those who were in the experimental group and were older at baseline. They 
came from families with higher monthly incomes and were more likely to be on HAART 
at baseline. The fact that older children did better could be due to the fact that these 
children were more likely to be slow progressors as described by Wiznia et al (1996). 
These children would have had a healthier infancy and be less likely to develop 
neurodevelopmental complications, they may also be better able to respond 
appropriately to intervention programmes. Families with higher income levels may be 
better placed to access health care services for their children and provide a more 
stimulating home environment. A higher level of caregiver education was also part of the 
set of factors predicting improvement in MDI. The fact that children who were already on 
HAART did better supports the international trend to start children on HAART as soon 
as possible.  
 
The children who showed the greatest improvement in their PDI scores were in the 
experimental group, were older at baseline assessment and on HAART at the onset of 
the study (see table 5.28b). They were less likely to be wasted but more likely to be 
malnourished at baseline. The fact that they were malnourished at baseline may indicate 
that they were more likely to gain weight once they could utilize the services offered by 
the clinic, and that this could lead to increased muscle bulk, improved muscle strength 
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and better motor performance. The children who had already been on HAART from the 
time they entered the study had a longer period in which to improve their immune status, 
general health and wellbeing than the children who only went on HAART during the 
course of the study. This relative health is reflected in the improvement in motor 
developmental status in these children. A higher level of caregiver education was not 
always associated with improved PDI scores. 
 
Many factors contributed to predicting improvement in developmental status and were 
able to account for less than 50% of the variance seen. Further investigation to 
determine the relative importance of each of these factors is needed. 
 
Being in the experimental group was predictive of improved MDI and PDI scores over 
the study period. The intervention programme will now be discussed in more detail. 
6.3.2 Intervention programme 
In designing the intervention programme the researcher was cognisant of the time and 
cost constraints facing both health care providers and users in South Africa. An 
intervention that was sustainable beyond the boundaries of the study was envisaged. 
The intervention was planned with these time and cost constraints in mind. 
 
Mothers infected with HIV have expressed the need for one point of call for all services 
(Marcenko and Samost, 1999; Hackl et al, 1997). The intervention was therefore 
administered at the clinic on the same day as the mother had an appointment to see the 
doctor. While this approach saved transport money and meant that there was not the 
stress of an extra appointment day which could mean time off work for the mother and a 
very early start and long day, it did present some challenges. The drawbacks of this 
approach are that the caregiver had input from a number of different people within a 
relatively short period of time. Some caregivers would see a doctor, a counselor, a 
dietician and the social worker as well as participate in the study all in one morning. 
Mothers may have been more receptive to the intervention programme if it was given in 
a calmer atmosphere and on a day where there was less competing information given. 
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The fact that the assessments and intervention were done at the clinic on the same day 
as the doctor’s appointment may also have lent the study credibility as it was seen as an 
integral part of the clinic services. The doctor’s support and interest also helped 
reinforce the messages that were given by the research assistant and the importance of 
the programme. Prado et al (2002) found that mothers were more likely to participate in 
a psychosocial intervention if they perceived a need for the intervention, had low social 
support, high stress levels and most importantly if they established a therapeutic alliance 
with the health care provider from an early stage in the intervention. Caregivers who 
participated in this study certainly seemed aware of their child’s developmental 
difficulties and expressed concern over their delay. Black et al (1994) noted that HIV 
positive mothers in her study were more receptive to the home programme given than 
HIV negative mothers, they also found that mother’s valued their parenting role highly 
and used the phrase “positive parenting” to describe the mothers’ involvement in their 
children’s lives. Perhaps the realisation that they may not have a lot of time with their 
children encourages HIV positive mothers to do the best for their children while they 
can. The research assistant who administered the intervention took time to address 
each caregiver’s concerns and to affirm them as parents. Although these factors were 
not formally measured the fact that many of the caregivers wished to continue with the 
programme once the study period was completed suggests that they saw the value of 
the programme and enjoyed their interactions with the research assistant.  
 
A non structured approach was used and the research assistant followed the leads 
given by the caregivers as to what aspects of development were delayed as well as her 
own assessment of the child’s strengths and weaknesses and the results of the most 
recent BSID II assessment. While this approach worked in this situation it does rely 
heavily on the clinical expertise and the critical thinking and decision making of the 
person administering the intervention. A more structured set of guidelines may be 
necessary to guide clinicians or community workers with less experience and expertise. 
The possibility of counsellors and home based caregivers administering a stimulation 
programme makes a lot of sense as more people could be reached more effectively. A 
set of guidelines and a developmental screening form are being developed and need 
testing. 
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A number of authors have recommended that any intervention programme should aim at 
increasing the child’s competence and functional abilities and should highlight the child’s 
strengths (Ong et al, 1998; Dyson, 1991). The intervention programme therefore 
focused mainly on activities of daily living that were age appropriate for each individual 
child. Caregivers were shown how to encourage play in positions that reguired use of 
antigravity muscles and games and activities that required increasing levels of physical 
activity were emphasised. Activities and handling skills that would facilitate and reinforce 
emerging motor skills were taught to the caregivers. Activities where the caregiver would 
be involved with the child anyway were used as learning opportunities, for example 
reinforcing colours when dressing, counting toes when washing them, leaning body 
parts when washing. Play activities were also strongly encouraged using common 
household appliances for example banging a pot with a spoon, pouring water from one 
cup to another, using a pair of rolled socks as a ball.  
 
The home programme could have influenced cognitive development through a number 
of different routes. By improving children’s mobility they would have a greater potential 
for enhanced sensorimotor experiences which has been shown to correlate to improved 
cognitive performance. Advice on positioning the children in positions that allowed for 
better communication and interaction could also contribute to providing more 
opportunities for cognitive stimulation. The home programme emphasised functional 
activities within the child’s natural environment. This allows the child to practice 
emerging skills in a meaningful way (McEwan and Hansen, 2006). 
 
The research assistant recorded comments made by the caregivers in this study in 
relation to the intervention programme and their child’s progress. A selection of these 
comments will be presented. 
 
Mothers expressed appreciation at having the underlying reasons for their child’s 
developmental delay explained to them. 
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• “I thought she was just lazy, now I don’t shout at her when she is slow to do 
things the other children can do.”  Mother of a twenty month old child. 
• “I knew HIV made his chest bad but I never knew it could get in his brain. My 
poor baby.”  Mother of a 6 month old child. 
 
There is very little information available in the form of pamphlets or booklets that 
addresses the impact of HIV infection on children in particular. Non governmental 
organisations and aid agencies tend to focus their education campaigns on young adults 
and have sorely neglected this aspect of the pandemic. 
 
Many caregivers felt that the programme gave them an opportunity to have a positive 
contribution to their child’s well being. They felt they were empowered by being able to 
play a role in their child’s management. This was a benefit of home programmes 
identified by Spiegel and Mayers (1991) in their review of psychosocial issues facing 
families affected by paediatric HIV. 
• “I feel powerful when we are playing your teaching games, my baby loves the 
attention and I feel I am doing something right for her.”  Mother of a 9 month old 
child. 
• “The medicine (HAART) makes her better, but she hates it and I hate fighting 
with her, but we continue because we must. The things we do with you are more 
fun and I feel proud that I can be the one to help my baby at home.”  Mother of a 
36 month old child. 
 
Not all caregivers were convinced of the value of the programme and did not always see 
it as a priority. This was not an unexpected finding considering the multiple stressors 
experienced by the caregivers in this study. Similar attitudes were expressed by 
Shannon (2004) in his study on barriers to family centered intervention. These feelings 
need to be respected and the priorities of the caregiver need to be addressed as well. 
These often include concerns about financial stability. 
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• “She likes it when I do games with her, but it does not make her better and I am 
too tired and too sad to keep trying.”  Grandmother of a 24 month 
encephalopathic child. 
• “It is medicine that will help my child, not games, the government must give us 
medicine.”  Mother of a 16 month old child prior to HAART being available. 
 
As children began to improve caregivers became more excited: 
• “She can read, she can read! When I ask her where the flower is she points to it” 
Grandmother of a three year old on returning her book. 
• “I never believed you when you said she would walk one day, I had no hope. Now 
I hold her hand and she takes her baby steps and we will go forward together.”  
Mother of a 22 month old girl who had just started walking. 
• “He is better and running and climbing, but ‘eish’ now he makes me tired!” 
Grandmother of a 30 month old boy. 
• “I stopped going to church when she was so sick and could do nothing. What 
would the people say? They would know she is positive. Now she can sit and she 
is gaining weight. I spend my spare money on beautiful outfits for her and I take 
my baby wherever I go, also to church. This clinic has given me my baby and my 
life back, thank you.” Mother of a 15 month old girl. 
• “I didn’t know such a small boy could be clever, he knows his body parts now and 
he knows red and blue.” Uncle of a 40 month old boy. 
 
All in all the intervention was perceived as positive by the caregivers who participated. 
 
Most children and their caregivers who participated in this study were recruited on their 
first or second visit to the clinic. Antiretrovirals became available at Harriet Shezi clinic in 
April 2004. This meant that from this point on many young infants were referred to the 
clinic. Before this time Harriet Shezi, like many other paediatric HIV clinics in South 
Africa, limited its services to children over two years who had a better chance of long 
term survival in the absence of antiretrovirals. The fact that caregivers began the 
intervention programme at the same time as accessing all the other services at the clinic 
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may have helped to establish the developmental programme as an integral part of their 
child’s management. The doctors, nurses and counsellors at Harriet Shezi clinic were 
also very supportive of this study and would enquire about the children’s progress and 
remind the mothers to see the research team as well. The commitment of the entire 
team at Harriet Shezi to addressing the developmental needs of the children in their 
care made the implementation of this programme possible.  
Clinical implications 
• Paediatric clinicians working with children infected with HIV need to take 
cognisance of the developmental and psychosocial needs of the children in their 
care. 
• A basic home stimulation programme should be available to all children infected 
with HIV and their caregivers. More attention needs to be paid to the education of 
caregivers on the possible effects of HIV on their child’s development and the role 
they can play in managing developmental delay.  
• The impact of HIV on the development of children needs to be better publicized in 
both lay and professional literature. All health care professionals need to be made 
aware of these issues and need to start addressing them. 
• Policies regarding service delivery to children who are HIV positive should include 
developmental assessments and management. 
Research implications  
• Alternative ways of delivering developmental programmes need to be explored 
and the most effective mode of service delivery should be established. This could 
include home visits and the training of community care workers in basic child 
development and stimulation. 
• Caregiver’s perceptions of the effectiveness and value of intervention 
programmes need to be established. 
• The role of other rehabilitation interventions for children who are HIV positive 
needs to be established. These should include, muscle strengthening, aerobic 
fitness, cognitive , perceptual , as well as speech and language issues. 
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• The functional problems facing older children have not been investigated in 
developing countries at all. This is an area that needs urgent research as more 
HIV positive children gain access to HAART and survive for longer. 
 
6.4 The Effect of HAART on Development 
The results of a sub-group of children (n=45), who were not on HAART at visit one but 
were on HAART by visit three, were analysed separately. This was done in an attempt 
to monitor the impact of going on HAART on children’s developmental status. 
  
There was no significant change in MDI scores for this group of children between visit 
one and visit five (p=0.77). The children in this group who received the stimulation 
programme did show an improvement in MDI while those in the control group 
deteriorated. 
 
The PDI scores for this group of children did improve significantly after going onto 
HAART (p<0.001). Children in both the control and the experimental groups improved, 
however the amount of improvement by children in the experimental group was 
significantly greater than that of children in the control group (p<0.001). 
 
The findings relating to the impact of HAART on cognitive development in this study are 
similar to those of Wolters et al (1997) who found that cognitive scores remained stable 
at six and 24 months after starting HAART. Sanchez-Ramon (2003) found that 
antiretroviral therapy was able to reverse neurologic deterioration in some patients and 
to prevent the onset of encephalopathy if commenced prior to the onset of symptoms. 
Studies that have investigated the effect of HAART on the cognitive development of 
children have often had a very broad age range of children in their samples (Raskino, et 
al, 1999). The natural maturation and stage of development of the CNS should be 
considered and children of similar ages should be compared. Very few studies make 
any mention of the effect of HAART on the motor development of young children. 
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The fact that the motor development showed an improvement after the initiation of 
HAART and cognitive development showed no improvement warrants further 
investigation with a longer follow up period. A possible reason for the changes seen in 
this study is that children may have become stronger as their health improved on 
HAART and may have gained muscle bulk. This increased muscle strength would 
contribute to improved motor performance. The fact that children in South Africa only 
start HAART once their CD4 count has dropped to below 20% may explain, in part why 
their cognitive scores did not improve after initiating treatment. By the time the CD4 
count has dropped to 20% irreversible brain damage may already have occurred due to 
the onset of HIV encephalopathy. Resino et al (2006) found that children who started 
HAART before their CD4 count was below 25% had the best chance of remaining 
asymptomatic and achieving and maintaining a CD4 count of over 30%. The WHO is 
also advocating that HAART be started when a child’s CD4 count is 25% in an attempt 
to prevent the long term, irreversible organ damage that may occur in children with CD4 
counts below 20% (ANECCA, 2005). The children who received HAART as well as the 
stimulation programme did show some improvement in MDI scores. This suggests that 
there is potential for some cognitive improvement in the right circumstances due to 
neural plasticity. This does not mean that the damage can be totally reversed and 
clinicians should be cautious in predicting complete reversal of cognitive deficits after 
starting HAART. 
 
Only 13 of the children enrolled on this study did not start HAART during the course of 
the study period. This makes it difficult to guage the impact of the home programme on 
developmental status without the confounding influence of HAART. Descriptive analysis 
of this very small sub-group did not reveal any obvious benefit of the intervention 
programme. This finding should be interpreted with caution due to the very small sample 
size. 
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Clinical implications 
• Initiation of HAART may have beneficial effects on motor development, but not 
always on cognitive development. Clinicians should continue to monitor both 
motor and cognitive development after commencing HAART. 
• Where possible HAART should be started as soon as possible in infants and 
before a child’s CD4 count drops below 25% as this may minimise permanent 
brain damage and long term cognitive deficits. 
Research implications 
• Further studies should monitor the long term effects of children on HAART and 
should compare children in the same age ranges and include cognitive and 
motor assessments. 
• CT scans should be used in conjunction with developmental assessments to 
monitor the impact of HAART on the developing CNS. 
• Further studies on muscle strength and motor development in young children 
with HIV need to be conducted. 
• The impact on neurodevelopment of starting HAART when the CD4 count is 25% 
needs to be established in the context of a developing country. 
• The neurodevelopmental status of children not eligible for HAART, and the 
impact of developmental stimulation in this group, warrants further investigation. 
 
The parenting stress levels experienced by the caregivers and how they changed over 
time will be discussed in section 6.5. 
 
6.5 Parenting Stress Levels. 
The parenting stress levels in the caregivers who participated in this study were 
extremely high at the baseline assessment (103±19.51). These very high parenting 
stress levels are of concern as any score over 90 is considered to be clinically significant 
and to warrant referral for further investigation (Abidin, 1995). All three sub-scales were 
equally elevated and there were no differences between the two groups in terms of sub-
scale scores.  
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Other studies that have used the PSI/SF with caregivers of disabled children have not 
documented scores as high as these even though their scores were also elevated 
(O’Neil et al, 2001; Button et al, 2001; Musil, 1998). It is important to remember that 
these studies were conducted on caregivers of children who were disabled, but not HIV 
positive, and direct comparisons can therefore not be made. Studies that have 
investigated the stress levels of caregivers of HIV positive children have not made use 
of the PSI/SF, this makes it difficult to compare levels of parenting stress measured in 
this study to those found in other studies.    
 
6.5.1 Predictors of parenting stress. 
The results of the stepwise regression analysis carried out revealed a number of factors 
which were predictive of high parenting stress at each of the visits at which it was 
assessed. Regression analyses were again characterised by wide confidence intervals 
and were not able to explain more than 50% of the variance seen despite having a very 
lenient p value for entry into the regression (0.9). Variables other than those assessed in 
this study must also have contributed to the levels of parenting stress experienced by 
the caregivers.  
 
The number of children in the household was an important predictor of parenting stress 
at visit one and visit five. The more children a caregiver had in their home, the higher 
their parenting stress levels were. This finding is in keeping with the findings of Ostburg 
and Hagekull (2000) but in contrast to the findings of Goldstein et al (2005).Neither of 
the above mentioned studies involved children who were HIV positive or needed any 
other special medical care. This fact makes it difficult to draw meaningful comparisons 
between the findings of this study and those of Ostburg and Hagekull (2000) and 
Goldstein et al (2005). A further factor that was predictive of parenting stress was the 
number of adults in the household. The more adults there were in the household the 
lower the parenting stress levels of the caregivers. The role of other adults in the 
household and their potential to reduce stress needs further investigation. Other female 
adults may provide valuable caregiving assistance while other adults may contribute 
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financially to the household. Interestingly, “sharing a house with others” was a predictor 
of higher parenting stress at visit three and five. This may indicate that the presence of 
adults who are not family members causes increased  parenting stress, possibly due to 
the lack of privacy and stigma. Many caregivers spoke about the stress of keeping their 
diagnosis secret from friends and even other family members. 
 
Higher CD4% counts contributed to lower parenting stress levels. Higher CD4 counts 
have been shown to be predictive of higher MDI and PDI scores. Although having a 
child with a disability has been shown to cause increased levels of parenting stress 
(Esdaile et al, 2003; Button et al, 2001; Ong et al, 1998; Dyson, 1991) the degree of 
disability does not consistently influence the amount of stress experienced (Button et al, 
2001; Silver et al, 1998; Dyson, 1991). It must also be remembered that although the 
children in the experimental group improved over the study period both groups of 
children were still significantly delayed developmentally at the end of the study period.  
 
The education level of the caregiver at visit five was an important factor in predicting 
parenting stress. Caregivers with higher levels of education had lower levels of 
parenting stress. These findings are in keeping with those of Ong et al (1998), who 
found that mothers of children with cerebral palsy experienced less parenting stress if 
they had a higher educational level. Higher levels of education may mean that the 
caregivers are more empowered and better able to access the services they need and 
get the most benefit out of them. 
 
The fact that over 80% of the children were still being cared for by their biological 
mothers is remarkable. Although this is the most desirable situation it does explain the 
very high parenting stress scores. Linsk and Mason (2004) investigated the stress levels 
of caregivers of children affected by HIV and found that caregivers who were HIV 
positive themselves experienced the highest levels of stress. In this study all the 
biological mothers as well as all their children were HIV positive giving dual reason for 
elevated stress levels. The mothers in this study were coping with their own ill health 
and meeting their own health care needs as well as worrying about the health and 
needs of their infected children. Many mothers had older children who were not infected 
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or more than one infected child. These factors were not explored in this study and 
warrant further investigation. 
 
Many studies have shown that having a child with a chronic illness leads to increased 
levels of parenting stress (Deater-Deckard and Scarr, 1996). It is not at all surprising 
that caregivers of children infected with HIV experience such high parenting stress 
levels. The levels in this study may be particularly high due to the feelings of 
helplessness that caregivers must experience when they are not able to access optimal 
care for their children. As access to HAART improves and the overall health status of 
children infected with HIV hopefully improves as well, it would be interesting to see 
whether the parenting stress levels of these caregivers begins to come down to more 
clinically acceptable levels. 
 
The multigenerational aspect of HIV sets it apart from most other chronic childhood 
disabilities. The fact that the mothers in this sample are dealing with their own 
diagnoses, that of their child, as well as possibly their partner may contribute to their 
extraordinarily high parenting stress levels. Social support has been shown to be a 
mediating factor for parenting stress in some (Raina et al, 2004; Ostburg and Hagekull, 
2000; McKinney and Peterson 1987) but not all studies done on parenting children with 
disabilities (Button et al, 2001; Hansell et al,1998). The fact that the caregivers in this 
study had to deal with the stigma and isolation often associated with HIV diagnosis may 
have made it more difficult for them to access social support (Orner, 2006; Antle et al, 
2001, Hackl et al, 1997). 
  
The results of the parenting stress of grandparents were not isolated from the overall 
group due to the fact that the number of caregivers who were not mothers was so small. 
The needs of grandparents caring for their HIV positive grandchildren must not be 
overlooked. Grandparents are in many cases having to assume financial responsibility 
for their grandchildren as well as becoming their primary caregiver. The physical 
challenges of caring for a young child again at a time of their lives when their own health 
care needs are increasing could be placing the health related quality of life of these 
grandparents in jeopardy. Numerous studies have found that grandparents, like 
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mothers, will place the needs of their children and grandchildren first and are at risk of 
neglecting their own health (Linsk and Mason, 2004; Musil, 1998; Joslin and Harrison, 
1998). The heath and psychosocial needs of grandmother caregivers should be given 
particular attention. 
 
6.5.2 Change in parenting stress levels. 
Both the experimental and the control group showed a decrease in parenting stress over 
the study period. There was no significant difference in the amount of improvement seen 
in the two groups. Of the three sub-scales, the Parental Dysfunction and Parent Child 
Dysfunctional Interaction scores came down significantly over the study period, however 
there was no significant improvement in the Difficult Child sub-scale scores over time. 
The parent’s perception of their child as being ‘difficult’ has been shown to be a predictor 
of increased levels of parenting stress (Ostburg and Hagekull, 2000). 
 
The addition of the intervention programme in the experimental group did not influence 
the parenting stress levels even though these children showed significant improvement 
in motor and mental development. It is important to remember that even though the 
children in the experimental group showed significant improvement they remained 
developmentally delayed at the end of the study period. 
 
The three factors which were the most important predictors of a decrease in parenting 
stress levels were, the educational level of the caregiver, the number of adults in the 
household and the type of house the family lived in. A higher level of education was 
predictive of a decrease in parenting stress. These caregivers may be better able to 
access the support and information offered to them at Harriet Shezi clinic. The more 
adults there were in the household the less likely the parenting stress levels were to 
come down. The stress of secrecy and stigma may have contributed to this. Living in a 
flat or their own house was predictive of decreasing parenting stress, however staying in 
a room or a shared house was predictive of increasing stress levels. The lack of privacy 
associated with living in a confined space or with other families are possible 
explanations for this. 
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Clinical implications 
• Caregivers of children who are HIV positive are experiencing clinically significant 
levels of parenting stress. Additional psychosocial support and possibly formal 
counseling and psychological services should be made available to these 
caregivers. 
Research implications. 
• The levels of parenting stress were extremely high in this group of caregivers. 
Although the PSI/SF scores did come down significantly over the study period 
they remained clinically significant. Further research is needed to explore in more 
detail the factors that contribute to such high parenting stress levels and to start 
to investigate how best to address this problem in this population of caregivers. 
• Qualitative research may help elucidate the problems experienced by different 
groups of caregivers and the particular needs of mothers, grandmothers and 
fathers. 
• The impact of the mother’s own health status on her levels of parenting stress 
should be established. 
 
6.6 Growth Parameters 
There were no significant differences between the two groups in terms of their growth 
parameters at baseline or at any point during the study period. This was to be expected 
as the groups were randomly assigned and the subsequent care that the children 
received was the same for both groups apart from the intervention programme which 
was not expected to influence growth in any significant way. 
 
The head circumferences of both groups of children was below normal at baseline but 
increased steadily throughout the study. By the end of the study period the head 
circumference-for-age z-scores were still below the internationally acceptable means at  
-1.53 for the experimental group and -1.48 for the control group. Most studies on growth 
in HIV positive children have focused on height and weight and not on head-
circumference. According to the World Health Organisation (1986) head circumference 
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can be considered a proxy for height and weight and is therefore not an essential 
measurement in studies of growth. Z-scores for head circumference are not readily 
available and could not be found for children over 36 months. The mean head 
circumference z-score for each group at each visit was therefore calculated. Measuring 
head circumference in this study was not always easy as many of the children had 
braids in their hair which made it difficult to get an accurate measurement. The head 
circumference measurements should therefore be interpreted with some caution.  
 
The two groups of children combined had decreased height-for-age at baseline with a z-
score of -2.86. Although the height-for-age increased throughout the study period the 
gains made were small. The children remained stunted with a final z-score of -2.61. 
Stunting is associated with poor socio-economic conditions and repeated or chronic 
infections as well as inadequate nutrition (WHO, 1986). It is therefore not surprising that 
stunting was observed in this group of children.  
 
Weight-for-age was decreased at the beginning of the study period (-2.39). Although 
there was a general improvement over the course of the study the children remained 
underweight with final weight-for-age z-scores of -1.94. 
 
Weight-for-height was slightly decreased at the start of the study period (-0.66) but 
compared favourably to international norms by the end of the study period (-0.43) 
indicating that the children were not wasted. This slight improvement would suggest that 
although the children gained weight during the study period their growth in length was 
less significant. The fact that the children were stunted but not wasted is similar to the 
findings of Bobat et al (2001) in their large cohort of black South African children in 
Durban. The widespread poverty still present in South Africa as well as the impact of 
repeated infections due to HIV infection are likely to account for the poor growth seen in 
HIV positive children in South Africa. The impact of HIV on the efficacy of circulating 
growth hormone must also be taken into account (Lepage et al, 1991; Laue et al, 1990). 
 
These anthropometric scores are of concern as they indicate that although the children 
had access to a dietician at the clinic and were able to get food supplements free of 
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charge there was very little improvement in their growth scores over the study period of 
one year. Wasting responds more quickly to improved nutritional circumstances while 
stunting takes longer to resolve as skeletal growth is a naturally slower process (WHO, 
1986).  
 
The growth parameters as measured in this study are lower than those reported by 
Bobat et al (2001) in a study which investigated early childhood growth in HIV-exposed 
and infected infants in Durban, South Africa. The children assessed by Bobat et al 
(2001) were only followed up until 18 months of age and were tending to show 
decreasing weight-for-age and height-for-age as they got older. This increasingly 
significant growth delay with increasing age was confirmed by Newell et al (2003) in 
their large, prospective European study. Further investigation into the growth of African 
children infected with HIV is needed. 
Clinical implications 
• All HIV infected children should have their height and weight monitored at regular 
intervals, even if they are asymptomatic. Nutritional support and dietary advice 
should be available to all HIV infected children as soon as their diagnosis is 
known. 
Research implications 
• The growth status of children infected with HIV in developing countries needs 
further investigation. Long term follow up studies with growth as the primary 
outcome measure need to be undertaken. 
• The best ways of providing scientifically sound nutritional support, in conjunction 
with appropriate medical management, to HIV infected children need to be 
investigated. 
• Growth deficits were very common in this group of children and require further 
follow-up and intervention. 
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6.7 Demographic Information 
The demographic information presented was collected using the form drawn up by the 
researcher as well as the Household Economic and Social Status Index (Barbarin and 
Khomo, 1997). The HESSI was not scored due to the fact that many of the caregivers 
were not able to provide all the information required, for example, educational level of 
child’s father and cost of electricity. It was therefore decided to extract the most relevant 
and complete sets of information for further analysis. 
 6.7.1 Age of children  
The two groups were very well matched at baseline in terms of all their demographic 
information. The average age of the children at baseline was 18.5 months. There were 
not that many very young infants in the study. This is a reflection of the time taken to 
diagnose children as being HIV positive. Many of these children are not being diagnosed 
soon after birth and are only diagnosed once a level of clinical suspicion has warranted 
further investigation. This is often only after the child has had at least one hopitalisation 
for pneumonia or gastroenteritis. The children who are slow progressors are often not 
diagnosed at a very young age as they are relatively well in infancy. The exceptions to 
this are the children born to mothers known to be HIV positive. These children are tested 
for HIV infection within the first few weeks after birth if their mothers are in agreement. 
This state of affairs explains why young infants are often not being seen at HIV clinics 
and also suggests that the results of this study may be somewhat biased as relatively 
healthy children may not be adequately represented in the sample. Young infants 
diagnosed with HIV in the Prevention of Mother to Child Transmission clinics or in the 
neonatal wards should be referred to their closest paediatric HIV clinic before they 
become symptomatic so that follow up and treatment can be initiated as soon as 
possible. 
6.7.2 Caregivers 
As has been previously mentioned, the majority of caregivers in this study were the 
biological mothers of the children (85.25%).  This high proportion of children being cared 
for by their own mothers is obviously the desired situation. However the children are still 
very young and many may lose their mothers in time to come. 
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The next biggest group of caregivers were grandmothers. Almost 10% of children in this 
study were being cared for by their grandmothers. The needs of grandmothers caring for 
their HIV infected grandchildren have been explored (Linsk and Mason, 2004; Schor et 
al, 2003; Joslin and Harrison,1998). However, very little has been done in the context of 
developing countries. A huge need exists for further investigation in this area. 
Grandmothers often expressed their fatigue especially when caring for active toddlers as 
well as their concern for what would become of their grandchildren should they die. 
 
 Only two children in this study were being cared for by their fathers. The role of fathers 
in child care in this group seemed insignificant with many of the mothers stating that the 
father was “not around” and not providing any emotional or financial support to her or 
the child. One cannot assume that if the mother dies the father will step forward to 
assume responsibility for his children. Jones et al (2005) identified lack of paternal 
support as one of the factors affecting lack of compliance with follow up of HIV infected 
children in their study conducted in Johannesburg, South Africa. 
 
Approximately 4% of children were being cared for by “others”. This included aunts, an 
uncle and a foster mother who subsequently adopted the child. The needs of this small 
group of caregivers should not be overlooked. Taking a child into one’s home is likely to 
bring many new concerns and stresses, especially if the child is infected with HIV 
(Brookes et al, 2004; Loening-Voysey, 2002). These families should be referred to a 
social worker or psychologist for counseling, support and monitoring.  
 
The mean age of the caregivers in this study was 30.7 years. The majority of the 
mothers were between the ages of 24 and 34 years. This is the age of young women 
most vulnerable to HIV infection (UNAIDS, 2005). A need exists for measures to help 
these young women protect themselves and their future children from infection. 
 
Only one quarter of caregivers had completed school and matriculated. The majority of 
caregivers had at least a grade nine level of education. While this would ensure basic 
numeracy and literacy, finding stable employment with less than a grade 12 level of 
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education is very difficult (Barbarin and Khomo, 1997). This means that many of these 
caregivers would be unemployed or be doing poorly paid menial work. Many caregivers 
reported that they sold sweets or vegetables on the side of the road to generate income 
for their families. 
  
The average household composition was 3.2 adults and 3.5 children. The mean monthly 
income was R1183 (±$170). The families in this study were therefore extremely poor 
with many similarities to the group studied by Barbarin and Khomo in Soweto in 1997. 
Reported income is not always accurate, some families may under-report their income in 
the hope that they will qualify for some form of financial aid while others may inflate their 
income out of embarrassment. Income may also be spent in very different ways in 
different households and therefore is not always indicative of material welfare or food 
security. Income should not be interpreted in isolation when determining family wellbeing 
(Barbarin and Richter, 2001).  
 
The impact of poverty on the lives of families affected by HIV cannot be underestimated. 
Jones et al (2005) identified poverty as a key factor influencing loss to follow up in a 
group of HIV infected mothers and their children attending a Prevention of Mother to 
Child Transmission clinic (PMTCT clinic) in Johannesburg, South Africa. Poverty was 
also identified as a key concern of caregivers of HIV positive individuals in South Africa 
by Orner (2006) and in Tanzania by Katapa (2004). 
 
While 42.6% of caregivers in this study lived in a brick house not shared with other 
families, 21.3% lived in shacks. The remaining families lived in shared brick homes or 
rented rooms. Those who lived in shacks shared outside toilet facilities with other 
families and did not have running water in the home. Very few shacks had an electricity 
supply. The increased burden of caring for a chronically ill child under such difficult 
circumstances is hard to imagine. In these situations it is easy to see why a 
developmental stimulation programme would not always be seen as a priority when 
basic shelter and food security are not being realized. Missed clinical appointments are 
also understandable in these circumstances where money for transport is not always 
available (Orner, 2006; Jones et al, 2005; Katapa, 2004). 
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Most caregivers included in this study had access to a refrigerator, a television and a 
cellular phone in the household (73.7%, 75.4% and 63.9%). Other household amenities 
were less commonly available. The fact that over 25% of caregivers of children infected 
with HIV did not have a refrigerator in their homes is of concern. Many medications, 
including some antiretrovirals require refrigeration. At Harriet Shezi clinic prior to 
prescribing HAART, doctors enquire about whether the family has access to a 
refrigerator, this determines which medications may be prescribed and in what form. 
Caregivers may be required to break open capsules which do not need to be 
refrigerated and mix the powder with water and then give it to the child. This is not ideal 
as the powder is bitter and unpalatable to the child. 
 
Only 5.7% of caregivers had access to a private car. The rest all relied on public 
transport to get to clinic appointments or to the hospital when the child is ill. This is an 
expensive, time consuming and unreliable form of transport and makes adherence with 
appointments difficult at times. Despite this and in contrast to the findings of Orner 
(2006) who identified lack of transport as one of the main reasons for missed clinical 
appointments in a group of HIV positive adults in Cape Town, South Africa, no 
caregivers in this study dropped out due to transport problems unless they were 
transferred to another clinic.   
Clinical implications. 
• More effort must be made to identify HIV infected children from a younger age 
and get them into clinics where they can receive comprehensive follow up from 
before they become symptomatic. This can be done through voluntary counseling 
and testing programmes which are already in operation. 
• Mothers should have access to counseling to plan for the care of their children 
after their own death. 
• Grandmothers need support in their parenting roles and ways of meeting their 
unique needs need to be investigated. 
• The diversity of families caring for children infected with HIV needs to be 
recognized and individual family centered programmes need to be applied. 
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• Poverty alleviation should be a national priority in South Africa and healthcare 
workers should advocate for programmes that can improve the wellbeing of the 
patients in their care.  
Research implications 
• Family structure and support mechanisms need to be explored. 
• The concept of resilience, not explored in this study, needs to be investigated in 
relation to families affected by HIV and caring for HIV infected children  
 
6.8 Challenges 
There are many challenges associated with conducting clinical research in a multi-
cultural, developing country such as South Africa. The challenges experienced during 
this study will be presented and their possible impact on the results will be discussed. 
6.8.1 Loss to Follow Up 
A large loss to follow up was anticipated in this study and a 20% dropout was built into 
the original sample size calculation. Loss to follow up was expected due to the nature of 
the disease and its high mortality rate, the fact that HAART was not yet available at the 
start of the study and that the anticipated rollout would influence which facilities would 
be used as referral centres. The fact that poverty is widespread and public transport is 
expensive and somewhat unreliable also influences people’s ability to adhere to clinic 
appointments. The multiple stresses that people experience in their daily lives mean that 
keeping appointments is not always possible or a priority. Thirty children were lost to 
follow-up in this study which equates to 24.6% of the initial sample size. The 
unexpectedly high loss to follow-up meant that the final power of the study was not as 
high  as anticipated. 
 
The main reasons for loss to follow up have been described in chapter five. Death of the 
child was the most common cause of loss to follow up (60%). The mean CD4 count of 
the children was very low at the beginning of the study placing the children at risk of 
death. Children were usually enrolled onto this study at their first or second visit to the 
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clinic. Getting on to HAART is a process which takes four to six weeks at Harriet Shezi 
clinic. Suitability of the child and the family has to be established and all the necessary 
pre-HAART counseling and education has to be completed. The children who died 
during the course of this study usually did so after their first or second visit to the clinic, 
usually before or soon after starting HAART. 
 
The next most common cause of loss to follow up was that the children were transferred 
to another hospital or clinic. As HAART became more widely available children were 
referred to the health care facility closest to their homes which was able to provide them 
with all the services and medication they required. This was done to reduce the pressure 
on the tertiary care facilities which initially saw the majority of children infected with HIV 
in their area. The caregivers of these children were not always willing or able to bring the 
children back to participate in this study. Many studies have identified the cost and 
inconvenience of finding transport to clinics as a major reason for loss to follow up in 
populations affected by HIV (Orner, 2006; Jones et al, 2005;  Katapa, 2004;  Hackl et al, 
1997). 
 
If the primary caregiver of the child died the child was either institutionalized or changed 
caregivers which sometimes meant moving out of the area. If the primary caregiver died 
the child was excluded from the study as the Parenting Stress Index had to be filled in 
by the same person every time and continuity in the home programme was required. 
 
Three children were institutionalized during the study, one due to poor socio-economic 
conditions at home and one because the mother was imprisoned. The third child went to 
live in a hospice facility with her dying mother as no one in the family could care for 
them. Institutionalisation of children is not common practice in South Africa and usually 
only occurs in cases of dire poverty or occasionally if no-one else in the family is willing 
to take the child (Richter et al, 2004). This was the case for the child whose mother was 
imprisoned as their family had rejected the mother and her child when they found out 
that they were HIV positive, they did however take in the two older uninfected siblings. 
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 6.8.2 Assessment tools 
Very few standardised assessment tools have been normed on South African 
populations. Researchers run the risk of drawing conclusions that are invalid if the 
assessment tool is not appropriate for use in a culture different from the one for which it 
was designed. The process to establish suitability of the assessment tools used in this 
study were described in chapter three. Some challenges were still faced despite the 
efforts of the researcher to eliminate these prior to commencing the study. Each of the 
assessment tools will be discussed. 
Bayley Scales of Infant Development 
As previously mentioned the BSID II has not been normed on South African children 
although the BSID I has been. Researchers should consider testing the BSID III which is 
now available on a large group of South African children to ensure its continued validity. 
 
The children all responded well to the test items and enjoyed participating in the 
activities. Many did not want to relinquish the test items when they went home, 
especially the car and the crayons. The doll was the only item which the children did not 
like and some coaxing was often required before they would interact with it. 
 
The researcher was not fluent in Zulu and  Southern Sotho and use had to be made of 
the mothers as interpreters. The instructions given to the children were therefore not 
always exactly the same. This is the procedure used by Richter and Griesel (1988) 
when they tested the BSID I on a large group of South African children and it did not 
appear to affect their results. In a country with eleven official languages it is often difficult 
to communicate with research subjects. The researcher and the research assistant did 
however have many years of experience working in paediatric units in government 
hospitals in South Africa. They were therefore well equipped to adapt to the situation. 
 
Many of the children in this study obtained index scores below 50. Extrapolated scores 
were therefore used for index scores of 30 to 49 and a score of 29 was assigned for all 
children with scores below 30. The measure of the extent of delay at the lower end of 
the scale is therefore not as reliable. 
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Parenting Stress Index/ Short form 
No problems over and above those identified in chapter three were experienced during 
administration of the parenting stress form. Caregivers took longer than anticipated to 
complete the form (up to 30 minutes), but appeared to understand and relate to the 
questions well. 
Household Economic and Social Status Index 
Unfortunately not all the caregivers were able to complete all the items on the 
questionnaire. This was particularly the case for young, unmarried women living with 
their parents. They often did not know the educational level of their child’s father, did not 
know how much rent was paid or how much electricity cost. Because of these gaps the 
HESSI was not scored as described by the authors and only the most relevant 
information was extracted from the questionnaire and analysed descriptively.  
6.8.3 Language and culture. 
Care was taken when giving the home programme to get as much input from the 
caregiver as possible in an attempt to understand and respect cultural differences in 
child rearing. The research assistant has many years of experience working with 
families of different cultures. Nurses and counselors at Harriet Shezi clinic were always 
willing to act as translators when this was required. 
6.8.4 Conclusion 
The children in this study had severe developmental delay which improved significantly 
after a home programme intervention. Although the children in the experimental group 
did improve, they remained delayed and require further follow-up and investigation.  
 
There are many factors which influence developmental status and parenting stress in 
HIV infected children in South Africa. Further research is needed to investigate the 
relative importance of these factors and to test intervention programmes. 
 
The conclusions drawn from this study will be presented in chapter seven. 
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Chapter 7 
CONCLUSIONS 
The main conclusions drawn from this study can now be summarised. 
 
• Children infected with HIV, living in South Africa are at great risk of having severe 
developmental delay. This delay affects both cognitive and motor development. 
 
• Children who received a basic home stimulation programme showed 
improvements in both cognitive and motor development when compared to 
children in the control group. This home programme is an easy and relatively cost 
effective intervention to administer. Although the children improved they remained 
delayed and require long-term follow up and management. 
 
• Children in the control group who started HAART showed an improvement in 
motor but not cognitive development after initiation of treatment. Improved muscle 
strength due to improved general health may be responsible for the improvement 
in motor development seen in these children. Irreversible brain damage may have 
already occurred thus limiting the potential for cognitive improvement after 
starting HAART. Additional support in the form of a developmental stimulation 
programme is recommended. Further studies are urgently required in this area. 
 
• A number of different factors were found to be predictive of developmental scores 
at each visit. The most important predictors of cognitive development include 
weight for age, the age of the child and whether they were on HAART. The 
important predictors of motor development were weight for age, the CD4% count 
and whether or not the child was on HAART. Being older at baseline assessment 
and in the experimental group were the most important factors predictive of 
improvement in cognitive and motor development over time.  
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• The children included in this study came from poor socioeconomic backgrounds. 
The majority of them were cared for by their biological mothers. The parenting 
stress levels of caregivers of these children were extremely high and was a cause 
of grave concern. Parenting stress decreased in both the control and 
experimental groups over the study period but remained clinically significant 
throughout. 
 
• A number of factors were found to be predictive of high parenting stress levels. 
The most important of these being the educational level of the caregiver, the type 
of housing and the number of children in the household. Higher educational level 
of the caregiver, the type of housing and the number of adults in the household 
were the factors that emerged as being the most important predictors of a 
decrease in parenting stress over time. 
 
• The psychosocial and developmental needs of young children infected with HIV 
in South Africa are not currently being met. Developmental assessment and a 
basic home stimulation programme should be available for all children infected 
with HIV. More attention needs to be paid to the concerns and stresses of 
caregivers of HIV positive children. A family centered approach to the 
assessment and management of children infected with HIV and their caregivers 
should be implemented at all paediatric HIV clinics in South Africa. 
 
 
 
“The true revelation of a society’s soul is the way in which it treats its children” 
Nelson Mandela 
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Appendix II 
Outline of home programme. 
A Longitudinal Study of Neurodevelopmental Delay in HIV Infected Children. 
198 
 
HOME PROGRAMME. 
 
Advice to the caregiver will be given in the following areas. Activities suggested must 
take into account the child’s age and developmental status. The main aim is to optimize 
the child’s functional potential and to encourage age appropriate behavior in normal 
movement patterns. 
 
Sleeping Positions 
Avoid supine 
Encourage alternate side lying. 
Prone for naps during the day. 
 
Dressing 
Encourage participation from the child 
Talk about the clothes as you put them on, including colour or describing pictures on the 
clothes. 
Encourage body awareness eg I am putting your shoe on your foot. 
Give the child an element of choice eg “Do you want to wear your red shirt or your blue 
shirt?” 
 
Feeding 
Encourage a symmetrical posture while eating. 
If the child is held during feeding it must be in an upright, well aligned position. 
If the child can sit independently they should sit at a table with their feet supported. 
Independent feeding should be encouraged. (Feeding utensils should be encouraged if 
culturally appropriate) 
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Bathing 
Use this time to encourage body awareness. Name body parts as you wash them. 
Encourage the child to do as much as possible for themselves. 
If the child baths in a tub play pouring games with different sized containers. 
 
Carrying 
Give alternatives to carrying the child on the caregivers back. 
Examples include:  
Against the chest, looking forward, one leg flexed 
Cradled, with both arms forward and shoulders protracted 
Prone over the caregivers arm 
If the child is very disabled and has a poor prognosis for independent walking a McLaran 
pushchair will be ordered for them. 
 
Play Activities 
Depending on the child’s functional level appropriate activities will be suggested. These 
will include games and activities that encourage fine and gross motor coordination. 
Interaction with other children will be encouraged. 
Games that include songs and rhymes will also be included. 
 
Speech and Language 
Verbal interaction with the child will be encouraged, picture books will be used to 
facilitate this. 
If appropriate, positions to optimize communication will be shown. 
If a child has significant feeding problems they will be referred to a speech therapist. 
 
Caregiver’s Concerns  
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Any additional aspects of the child’s development that the caregiver identifies as being 
problematic will be addressed. 
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Appendix III 
Informed consent letter. 
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INFORMATION SHEET 
Dear parent/caregiver 
Good morning and thank you for taking the time to read this information. My name is 
Joanne Potterton and I am a physiotherapist. I am busy doing some research to find out 
more about the development of children with HIV and the stress of the person caring for 
the child with HIV. If your child meets the criteria for the study then I would like to ask 
you whether you and your child would join my study. I am doing this study to try to find 
the best way to treat children who have got HIV and to see whether we can do anything 
to make your stress about caring for your child less. 
 
I will do an assessment of what your child can do every 6 months for one year. This will 
tell me how well your child is developing. I will also ask you to fill in a questionnaire to 
find out more about the stress you feel as a parent/caregiver. I will do this at your normal 
clinic visits. The assessment of your child will take about one hour and it will take you 
about 15 minutes to fill in the questionnaire. I will also look in your child’s file to get the 
results of their last blood tests. 
 
I will divide the children into 2 groups. Both groups will come to see me every 3 months. 
I will pay transport for the extra visits. Group one will have their height, weight and their 
heads measured. Group 2 will also have their height, weight and their heads measured, 
their parent/caregiver will also be given a programme to do with their child at home to 
stimulate them. I am doing this to try and find out the best way to care for children who 
have got HIV. 
 
Nothing that I do will hurt your child and all your information will be kept private. If you do 
not want to be part of this study you do not have to, and you will still get all the other 
services at the clinic. If you do join the study, you may change your mind and may take 
your child out of the study at any time, without any prejudice being held against you. 
 
If you agree for you and your child to be in this study please sign the form below. 
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Thank you for your help. 
 
Joanne Potterton. 
 
……………………………………………………………………………………………. 
 
 
 
 
 
 
I………………………....agree that I and my child……………………………….will join this 
study. I agree that Joanne Potterton may look at my child’s file to get their blood results. 
I understand that we may withdraw from the study at any time. 
 
Signed……………………. 
Date………………………. 
Researcher……………….. 
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Appendix IV 
Biographical questionnaire. 
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DEMOGRAPHIC QUESTIONNAIRE. 
 
 
Caregivers name:………………………………………………… 
Age:……………………………………………………………………………. 
Relationship to child:…………………………………………………………… 
Level of education:…………………………………………………………….. 
Number of people in household    Adults……………. Children……………… 
Ages of people in household…………………………………………………… 
Address…………………………………………………………………………… 
……………………………………………………………………………………. 
Telephone number……………………………………………………………….. 
Occupation………………………………………………………………………. 
Home language…………………………………………………………………..  
Approximate monthly income for household…………………………………….. 
Do you belong to a support group?………………………………………………. 
If Yes, how often do you meet?…………………………………………………… 
 
 
 
 
Child’s name………………………………………………………………………… 
Date of birth………………………………………………………………………… 
Random number……………………………………………………………………. 
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Appendix V 
Parenting Stress Index/Short form. 
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Appendix VI 
Household Economic and Social Status Index. 
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